Membership Directory

Row ID	Picture	Primary Column	First Name	Last Name	Program	Email	Department	Phone Number 1	Phone Number 2	Website	Title	Tags	Decision	Meeting Date	Status	Requested Program	Credentials/Degrees	eRA Commons ID	ORCID	Referral	Active Grants/Awards	Research Interest	Created	Ln Fn	Program Abb	Finalize	Mentor committee
2		abbott@surgery.wisc.edu	Daniel	Abbott	Cancer Prevention and Control	abbott@surgery.wisc.edu	Surgery	608-263-1387		http://www.surgery.wisc.edu/profile/daniel-abbott	Associate Professor (CHS)					Cancer Prevention and Control Developmental Therapeutics Genetic and Epigenetic Mechanism Imaging and Radiation Tumor Microenvironment	MD			Dr. Amy Fowler, Dr. Kristina Matkowskyj		I am a part of the Breast and Gynecologic and Cytopathology subspecialty team. As a part of that, I have worked with Dr. Amy Fowler whose research has been impactful in the breast cancer world. In collaboration, we have published several manuscripts and presented our research at national meetings. I have been a member of the Breast Cancer Research Advisory Network since 2014. I am also the Director of the Surgical Pathology division that comprises about 29 pathologists across subspecialties such as Breast and Gynecologic, GU/ENT, GI, etc. As a part of this role, I am involved in the internal review and approval of IRBs routed to my division to ensure that they receive appropriate division and laboratory resources. A large part of these are projects are cancer center related. Additionally, I am a part of my department’s Research Support Workgroup.		Mahajan, Aparna	unaligned	TRUE
3		abel@urology.wisc.edu	E. Jason	Abel	Developmental Therapeutics	abel@urology.wisc.edu	Urology	608-263-4563		http://www.urology.wisc.edu/profile/jason-abel	Associate Professor (CHS)					Cancer Prevention and Control Developmental Therapeutics	MD MS			Paul Weisman (colleague)	Pathology Department R&D Award 08/2021- current ($29,513) Title: Biomarkers associated with pilar differentiation in non-cutaneous carcinomas Role: Co-Investigator with Dr. Paul Weisman Pathology Department R&D Award 03/2021- current ($12,059) Title: Clinicopathological impact of basal-like phenotype on ER low breast cancers Role: Principle Investigator Pathology Department R&D Award 02/2020 - current ($8,668) Title: Stratification of low-grade cervical and vulvar lesions using HPV-related biomarkers Role: Co-Investigator with Dr. Megan Fitzpatrick Pathology Department R&D Award 02/2020 - current ($11,000) Title: TILs and PD-L1 in High Grade Serous Carcinoma Role: Co-Investigator with Dr. Stephanie McGregor	My research focuses primarily on cancers arising in women, including gynecological tract neoplasms and breast cancer. I aim to advance our understanding of the mechanisms of tumor progression and acquired resistance to therapy, in order to develop biomarkers that will help clinicians to tailor their treatment of patients with these diseases.	21/01/2008 07:32 PM	Xu, Jin	unaligned	TRUE
5		ahlquist@wisc.edu	Paul	Ahlquist	Human Cancer Virology	ahlquist@wisc.edu	Oncology	608-263-5916		https://mcardle.wisc.edu/who-we-are/mcardle-faculty/paul-g-ahlquist-phd	Professor					Genetic and Epigenetic Mechanism	PhD	jdkueck	0000-0001-9700-4785		R00CA234391-03 Characterization of the role of super-enhancers in ovarian cancer treatment response LANG, JESSICA (PI)	Epigenetic dysfunction is common in ovarian cancers, particularly somatic mutation to specific epigenetic modifier genes, such as members of the SWI/SNF complex. Our lab seeks to understand the consequent epigenetic landscapes in ovarian cancers with these mutations, how it is modified by current standard of care therapies, and identify therapeutics targeting this epigenetic dysfunction.	21/02/2009 04:41 PM	Lang, Jessica	DT
6		nahmad@wisc.edu	Nihal	Ahmad	Cancer Prevention and Control	nahmad@wisc.edu	Dermatology	608-263-5359		https://dermatology.wisc.edu/staff/ahmad-nihal/	Professor					Cancer Prevention and Control	PhD	PIASECKIT	0000-0002-2793-2049	Michael C. Fiore, M.D., M.P.H., M.B.A.	UW SMPH start-up package includes $25,000 grant from the UWCCC in the form of a grant for a pilot project that has a UWCCC co-PI who is not a member of the Center for Tobacco Research and Intervention National Institute of Alcohol Abuse and Alcoholism (AA025451) “Characterizing Low Alcohol Sensitivity in Laboratory and Real-World Contexts” (R01) Period: 3/1/18-2/28/23 Total Direct Costs: $1,602,144 (MPIs: Bartholow & Piasecki)	My research focuses on motivational processes in addictive behaviors, particularly tobacco and alcohol use. These behaviors are risk factors for multiple forms of cancer. I also study smoking cessation treatments, processes. and outcomes. I am interested in using genetically informative data to identify environmental and genetic risks for addictive behaviors, including tobacco-related phenotypes such as tobacco dependence, smoking heaviness, withdrawal symptom severity, and relapse to smoking.		Piasecki, Thomas M.	CPC	TRUE
7		aladra@wisc.edu	David	Al-Adra	Tumor Microenvironment	aladra@wisc.edu	Surgery	608-265-6471		https://www.surgery.wisc.edu/staff/david-p-al-adra-md-phd/	Assistant Professor					Cancer Prevention and Control	PhD	slutskew	0000-0003-4502-6936	Michael Fiore	none	I am interested in genetic and environmental factors that contribute to tobacco use, from initial initiation of use to cessation among those nicotine dependent.	21/02/2011 02:40 PM	Slutske, Wendy	CPC	TRUE
9		alagoz@engr.wisc.edu	Oguzhan	Alagoz	Cancer Prevention and Control	alagoz@engr.wisc.edu	Industrial Engineering	608-890-0399		http://www.engr.wisc.edu/ie/faculty/alagoz_oguzhan.html	Professor					Imaging and Radiation	MD PhD	10538424	0000-0003-1736-8218	Alejandro Roldan Alzate, Scott Reeder, Thomas Grist, Jason Abel	DoD grants pending, but no active funding	My research is focused on the development and application of artificial intelligence to abdominal imaging, specifically related to cancer of the genitourinary system. My budding projects target the imaging appearance of renal cell carcinoma and how this appearance correlates with the biological underpinnings of this disease process. I am collaborating across multiple departments and currently work with Drs. Jason Abel (Urology), Daniel Shapiro (Urology), and Hamid Emamekhoo (Hematology/Oncology), along with other members of my department (Radiology).		Wentland, Andrew	IR	TRUE
Membership-107		Alapan-TM	Yunus	Alapan	Tumor Microenvironment	alapan@wisc.edu	Mechanical Engineering	6082655673		https://biointegratedroboticslab.wiscweb.wisc.edu/	Assistant Professor		Core		Complete	Imaging and Radiation	MD MS	ANKUSH		I have e-mailed the directors of the imaging and radiation program		I am interested in novel imaging biomarkers to improve patient selection for targeted therapies in glioma. Additionally, I hope to bring several clinical trials both as a site PI but also investigator-initiated studies that are currently in development.	21/09/2012 05:16 PM	Bhatia, Ankush	IR	TRUE
11		mra@medicine.wisc.edu	Mark	Albertini	Developmental Therapeutics	mra@medicine.wisc.edu	Medicine	608-263-0117		https://www.medicine.wisc.edu/people-search/people/staff/5/ALBERTINI_MARK_R	Associate Professor													Abbott, Daniel
12		alexander@oncology.wisc.edu	Caroline	Alexander	Developmental Therapeutics	alexander@oncology.wisc.edu	Oncology	608-265-5182		https://mcardle.wisc.edu/who-we-are/mcardle-faculty/caroline-m-alexander-phd	Professor													Ahmad, Nihal
Membership-160		alisch@wisc.edu	Reid	Alisch	Genetic and Epigenetic Mechanisms	alisch@wisc.edu	Neurological Surgery	4042104394		http://www.neurosurgery.wisc.edu/research/alisch	Associate Professor
14		raanders@wisc.edu	Richard	Anderson	Developmental Therapeutics	raanders@wisc.edu	Administration	608-262-3753	608-262-4947	https://molpharm.wisc.edu/staff/anderson-phd-richard/	Professor													Alagoz, Oguzhan
15		rmanderson@medicine.wisc.edu	Rozalyn	Anderson	Tumor Microenvironment	rmanderson@medicine.wisc.edu	Administration	608-262-3753	608-262-4947	http://www.medicine.wisc.edu/geriatrics/andersonlabmain	Associate Professor													Barroilhet, Lisa
16		lmarendt@wisc.edu	Lisa	Arendt	Tumor Microenvironment	lmarendt@wisc.edu	Comparative Biosciences	608-890-2265		https://www.cmp.wisc.edu/profile/lisa-arendt	Assistant Professor													Berian, Julia
Membership-81		Arkin-CPC	Lisa	Arkin	Cancer Prevention and Control	larkin@dermatology.wisc.edu	Dermatology	6462281179		https://dermatology.wisc.edu/staff/arkin-lisa/	Associate Professor of Dermatology and Pediatrics		Affiliate	23/12/2005	Complete									Bradfield, Christopher
17		sa@medicine.wisc.edu	Sanjay	Asthana	Unaligned	sa@medicine.wisc.edu	Medicine	608-265-5862		http://aging.wisc.edu/research/affil.php?Ident=3	Professor; Associate Dean													Burnside, Elizabeth
18		adattie@wisc.edu	Alan	Attie	Genetic and Epigenetic Mechanisms	adattie@wisc.edu	Biomolecular Chemistry	608-262-1372	608-262-4705	https://biochem.wisc.edu/labs/attie	Professor													Cadmus-Bertram, Lisa
19		audhya@wisc.edu	Anjon	Audhya	Developmental Therapeutics	audhya@wisc.edu	Biomolecular Chemistry	608-262-3761		https://stemcells.wisc.edu/staff/audhya-anjon/	Associate Professor													Campbell, Toby
Membership55		Ayuso Dominguez-TM	Jose Maria	Ayuso Dominguez	Tumor Microenvironment	ayusodomingu@wisc.edu	Dermatology	6084242754		Note: The Dermatology department is still preparing the website for my lab.	Assistant Professor		Core		Complete									Chewning, Betty
Membership-122		Bailey-VR	Adam	Bailey	Human Cancer Virology	albailey@wisc.edu	Pathology & Laboratory Medicine	5855057928		bailey.pathology.wisc.edu	Assistant Professor		Core		Complete									Cook, Jessica
21		Mei.Baker@wisc.edu	Mei	Baker	Genetic and Epigenetic Mechanisms	mei.baker@wisc.edu	Pediatrics	608-890-1796		https://www.waisman.wisc.edu/staff/baker-mei/	Professor (CHS)													Costanzo, Erin
Membership54		Balentine-CPC	Courtney	Balentine	Cancer Prevention and Control	balentine@surgery.wisc.edu	Endocrine Surgery	8327217272			Associate Professor		Affiliate	22/11/2011	Complete									Dubenske, Lori
23		barroilhet@wisc.edu	Lisa	Barroilhet	Cancer Prevention and Control	barroilhet@wisc.edu	Obstetrics and Gynecology	608-265-2319		http://www.uwhealth.org/findadoctor/profile/lisa-m-barroilhet-md/9251	Associate Professor (CHS)													Francis, David
24		baschnagel@humonc.wisc.edu	Andrew	Baschnagel	Imaging and Radiation Sciences	baschnagel@humonc.wisc.edu	Human Oncology	608-262-9169		https://www.humonc.wisc.edu/index.php/Andrew_Baschnagel	Assistant Professor (CHS)													Gangnon, Ronald
25		bassetti@humonc.wisc.edu	Michael	Bassetti	Imaging and Radiation Sciences	bassetti@humonc.wisc.edu	Human Oncology	608-263-8500		https://www.humonc.wisc.edu/index.php/Michael_Bassetti	Assistant Professor (CHS)													Gilson, Aaron
Membership-101		Beck-GEM	Anna	Beck	Genetic and Epigenetic Mechanisms	beckan@surgery.wisc.edu	Surgery	2630736		https://www.surgery.wisc.edu/staff/anna-beck/	Assistant Professor, Division of Surgical Oncology, Department of Surgery		Affiliate	24/10/2005	Complete									Gustafson, David
27		bbednarz2@wisc.edu	Bryan	Bednarz	Imaging and Radiation Sciences	bbednarz2@wisc.edu	Medical Physics	608-262-5225		https://directory.engr.wisc.edu/ep/Faculty/Bednarz_Bryan/	Associate Professor													Hohl, Sarah
28		djbeebe@wisc.edu	David	Beebe	Tumor Microenvironment	djbeebe@wisc.edu	Pathology and Laboratory Medicine	608-262-2260	608-263-4660	http://www.engr.wisc.edu/bme/faculty/beebe_david.html	Professor													Hu, Rong
29		berian@wisc.edu	Julia	Berian	Cancer Prevention and Control	berian@wisc.edu	Surgery	608-263-4224		https://www.surgery.wisc.edu/staff/julia-berian/	Assistant Professor (CHS)													Huang, Wei
Membership-120		Bhargava-IR	Aarushi	Bhargava	Imaging and Radiation Sciences	aarushi.bhargava@wisc.edu	Biomedical Engineering	6089492250		https://sites.google.com/view/sonimate/home	Assistant Professor		Affiliate		Complete									Johnson, Adrienne
Membership48		Bhatia-IR	Ankush	Bhatia	Imaging and Radiation Sciences	ankushbhatia1@gmail.com	Medicine - Hematology, Medical Oncology and Palliative Care			https://www.neurology.wisc.edu/faculty-and-staff/profiles/ankush-bhatia-md	Assistant Professor (CHS Track)		Affiliate	22/11/2002	Complete									Kaiksow, Farah
Membership56		Birbrair-TM	Alexander	Birbrair	Tumor Microenvironment	abirbrair@dermatology.wisc.edu	Dermatology	6086980034		https://dermatology.wisc.edu/staff/birbrair-alexander/	Assistant Professor		Affiliate		Complete									Kaye, Jesse
30		blackwell@chem.wisc.edu	Helen	Blackwell	Developmental Therapeutics	blackwell@chem.wisc.edu	Chemistry	608-262-1503		http://www.chem.wisc.edu/users/blackwel	Professor													Kwekkeboom, Kristine
Membership-104		Blanc-GEM	Romeo	Blanc	Genetic and Epigenetic Mechanisms	rblanc@wisc.edu	Cell and Regenerative Biology	6088902915		https://crb.wisc.edu/staff/blanc-romeo/	Assistant Professor		Affiliate		Complete									Lautner, Meeghan Ann
Membership59		Blitzer-unaligned	Grace	Blitzer	Imaging and Radiation Sciences	gblitzer@humonc.wisc.edu	Human Oncology	6082638500		https://www.humonc.wisc.edu/team_member/blitzer-grace/#biography	Assistant Professor		Affiliate		Complete									Lawson, Elise
31		wfblock@wisc.edu	Walter	Block	Imaging and Radiation Sciences	wfblock@wisc.edu	Biomedical Engineering	608-265-9686		https://directory.engr.wisc.edu/bme/Faculty/Block_Walter/	Professor													Lee-Miller, Cathy
Membership-82		Bolling-CPC	Bradley	Bolling	Cancer Prevention and Control	bwbolling@wisc.edu	Food Science	6088900212		https://bolling.foodsci.wisc.edu/	Associate Professor		Affiliate	23/12/2005	Complete									Litzelman, Kristin
Membership-123		Boros-IR	Eszter	Boros	Imaging and Radiation Sciences	eboros@wisc.edu	Chemistry, Medical Physics	6082624941		https://chem.wisc.edu/staff/boros-eszter/	Hall-Fisher Associate Professor, Department of Chemistry		Core		Complete									LoConte, Noelle
33		clbrace@wisc.edu	Chris	Brace	Imaging and Radiation Sciences	clbrace@wisc.edu	Radiology	608-262-4151		https://directory.engr.wisc.edu/display.php/faculty/brace_chris?page=bme&search=faculty&item=brace_chris	Associate Professor													Martin Rother, Maria Daniela
34		bradfield@oncology.wisc.edu	Christopher	Bradfield	Cancer Prevention and Control	bradfield@oncology.wisc.edu	Oncology	608-262-2024	608-262-1209	https://mcardle.wisc.edu/who-we-are/mcardle-faculty/christopher-bradfield-phd	Professor													McCarthy, Danielle
35		kabradley@humonc.wisc.edu	Kristin	Bradley	Imaging and Radiation Sciences	kabradley@humonc.wisc.edu	Human Oncology	608-263-8500		https://www.humonc.wisc.edu/index.php/Kristin_Bradley	Associate Professor (CHS)													Minter, Rebecca
Membership-93		Brand-GEM	Marjorie	Brand	Genetic and Epigenetic Mechanisms	mbrand3@wisc.edu	Cell and Regenerative Biology	6082624676		http://www.marjoriebrandlab.com/ https://wibloodcancer.wisc.edu/marjorie-brand/	Professor		Core		Complete									Montgomery, Kathleen
36		abrasier@wisc.edu	Allan	Brasier	Genetic and Epigenetic Mechanisms	abrasier@wisc.edu	Institute for Clinical and Translational Research	608-263-7371		https://ictr.wisc.edu/staff/brasier-allan/	Director													Mundt, Marlon
37		ehbresni@wisc.edu	Emery	Bresnick	Genetic and Epigenetic Mechanisms	ehbresni@wisc.edu	Cell and Regenerative Biology	608-265-6446		https://crb.wisc.edu/staff/bresnick-emery/	Professor													Narayan, Anand
Membership-102		Brockman-TM	Joshua	Brockman	Tumor Microenvironment	jmbrockman2@wisc.edu	Biomedical Engineering	6088902616		https://directory.engr.wisc.edu/bme/Faculty/Brockman_Joshua/	Assistant Professor		Core		Pending									Neuman, Heather
Membership-100		Brown-DT	Matthew	Brown	Developmental Therapeutics	brownm@surgery.wisc.edu	Surgery	6082631727		https://www.surgery.wisc.edu/research/researchers-labs/brown/	Assistant Professor		Affiliate	24/12/2004	Complete									Patel, Monica
38		jybruce@medicine.wisc.edu	Justine	Bruce	Developmental Therapeutics	jybruce@medicine.wisc.edu	Medicine	608-262-4961	608-263-8600	https://www.uwhealth.org/findadoctor/profile/justine-y-bruce-md/8272	Assistant Professor (CHS)													Piper, Megan
39		tim.bugni@wisc.edu	Tim	Bugni	Developmental Therapeutics	tim.bugni@wisc.edu	Pathobiological Sciences	608-263-2519		https://pharmacy.wisc.edu/bugni-lab/	Professor													Pophali, Priyanka
43		eburnside@uwhealth.org	Elizabeth	Burnside	Cancer Prevention and Control	eburnside@uwhealth.org	Radiology	608-265-4099	608-262-2939	https://www.radiology.wisc.edu/profile/elizabeth-burnside-8/	Professor													Richards, Kyle
44		cadmusbertra@wisc.edu	Lisa	Cadmus-Bertram	Cancer Prevention and Control	cadmusbertra@wisc.edu	Kinesiology	608-265-5946		https://kinesiology.education.wisc.edu/staff/cadmus-bertram-lisa/	Assistant Professor													Sanger, Cristina
45		wcai@uwhealth.org	Weibo	Cai	Imaging and Radiation Sciences	wcai@uwhealth.org	Radiology	608-262-1749		http://mi.wisc.edu/bio.htm	Professor													Schneider, David
46		nsc@medicine.wisc.edu	Natalie	Callander	Developmental Therapeutics	nsc@medicine.wisc.edu	Medicine	608-265-8690		http://www.uwhealth.org/findadoctor/profile/natalie-s-callander-md/5646	Professor (CHS)													Shaw, Bret
47		pcampagnola@wisc.edu	Paul	Campagnola	Tumor Microenvironment	pcampagnola@wisc.edu	Biomedical Engineering	608-890-3575		https://directory.engr.wisc.edu/bme/faculty/campagnola_paul	Professor													Spencer, Ryan
48		tcc@medicine.wisc.edu	Toby	Campbell	Cancer Prevention and Control	tcc@medicine.wisc.edu	Medicine	608-263-3962		http://www.uwhealth.org/findadoctor/profile/toby-c-campbell-md/8053	Associate Professor (CHS); Clinical Associate Professor													Trentham-Dietz, Amy
49		jrcantor2@wisc.edu	Jason	Cantor	Developmental Therapeutics	jrcantor2@wisc.edu	Biomolecular Chemistry	608-316-4565		https://biochem.wisc.edu/faculty/cantor	Assistant Professor													Wallace, Sumer
50		ccapitini@pediatrics.wisc.edu	Christian	Capitini	Developmental Therapeutics	ccapitini@pediatrics.wisc.edu	Pediatrics	608-262-2415		https://www.pediatrics.wisc.edu/research/research-groups/capitini	Associate Professor													Ward, Earlise
51		carchman@wisc.edu	Evie	Carchman	Human Cancer Virology	carchman@wisc.edu	Surgery	608-263-2521		http://www.surgery.wisc.edu/profile/evie-carchman	Assistant Professor													Warren Andersen, Shaneda
53		hchang@dermatology.wisc.edu	Hao	Chang	Genetic and Epigenetic Mechanisms	hchang@dermatology.wisc.edu	Dermatology	608-263-4195		https://dermatology.wisc.edu/staff/chang-hao/	Assistant Professor													Wegner, Mark
55		chappell@stat.wisc.edu	Richard	Chappell	Imaging and Radiation Sciences	chappell@stat.wisc.edu	Statistics	608-263-5572	608-262-2733	https://www.biostat.wisc.edu/content/chappell-richard-j	Professor													Weiss, Jennifer
56		gchen7@wisc.edu	Guang-Hong	Chen	Imaging and Radiation Sciences	gchen7@wisc.edu	Medical Physics	608-263-0089		https://www.radiology.wisc.edu/profile/guang-hong-chen-291/	Professor													Zafar, Syed Nabeel
Membership-119		Chen-CPC	Guanhua	Chen	Cancer Prevention and Control	gchen25@wisc.edu	Biostatistics and Medical Informatics	6082620765		https://sites.google.com/view/gchenwisc/ https://biostat.wiscweb.wisc.edu/staff/chen-guanhua/	Associate Professor		Core		Complete									Zhong, Weixiong
57		bachewning@pharmacy.wisc.edu	Betty	Chewning	Cancer Prevention and Control	bachewning@pharmacy.wisc.edu	Pharmacy	608-263-4878	608-263-9664	https://apps.pharmacy.wisc.edu/sopdir/betty_chewning/	Professor													Abel, E. Jason
59		jchurpek@wisc.edu	Jane	Churpek	Genetic and Epigenetic Mechanisms	jchurpek@wisc.edu	Oncology			https://www.medicine.wisc.edu/people-search/people/staff/6752/Churpek_Jane	Assistant Professor													Albertini, Mark
60		lara.collier@wisc.edu	Lara	Collier	Genetic and Epigenetic Mechanisms	lara.collier@wisc.edu	Pharmacy	608-890-2149		https://apps.pharmacy.wisc.edu/sopdir/lara_collier/	Associate Professor													Alexander, Caroline
62		connor@surgery.wisc.edu	Nadine	Connor	Imaging and Radiation Sciences	connor@surgery.wisc.edu	Communication Sciences and Disorders	608-265-8711		http://www.surgery.wisc.edu/profile/nadine-connor	Associate Vice Chancellor; Professor													Anderson, Richard
63		jwcook@ctri.medicine.wisc.edu	Jessica	Cook	Cancer Prevention and Control	jwcook@ctri.medicine.wisc.edu	Medicine	608-265-9775	608-262-8673	https://www.medicine.wisc.edu/people-search/people/staff/742/Cook_Jessica	Associate Professor													Audhya, Anjon
64		jcoon@chem.wisc.edu	Joshua	Coon	Genetic and Epigenetic Mechanisms	jcoon@chem.wisc.edu	Biomolecular Chemistry	608-263-1718		http://coonlabs.com/about/team/josh-coon/	Professor													Blackwell, Helen
65		cosper@wisc.edu	Pippa	Cosper	Imaging and Radiation Sciences	cosper@wisc.edu	Human Oncology			https://www.humonc.wisc.edu/team_member/pippa-cosper-md-phd/	Instructor (CHS)													Bruce, Justine
66		ecostanzo@wisc.edu	Erin	Costanzo	Cancer Prevention and Control	ecostanzo@wisc.edu	Psychiatry	608-262-7515		http://www.uwhealth.org/findadoctor/profile/erin-s-costanzo-phd/8400	Associate Professor (CHS)													Bugni, Tim
Membership-152		Crabtree-DT	Gordon	Crabtree	Developmental Therapeutics	gcrabtree@wisc.edu	Ophthalmology and Visual Sciences	6082622515		https://www.ophth.wisc.edu/blog/staff/crabtree-gordon/			Affiliate		Complete									Callander, Natalie
68		craven@biostat.wisc.edu	Mark	Craven	Genetic and Epigenetic Mechanisms	craven@biostat.wisc.edu	Biostatistics and Medical Informatics	608-265-6181		https://www.biostat.wisc.edu/~craven/	Professor													Cantor, Jason
69		vlcryns@medicine.wisc.edu	Vincent	Cryns	Developmental Therapeutics	vlcryns@medicine.wisc.edu	Medicine	608-262-4786		https://www.medicine.wisc.edu/people-search/people/staff/1098/Cryns_Vincent	Professor													Capitini, Christian
Membership-116		Culberson-IR	Wesley	Culberson	Imaging and Radiation Sciences	wsculberson@wisc.edu	Medical Physics	6082625084		https://medphysics.wisc.edu/blog/staff/culberson-wesley/	Associate Professor (CHS)		Core		Complete									Cryns, Vincent
Membership-143		Czerlanis-DT	Cheryl	Czerlanis	Developmental Therapeutics	cczerlanis@medicine.wisc.edu	Department of Medicine, Division of Hematology, Medical Oncology, and Palliative Care	6082654178			Professor of Medicine (CHS)		Core		Complete									Dai, Jun
71		jdai32@wisc.edu	Jun	Dai	Developmental Therapeutics	jdai32@wisc.edu	Pharmacy	608-262-3196		https://apps.pharmacy.wisc.edu/sopdir/jun_dai/	Assistant Professor													Deming, Dustin
Membership-108		Davis-TM	Ruth	Davis	Tumor Microenvironment	rjdavis3@wisc.edu	Surgery	6083341893		https://www.surgery.wisc.edu/staff/ruth-davis/	Assistant Professor		Core		Pending									Eastman, Michael
74		ddeming@medicine.wisc.edu	Dustin	Deming	Developmental Therapeutics	ddeming@medicine.wisc.edu	Medicine	608-265-1042		http://www.medicine.wisc.edu/people-search/people/staff/506/Deming_Dustin/	Associate Professor													Eickhoff, Jens
75		dempsey@neurosurg.wisc.edu	Robert	Dempsey	Tumor Microenvironment	dempsey@neurosurg.wisc.edu	Neurological Surgery	608-265-5967	608-263-9585	http://www.neurosurgery.wisc.edu/people/faculty/dempsey	Department Chairperson; Professor													Erbe-Gurel, Amy
76		jmdenu@wisc.edu	John	Denu	Genetic and Epigenetic Mechanisms	jmdenu@wisc.edu	Biomolecular Chemistry	608-316-4341		https://bmolchem.wisc.edu/staff/denu-john/	Professor													Gellman, Samuel
Membership-158		rdenu@wisc.edu	Ryan	Denu	Genetic and Epigenetic Mechanisms	rdenu@wisc.edu	Medicine - Hematology, Medical Oncology and Palliative Care	4144122948			Assistant Professor
78		ladewerd@wisc.edu	Larry	DeWerd	Imaging and Radiation Sciences	ladewerd@wisc.edu	Medical Physics	608-262-6320		https://www.medphysics.wisc.edu/blog/staff/dewerd-larry-a/	Professor													Golden, Jennifer
79		cdewey@biostat.wisc.edu	Colin	Dewey	Genetic and Epigenetic Mechanisms	cdewey@biostat.wisc.edu	Biostatistics and Medical Informatics	608-263-7610		http://www.biostat.wisc.edu/%7Ecdewey/	Professor													Gong, Shaoqin
80		dey@neurosurgery.wisc.edu	Mahua	Dey	Tumor Microenvironment	dey@neurosurgery.wisc.edu	Neurological Surgery			https://www.neurosurgery.wisc.edu/staff/dey-mahua/	Assistant Professor													Hall, Aric
Membership-77		Dilworth-GEM	F Jeffrey	Dilworth	Genetic and Epigenetic Mechanisms	fdilworth@wisc.edu	Cell and Regenerative Biology	6082653758		https://cmb.wisc.edu/staff/dilworth-jeffrey/	Professor		Affiliate	23/12/2005	Complete									Hartenbach, Ellen
81		huy.dinh@wisc.edu	Huy	Dinh	Genetic and Epigenetic Mechanisms	huy.dinh@wisc.edu	Oncology			https://mcardle.wisc.edu/faculty-draft-jenny/huy-dinh/	Assistant Professor													Hegeman, Robert
Membership-139		Dittus-CPC	Kim	Dittus	Cancer Prevention and Control	kdittus@medicine.wisc.edu	Department of Medicine, Division of Hematology, Medical Oncology, and Palliative Care	8028258862		https://www.uwhealth.org/providers/kim-dittus-md	Professor		Affiliate		Complete									Hong, Seungpyo
Membership52		Drolet-DT	Beth	Drolet	Developmental Therapeutics	bdrolet@dermatology.wisc.edu	Dermatology	(141) 475-0714		https://dermatology.wisc.edu/2022/03/07/faculty-highlight-beth-a-drolet-md/			Core		Complete									Jiang, Jiaoyang
83		dubenske@wisc.edu	Lori	Dubenske	Cancer Prevention and Control	dubenske@wisc.edu	Psychiatry	608-265-5926		http://www.uwhealth.org/findadoctor/profile/lori-l-dubenske-phd/8398	Senior Psychologist													Keck, James
85		eastman@wisc.edu	Michael	Eastman	Developmental Therapeutics	eastman@wisc.edu	Medicine	920-699-3500		http://www.uwhealth.org/findadoctor/profile/michael-e-eastman-md/5915	Clinical Assistant Professor													Kenkre, Vaishalee
86		eickhoff@biostat.wisc.edu	Jens	Eickhoff	Cancer Prevention and Control, Developmental Therapeutics	eickhoff@biostat.wisc.edu	Biostatistics and Medical Informatics	608-265-5376		https://www.biostat.wisc.edu/content/eickhoff-jens	Senior Scientist													Klein, Bruce
87		eliceiri@wisc.edu	Kevin	Eliceiri	Tumor Microenvironment	eliceiri@wisc.edu	Molecular Biology	608-263-6288	608-263-8481	http://www.engr.wisc.edu/bme/faculty/eliceiri_kevin.html	Associate Professor													Knoll, Laura
Membership-133		Ellis-CPC	Shellie	Ellis	Cancer Prevention and Control	sellis8@wisc.edu	Oncology	6082621433		https://www.medicine.wisc.edu/directory/ellis_shellie	Visiting Professor		Core		Complete									Kratz, Jeremy
88		paellison@wisc.edu	Paul	Ellison	Imaging and Radiation Sciences	paellison@wisc.edu	Medical Physics	608-262-4396		https://www.medphysics.wisc.edu/blog/staff/ellison-paul/	Assistant Professor													Kushner, David
90		cengelman@wisc.edu	Corinne	Engelman	Genetic and Epigenetic Mechanisms	cengelman@wisc.edu	Population Health Sciences	608-265-5491		http://www.pophealth.wisc.edu/faculty/engelman	Associate Professor													Kyriakopoulos, Christos
91		fengin@wisc.edu	Feyza	Engin	Tumor Microenvironment	fengin@wisc.edu	Biomolecular Chemistry	608-262-8667		https://www.cmp.wisc.edu/node/227	Assistant Professor													Lamming, Dudley
92		jwengle@wisc.edu	Jonathan	Engle	Imaging and Radiation Sciences	jwengle@wisc.edu	Medical Physics	608-263-5805		https://cyclotron.wisc.edu/staff/engle-jonathan-w/	Assistant Professor													LeBeau, Aaron
93		aerbe@wisc.edu	Amy	Erbe-Gurel	Developmental Therapeutics	aerbe@wisc.edu	Human Oncology	608-263-6537		https://www.pediatrics.wisc.edu/staff/erbe-gurel-amy/	Senior Scientist													Liu, Glenn
94		dtevans2@wisc.edu	David	Evans	Human Cancer Virology	dtevans2@wisc.edu	Pathology and Laboratory Medicine			https://www.cmp.wisc.edu/trainers/david-evans	Professor													Lubner, Sam
95		jfan@morgridge.org	Jing	Fan	Tumor Microenvironment	jfan@morgridge.org	Nutritional Sciences			https://nutrisci.wisc.edu/jing-fan/	Assistant Professor													Mattison, Ryan
96		jsferguson@medicine.wisc.edu	John	Ferguson	Imaging and Radiation Sciences	jsferguson@medicine.wisc.edu	Medicine	608-263-5152		http://www.uwhealth.org/findadoctor/profile/j-scott-ferguson-md/8339	Professor (CHS)													McClean, Megan
Membership51		Fletcher-DT	Christopher	Fletcher	Developmental Therapeutics	cdfletcher@medicine.wisc.edu	Medicine - Hematology, Medical Oncology and Palliative Care			https://www.medicine.wisc.edu/people-search/people/staff/1041/Fletcher_Christopher	Assistant Professor (CHS)		Core		Complete									McNeel, Douglas
99		jfloberg@humonc.wisc.edu	John	Floberg	Imaging and Radiation Sciences	jfloberg@humonc.wisc.edu	Human Oncology	608-263-8500		https://www.uwhealth.org/findadoctor/profile/john-m-floberg-md/11207	Assistant Professor													Merrins, Matt
101		afowler@wisc.edu	Amy	Fowler	Imaging and Radiation Sciences	afowler@wisc.edu	Radiology	608-263-8340		https://www.radiology.wisc.edu/profile/amy-fowler-1075/	Assistant Professor													Miyamoto, Shigeki
102		dofrancis@wisc.edu	David	Francis	Cancer Prevention and Control	dofrancis@wisc.edu	Surgery	608-262-8693		https://www.surgery.wisc.edu/staff/david-francis/	Associate Professor													Nadiminti, Kalyan
103		cfranck@wisc.edu	Christrian	Franck	Tumor Microenvironment	cfranck@wisc.edu	Mechanical Engineering Radiology	608-265-8481		https://directory.engr.wisc.edu/me/Faculty/Franck_Christian/	Associate Professor													Patankar, Manish
105		ting.fu@wisc.edu	Ting	Fu	Genetic and Epigenetic Mechanisms	ting.fu@wisc.edu	Pathobiological Sciences	608-890-3508		https://apps.pharmacy.wisc.edu/sopdir/ting_fu/index.php	Assistant Professor													Pipp-Dahm, Michele
Membership-80		Gaglia-VR	Marta	Gaglia	Human Cancer Virology	Marta.Gaglia@wisc.edu	Medical Microbiology and Immunology	6082635551		gaglialab.mmi.wisc.edu	Associate Professor		Core	23/12/2005	Complete									Rajguru, Saurabh
106		jgalipeau@wisc.edu	Jacques	Galipeau	Developmental Therapeutics	jgalipeau@wisc.edu	Medicine	608-265-1700		http://www.uwhealth.org/findadoctor/profile/jacques-galipeau-md/10404	Professor													Ranheim, Erik
107		agalmozzi@medicine.wisc.edu	Andrea	Galmozzi	Tumor Microenvironment	agalmozzi@medicine.wisc.edu	Medicine	608-263-6840		https://www.medicine.wisc.edu/people-search/people/staff/7334	Assistant Professor													Romero, Philip
108		ronald@biostat.wisc.edu	Ronald	Gangnon	Cancer Prevention and Control	ronald@biostat.wisc.edu	Population Health Sciences	608-265-0688		https://pophealth.wisc.edu/ronald-gangnon	Professor													Rose, Stephen
Membership-89		Gao-TM	Xin	Gao	Tumor Microenvironment	xgao37@wisc.edu	Pathology and Laboratory Medicine	6086988538		https://xingaolab.org This is my lab website and my UW website will come out soon.	Assistant Professor		Core		Complete									Rui, Lixin
109		agasch@wisc.edu	Audrey	Gasch	Genetic and Epigenetic Mechanisms	agasch@wisc.edu	Genetics	608-265-0859		https://gasch.genetics.wisc.edu/	Professor; Director													Sauer, John-Demian
110		ge2@wisc.edu	Ying	Ge	Tumor Microenvironment	ge2@wisc.edu	Cell and Regenerative Biology	608-265-4744	608-263-9212	https://www.cmp.wisc.edu/trainers/ying-ge	Associate Professor													Schmidt, Timothy
111		gellman@chem.wisc.edu	Samuel	Gellman	Developmental Therapeutics	gellman@chem.wisc.edu	Chemistry	608-262-3303		https://gellman.chem.wisc.edu/	Professor													Setaluri, Vijay
112		amgilson@uwcarbone.wisc.edu	Aaron	Gilson	Cancer Prevention and Control	amgilson@uwcarbone.wisc.edu	Carbone Cancer Center	608-263-8448	608-263-7662	http://www.emergingsolutionsinpain.com/about-us/contributing-faculty/53-aaron-gilson	Senior Scientist													Shusta, Eric
113		gitter@biostat.wisc.edu	Anthony	Gitter	Genetic and Epigenetic Mechanisms	gitter@biostat.wisc.edu	Biostatistics and Medical Informatics	608-316-4442		https://www.biostat.wisc.edu/content/gitter-anthony	Assistant Professor													Sippel, Rebecca
114		glidehurst@humonc.wisc.edu	Carri	Glide-hurst	Imaging and Radiation Sciences	glidehurst@humonc.wisc.edu	Human Oncology			https://www.humonc.wisc.edu/team_member/carri-glide-hurst-phd/	Associate Professor													Slukvin, Igor
115		jennifer.golden@wisc.edu	Jennifer	Golden	Developmental Therapeutics	jennifer.golden@wisc.edu	Pharmacy	608-263-7287		https://apps.pharmacy.wisc.edu/sopdir/jennifer_golden/	Assistant Professor													Sondel, Paul
116		shaoqingong@wisc.edu	Shaoqin	Gong	Developmental Therapeutics	shaoqingong@wisc.edu	Ophthalmology and Visual Sciences	608-316-4311		https://www.ophth.wisc.edu/blog/staff/gong-shaoqin-sarah/	Professor													Svaren, John
119		aegriep@facstaff.wisc.edu	Anne	Griep	Genetic and Epigenetic Mechanisms	aegriep@facstaff.wisc.edu	Cell and Regenerative Biology	608-262-8988	608-263-6323	https://crb.wisc.edu/staff/griep-anne/	Professor													Swanson, Steven
120		tgrist@uwhealth.org	Thomas	Grist	Imaging and Radiation Sciences	tgrist@uwhealth.org	Radiology	608-265-8231		https://www.uwhealth.org/findadoctor/profile/thomas-m-grist-md/6165	Department Chairperson; Professor													Tang, Weiping
121		jegumperz@wisc.edu	Jenny	Gumperz	Human Cancer Virology	jegumperz@wisc.edu	Medical Microbiology and Immunology	608-263-6902		https://www.cmp.wisc.edu/trainers/jenny-gumperz	Professor													Thibeault, Susan
122		dgustafson@wisc.edu	David	Gustafson	Cancer Prevention and Control	dgustafson@wisc.edu	Industrial Engineering	608-263-4882	608-262-3768	http://www.engr.wisc.edu/ie/faculty/gustafson_david.html	Emeritus													Uboha, Nataliya
125		achall@medicine.wisc.edu	Aric	Hall	Developmental Therapeutics	achall@medicine.wisc.edu	Medicine	608-265-9459	608-262-2170	https://www.uwhealth.org/findadoctor/profile/aric-c-hall-md/9914	Assistant Professor (CHS)													Vezina, Chad
Membership-125		Hannan-IR	Johanna	Hannan	Imaging and Radiation Sciences	hannan@urology.wisc.edu	Urology	6082659822		https://urology.wisc.edu/blog/staff/hannan-phd-johanna/	Visiting Associate Professor		Core		Complete									Weaver, Beth
128		harari@humonc.wisc.edu	Paul	Harari	Imaging and Radiation Sciences	harari@humonc.wisc.edu	Human Oncology	608-263-5009	608-263-8500	http://www.humonc.wisc.edu/index.php/Paul_Harari	Department Chairperson; Professor													Weber, Sharon
129		mharrison3@wisc.edu	Melissa	Harrison	Genetic and Epigenetic Mechanisms	mharrison3@wisc.edu	Biomolecular Chemistry	608-262-2382		https://bmolchem.wisc.edu/staff/harrison-melissa/	Associate Professor													Williams, Eliot
130		emharten@wisc.edu	Ellen	Hartenbach	Developmental Therapeutics	emharten@wisc.edu	Obstetrics and Gynecology	608-263-1210	608-263-1209	http://www.obgyn.wisc.edu/directory/detail.aspx?id=29	Professor													Xing, Yongna
Membership-74		Hayden-CPC	Dana	Hayden	Cancer Prevention and Control	haydend@surgery.wisc.edu	Surgery	6082422800		https://www.surgery.wisc.edu/staff/dana-hayden/	Chair, Division of Colon and Rectal Surgery		Affiliate		Complete									Xu, Yaohui
Membership-124		Heaton-TM	Alexa	Heaton	Tumor Microenvironment	aheaton@morgridge.org	UW Biomedical Engineering and Morgridge Institute for Research	8109380636		https://morgridge.org/profile/alexa-heaton/	Assistant Scientist		Affiliate		Complete									Yang, David
133		robert.hegeman@uwmf.wisc.edu	Robert	Hegeman	Developmental Therapeutics	robert.hegeman@uwmf.wisc.edu	Medicine	608-287-2052		http://www.uwhealth.org/findadoctor/profile/robert-b-hegeman-md/6268	Clinical Associate Professor													Zhang, Jing
136		hernandez6@wisc.edu	Reinier	Hernandez	Imaging and Radiation Sciences	hernandez6@wisc.edu	Medical Physics Radiology			https://www.medphysics.wisc.edu/blog/staff/hernandez-reinier/	Assistant Professor													Zhang, Wei
137		dhernando@wisc.edu	Diego	Hernando	Imaging and Radiation Sciences	dhernando@wisc.edu	Radiology	608-265-7590		https://qiml.radiology.wisc.edu/	Assistant Professor													Attie, Alan
138		ghess3@wisc.edu	Gaelen	Hess	Genetic and Epigenetic Mechanisms	ghess3@wisc.edu	Biomolecular Chemistry			https://ipib.wisc.edu/staff/hess-gaelen/	Assistant Professor													Baker, Mei
Membership-149		Hill-unaligned	Patrick	Hill	Imaging and Radiation Sciences	phill@humonc.wisc.edu	Human Oncology	6082636465		https://www.humonc.wisc.edu/team_member/patrick-hill/	Associate Professor		Core		Complete									Brasier, Allan
140		hohl@wisc.edu	Sarah	Hohl	Cancer Prevention and Control	hohl@wisc.edu	Center for Tobacco Research and Intervention			https://ctri.wisc.edu/researchers/research-staff/sarah-hohl/	Associate Scientist													Bresnick, Emery
Membership-141		Holle-CPC	Lisa	Holle	Cancer Prevention and Control	lholle@wisc.edu	School of Pharmacy, Pharmaceutical Sciences	8602141714		https://apps.pharmacy.wisc.edu/sopdir/lisa_holle/	Associate Professor (CHS)		Affiliate		Complete									Chang, Hao
141		seungpyo.hong@wisc.edu	Seungpyo	Hong	Developmental Therapeutics	seungpyo.hong@wisc.edu	Pharmacy	608-890-0699		https://apps.pharmacy.wisc.edu/sopdir/seungpyo_hong/	Professor													Churpek, Jane
Membership-99		Hoover-Regan-DT	Margo	Hoover-Regan	Developmental Therapeutics	mhooverregan@wisc.edu	Pediatrics	6083326386		https://www.pediatrics.wisc.edu/divisions/hematology-oncology-bone-marrow-transplant/	Associate Professor and Clinical Director Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant Pediatric Palliative Care		Affiliate	24/08/2003	Complete									Collier, Lara
142		ahoskins@wisc.edu	Aaron	Hoskins	Genetic and Epigenetic Mechanisms	ahoskins@wisc.edu	Biomolecular Chemistry	608-890-2101		https://biochem.wisc.edu/faculty/hoskins	Associate Professor													Coon, Joshua
Membership-121		Hossan-DT	Md Shahadat	Hossan	Developmental Therapeutics	mshossan@medicine.wisc.edu	Medicine	6087707417		https://www.medicine.wisc.edu/directory/hossan_md-shahadat https://kratzlab.medicine.wisc.edu/staff/shahadat-hossan/	Scientist II		Affiliate		Complete									Craven, Mark
144		rhu6@wisc.edu	Rong	Hu	Tumor Microenvironment	rhu6@wisc.edu	Pathology and Laboratory Medicine	608-262-1834		https://pathology.wisc.edu/staff/hu-rong/	Assistant Professor (CHS)													Denu, John
Membership5		qhu66@wisc.edu	Quanyin	Hu	Developmental Therapeutics	qhu66@wisc.edu	School of Pharmacy, Pharmaceutical Sciences	608-262-3814		www.huciptlab.net	Assistant Professor		Core		Complete									Dewey, Colin
145		whuang23@wisc.edu	Wei	Huang	Cancer Prevention and Control	whuang23@wisc.edu	Pathology and Laboratory Medicine	608-262-5787		https://pathology.wisc.edu/staff/huang-wei/	Professor (CHS)													Dinh, Huy
147		huttenlocher@wisc.edu	Anna	Huttenlocher	Tumor Microenvironment	huttenlocher@wisc.edu	Pediatrics	608-265-4642	608-265-4669	https://www.pediatrics.wisc.edu/research/research-groups/huttenlocher	Professor													Ellison, Paul
148		giyer@humonc.wisc.edu	Gopal	Iyer	Imaging and Radiation Sciences	giyer@humonc.wisc.edu	Human Oncology	608-263-0662		https://www.humonc.wisc.edu/index.php/Gopal_Iyer	Assistant Professor													Engelman, Corinne
149		jarrard@urology.wisc.edu	David	Jarrard	Genetic and Epigenetic Mechanisms	jarrard@urology.wisc.edu	Urology	608-262-0759		https://www.uwhealth.org/findadoctor/profile/david-f-jarrard-md/6413	Professor													Fu, Ting
151		rjeraj@wisc.du	Robert	Jeraj	Imaging and Radiation Sciences	rjeraj@wisc.du	Medical Physics	608-263-8619		https://directory.engr.wisc.edu/bme/Faculty/Jeraj_Robert/	Professor													Gasch, Audrey
152		jiaoyang.jiang@wisc.edu	Jiaoyang	Jiang	Developmental Therapeutics	jiaoyang.jiang@wisc.edu	Pharmacy	608-265-6732		https://apps.pharmacy.wisc.edu/sopdir/jiaoyang_jiang/	Associate Professor													Gitter, Anthony
153		ejohannsen@medicine.wisc.edu	Eric	Johannsen	Human Cancer Virology	ejohannsen@medicine.wisc.edu	Medicine	608-262-9952		https://www.medicine.wisc.edu/people-search/people/staff/1118/Johannsen_Eric	Associate Professor													Griep, Anne
154		aljohnson43@wisc.edu	Adrienne	Johnson	Cancer Prevention and Control	aljohnson43@wisc.edu	Medicine	608-265-4797		https://ctri.wisc.edu/researchers/research-staff/adrienne-johnson-phd/	Assistant Scientist													Harrison, Melissa
155		scj@medicine.wisc.edu	Sterling	Johnson	Imaging and Radiation Sciences	scj@medicine.wisc.edu	Medicine	608-262-9549	608-263-9243	http://aging.wisc.edu/research/affil.php?Ident=120	Professor													Hess, Gaelen
157		jsjorgensen@wisc.edu	Joan	Jorgensen	Tumor Microenvironment	jsjorgensen@wisc.edu	Comparative Biosciences	608-890-2337		http://www.vetmed.wisc.edu/people/jsjorgensen	Associate Professor													Hoskins, Aaron
158		fkaiksow@medicine.wisc.edu	Farah	Kaiksow	Cancer Prevention and Control	fkaiksow@medicine.wisc.edu	Medicine	608-440-6400		https://www.uwhealth.org/findadoctor/profile/farah-kaiksow-md/10282	Assistant Professor													Jarrard, David
159		rfkalejta@wisc.edu	Robert	Kalejta	Human Cancer Virology	rfkalejta@wisc.edu	Oncology	608-265-5546	608-265-5390	https://mcardle.wisc.edu/who-we-are/mcardle-faculty/robert-f-kalejta-phd	Professor													Kang, Junsu
Membership-154		Kalogriopoulos-DT	Nicholas	Kalogriopoulos	Developmental Therapeutics	nicholas.kalogriopoulos@wisc.edu	Pharmaceutical Sciences Division	4144304030		https://apps.pharmacy.wisc.edu/sopdir/nicholas_kalogriopoulos/	Assistant Professor		Core		Complete									Keles, Sunduz
160		tjk@medicine.wisc.edu	Timothy	Kamp	Unaligned	tjk@medicine.wisc.edu	Medicine	608-263-1172		https://www.med.wisc.edu/research/researcher-profiles/timothy-kamp/	Professor, Co-Director													Kendziorski, Christina
161		junsu.kang@wisc.edu	Junsu	Kang	Genetic and Epigenetic Mechanisms	junsu.kang@wisc.edu	Cell and Regenerative Biology	919-428-1773		https://crb.wisc.edu/staff/kang-junsu/	Assistant Professor													Lewis, Peter
Membership-112		Kathuria-CPC	Hasmeena	Kathuria	Cancer Prevention and Control	hasmeena.kathuria@ctri.wisc.edu	Medicine	6082655928		https://ctri.wisc.edu/	Professor, Department of Medicine Director, UW Center for Tobacco Research and Intervention (UW-CTRI)		Core		Complete									Marker, Paul
162		jtkaye@ctri.wisc.edu	Jesse	Kaye	Cancer Prevention and Control	jtkaye@ctri.wisc.edu	Medicine			https://ctri.wisc.edu/researchers/research-staff/jesse-kaye-phd/	Assistant Scientist													Matson, Daniel
163		jlkeck@facstaff.wisc.edu	James	Keck	Developmental Therapeutics	jlkeck@facstaff.wisc.edu	Biomolecular Chemistry	608-263-1815	608-263-1954	https://bmolchem.wisc.edu/staff/keck-james/	Academic Program Director; Professor; Associate Dean													Murtaza, Muhammed
164		keles@stat.wisc.edu	Sunduz	Keles	Genetic and Epigenetic Mechanisms	keles@stat.wisc.edu	Statistics	608-263-4533		https://www.waisman.wisc.edu/staff/keles-sunduz/	Professor													Newton, Michael
165		npkeller@wisc.edu	Nancy	Keller	Tumor Microenvironment	npkeller@wisc.edu	Medical Microbiology and Immunology	608-262-9795		https://genetics.wisc.edu/staff/keller-nancy/	Professor													Ong, Irene
Membership-68		Kelly-CPC	Kaitlyn	Kelly	Cancer Prevention and Control	kjkelly3@wisc.edu	Surgery	6082652981		https://www.surgery.wisc.edu/staff/kaitlyn-kelly/	Associate Professor of Surgery, Division of Surgical Oncology		Affiliate		Complete									Pan, Xuan
166		kendzior@biostat.wisc.edu	Christina	Kendziorski	Genetic and Epigenetic Mechanisms	kendzior@biostat.wisc.edu	Biostatistics and Medical Informatics	608-262-3146		https://www.biostat.wisc.edu/content/kendziorski-christina	Professor													Prolla, Tomas
167		vpkenkre@medicine.wisc.edu	Vaishalee	Kenkre	Developmental Therapeutics	vpkenkre@medicine.wisc.edu	Medicine	608-263-1699		http://www2.medicine.wisc.edu/home/people-search/people/staff/864/Kenkre_Vaishalee/	Associate Professor (CHS)													Roopra, Avtar
168		skenney@wisc.edu	Shannon	Kenney	Human Cancer Virology	skenney@wisc.edu	Oncology	608-265-0533	608-261-1196	https://www.medicine.wisc.edu/people-search/people/staff/598/Kenney_Shannon	Professor													Roy, Sushmita
397		skerr2@wisc.edu	Sheena	Kerr	Tumor Microenvironment	skerr2@wisc.edu	Carbone Cancer Center	608-265-1441		https://directory.engr.wisc.edu/bme/Faculty/Kerr_Sheena/	Research Assistant Professor		Core		Complete									Smith, Lloyd
Membership-117		Khan-IR	Ahtesham Ullah	Khan	Imaging and Radiation Sciences	akhan49@wisc.edu	Medical Physics	3155273861		https://uwmrrc.wisc.edu/	Assistant Professor (Incoming) with 07/01/2025 start date		Affiliate		Complete									Sridharan, Rupa
169		dh.kim@hosp.wisc.edu	David	Kim	Imaging and Radiation Sciences	dh.kim@hosp.wisc.edu	Radiology	608-262-7932	608-263-9028	https://www.radiology.wisc.edu/profile/david-kim-29/	Professor (CHS)													Sussman, Michael
171		rkimple@humonc.wisc.edu	Randall	Kimple	Imaging and Radiation Sciences	rkimple@humonc.wisc.edu	Human Oncology	608-263-3611	608-265-3716	http://www.humonc.wisc.edu/index.php/Randall_Kimple	Associate Professor													Suzuki, Aussie
173		bsklein@pediatrics.wisc.edu	Bruce	Klein	Developmental Therapeutics	bsklein@pediatrics.wisc.edu	Pediatrics	608-263-9217	608-263-6203	http://www.cmp.wisc.edu/trainers/bruce-klein	Professor													Wellik, Deneen
Membership-150		Knavel Koepsel-unaligned	Erica	Knavel Koepsel	Imaging and Radiation Sciences	knavel@wisc.edu	Radiology	8477573521		https://radiology.wisc.edu/profile/erica-knavel-koepsel-798/	Associate Professor, Chief of Interventional Radiology, Andrew B. Crummy Professor of Radiology, Director of Interventional MRI		Core		Complete									Wisinski, Kari
175		ljknoll@wisc.edu	Laura	Knoll	Developmental Therapeutics	ljknoll@wisc.edu	Medical Microbiology and Immunology	608-262-3161	608-262-4242	https://immunology.wisc.edu/staff/knoll-phd-laura/	Professor													Xu, Wei
Membership-113		Konopka-DT	Adam	Konopka	Developmental Therapeutics	akonopka@medicine.wisc.edu	Medicine	5076022322			Assistant Professor		Affiliate		Complete									Ahlquist, Paul
176		dkosoff1@medicine.wisc.edu	David	Kosoff	Tumor Microenvironment	dkosoff1@medicine.wisc.edu	Oncology	(847) 207-0383		https://www.uwhealth.org/findadoctor/profile/david-kosoff-md/10828	Assistant Professor													Carchman, Evie
178		jdkratz@medicine.wisc.edu	Jeremy	Kratz	Developmental Therapeutics	jdkratz@medicine.wisc.edu	Medicine			https://www.medicine.wisc.edu/people-search/people/staff/6261/Kratz_Jeremy	Assistant Professor													Evans, David
179		kreeger@wisc.edu	Pamela	Kreeger	Tumor Microenvironment	kreeger@wisc.edu	Biomedical Engineering	608-890-2915	608-890-2916	http://www.engr.wisc.edu/bme/faculty/kreeger_pamela.html	Associate Professor													Gumperz, Jenny
Membership-95		Kuchnia-CPC	Adam	Kuchnia	Cancer Prevention and Control	kuchnia@wisc.edu	Nutritional Sciences	6082634316		https://kuchnialab.nutrisci.wisc.edu/	Assistant Professor		Affiliate	24/12/2001	Complete									Johannsen, Eric
180		dmkushner@facstaff.wisc.edu	David	Kushner	Developmental Therapeutics	dmkushner@facstaff.wisc.edu	Obstetrics and Gynecology	608-263-1210	608-263-1209	http://www.obgyn.wisc.edu/directory/detail.aspx?id=30	Professor													Kalejta, Robert
181		kwekkeboom@wisc.edu	Kristine	Kwekkeboom	Cancer Prevention and Control	kwekkeboom@wisc.edu	School of Nursing	608-263-5168	608-265-9863	https://nursing.wisc.edu/staff/kwekkeboom-kristine-l/	Professor													Kenney, Shannon
182		glen.kwon@wisc.edu	Glen	Kwon	Developmental Therapeutics	glen.kwon@wisc.edu	Pharmacy	608-265-5183		http://apps.pharmacy.wisc.edu/sopdir/glen_kwon	Professor													Lambert, Paul
183		ckyriako@medicine.wisc.edu	Christos	Kyriakopoulos	Developmental Therapeutics	ckyriako@medicine.wisc.edu	Medicine	608-263-0786		http://www.uwhealth.org/findadoctor/profile/christos-kyriakopoulos-md/9675	Associate Professor (CHS)													Majumder, Kinjal
184		plaeseke@uwhealth.org	Paul	Laeseke	Imaging and Radiation Sciences	plaeseke@uwhealth.org	Radiology	608-262-7508		https://www.radiology.wisc.edu/profile/paul-laeseke-108/	Assistant Professor													Sherer, Nathan
185		lambert@oncology.wisc.edu	Paul	Lambert	Human Cancer Virology	lambert@oncology.wisc.edu	Oncology	608-262-8533	608-262-6407	https://mcardle.wisc.edu/who-we-are/mcardle-faculty/paul-f-lambert-phd	Department Chairperson; Professor													Spurgeon, Megan
186		dlamming@medicine.wisc.edu	Dudley	Lamming	Developmental Therapeutics	dlamming@medicine.wisc.edu	Medicine	608-256-1901		http://www.medicine.wisc.edu/endocrinology/lamminglab	Associate Professor													Striker, Robert
Membership38		Lang-DT	Jessica	Lang	Developmental Therapeutics	jessica.lang@wisc.edu	Pathology and Laboratory Medicine			TBD	Assistant Professor		Core		Complete									Sugden, Bill
187		jmlang@medicine.wisc.edu	Joshua	Lang	Tumor Microenvironment	jmlang@medicine.wisc.edu	Medicine	608-265-8131		http://www.medicine.wisc.edu/people-search/people/staff/822/Lang_Joshua/	Associate Professor													Westergaard, Ryan
Membership-144		Larson-unaligned	Matthew	Larson	Imaging and Radiation Sciences	melarson3@wisc.edu	Radiology	6082635660		https://radiology.wisc.edu/profile/matthew-larson-2159/	Assistant Professor (CHS)		Affiliate		Complete									Yin, John
Membership-144		Larson-unaligned	Matthew	Larson	Imaging and Radiation Sciences	melarson3@wisc.edu	Radiology	6082635660		https://radiology.wisc.edu/profile/matthew-larson-2159/	Assistant Professor (CHS)		Affiliate		Pending									Baschnagel, Andrew
188		lautner@surgery.wisc.edu	Meeghan Ann	Lautner	Cancer Prevention and Control	lautner@surgery.wisc.edu	Surgery	608-890-4165		https://www.surgery.wisc.edu/staff/meeghan-lautner/	Associate Professor													Bassetti, Michael
Membership-146		Lawless-unaligned	Michael	Lawless	Imaging and Radiation Sciences	mjlawless@wisc.edu	Human Oncology	6082659455		https://www.humonc.wisc.edu/team_member/lawless/	Associate Professor Director of Theranostic Physics		Affiliate		Complete									Bednarz, Bryan
190		lawson@surgery.wisc.edu	Elise	Lawson	Cancer Prevention and Control	lawson@surgery.wisc.edu	Surgery	608-263-2521		http://www.surgery.wisc.edu/profile/elise-lawson	Assistant Professor (CHS)													Block, Walter
191		leh@surgery.wisc.edu	Hau	Le	Developmental Therapeutics	leh@surgery.wisc.edu	Surgery	608-262-6482		https://www.surgery.wisc.edu/staff/hau-le/	Assistant Professor													Brace, Chris
192		aaron.lebeau@wisc.edu	Aaron	LeBeau	Developmental Therapeutics	aaron.lebeau@wisc.edu	Pathology and Laboratory Medicine	608-262-5586		https://pathology.wisc.edu/staff/lebeau-aaron/	Associate Professor													Bradley, Kristin
193		ft.lee@hosp.wisc.edu	Fred	Lee	Imaging and Radiation Sciences	ft.lee@hosp.wisc.edu	Radiology	608-263-0885		https://www.uwhealth.org/findadoctor/profile/fred-t-lee-jr.-md/6685	Professor													Cai, Weibo
Membership-135		Lee-IR	Christoph	Lee	Imaging and Radiation Sciences	cilee3@wisc.edu	Radiology				Vice Chair of Research, Professor, Department of Radiology		Core		Complete									Chappell, Richard
194		calee4@wisc.edu	Cathy	Lee-Miller	Cancer Prevention and Control	calee4@wisc.edu	Pediatrics	608-263-6200		https://www.pediatrics.wisc.edu/staff/lee-miller-md-cathy/	Assistant Professor (CHS)													Chen, Guang-Hong
195		pwlewis2@wisc.edu	Peter	Lewis	Genetic and Epigenetic Mechanisms	pwlewis2@wisc.edu	Biomolecular Chemistry	608-316-4388		http://wid.wisc.edu/profile/peter-lewis/	Associate Professor													Connor, Nadine
196		lingjun.li@wisc.edu	Lingjun	Li	Tumor Microenvironment	lingjun.li@wisc.edu	Pharmacy	608-265-8491		https://apps.pharmacy.wisc.edu/sopdir/lingjun_li/	Professor													Cosper, Pippa
Membership60		Lim-unaligned	Ci Ji	Lim	Genetic and Epigenetic Mechanisms	ciji.lim@wisc.edu	Biomolecular Chemistry	7206391480		https://biochem.wisc.edu/faculty/Lim	Assistant Professor		Core		Complete									DeWerd, Larry
198		litzelman@wisc.edu	Kristin	Litzelman	Cancer Prevention and Control	litzelman@wisc.edu	Human Development and Family Studies	608-265-8689		https://sohe.wisc.edu/staff/kristin-litzelman/	Assistant Professor													Engle, Jonathan
199		gxl@medicine.wisc.edu	Glenn	Liu	Developmental Therapeutics	gxl@medicine.wisc.edu	Medicine	608-265-4377		http://www.uwhealth.org/findadoctor/profile/glenn-liu-md/6726	Professor													Ferguson, John
Membership-88		Liu-DT	Hongtao	Liu	Developmental Therapeutics	hliu@medicine.wisc.edu	Medicine	6082650106		https://www.medicine.wisc.edu/people-search/people/staff/8511/Liu_Hongtao	Director of Bone Marrow transplant		Core		Complete									Floberg, John
Membership-134		LIU-GEM	PENG	LIU	Genetic and Epigenetic Mechanisms	pliu@biostat.wisc.edu	Biostatistics and Medical Informatics	6082652359		https://biostat.wiscweb.wisc.edu/staff/liu-peng/	Scientist III		Affiliate		Complete									Fowler, Amy
202		ns3@medicine.wisc.edu	Noelle	LoConte	Cancer Prevention and Control	ns3@medicine.wisc.edu	Medicine	608-265-5883		http://www.uwhealth.org/findadoctor/profile/noelle-k-loconte-md/6732	Associate Professor													Glide-hurst, Carri
205		sjlubner@medicine.wisc.edu	Sam	Lubner	Developmental Therapeutics	sjlubner@medicine.wisc.edu	Medicine	608-262-7358	608-262-2170	http://www.uwhealth.org/findadoctor/profile/sam-j-lubner-md/8665	Associate Professor (CHS)													Grist, Thomas
Membership-153		tianyuan.lu@wisc.edu	Tianyuan	Lu	Cancer Prevention and Control	tianyuan.lu@wisc.edu	Population Health Sciences	6082134356		https://lulab.pophealth.wisc.edu/	Assistant Professor
Membership43		Vincent Ma - DT	Vincent	Ma	Developmental Therapeutics	vtma@medicine.wisc.edu	Medicine - Hematology, Medical Oncology and Palliative Care			https://www.medicine.wisc.edu/people-search/people/staff/7477/Ma_Vincent	Assistant Professor (CHS)		Core		Complete									Harari, Paul
Membership32		Mahajan-unaligned	Aparna	Mahajan	Unaligned	amahajan@uwhealth.org	Pathology and Laboratory Medicine			https://pathology.wisc.edu/staff/mahajan-aparna/	Associate Professor, Director of Surgical Pathology		Affiliate		Complete									Hernandez, Reinier
208		kmajumder@wisc.edu	Kinjal	Majumder	Human Cancer Virology	kmajumder@wisc.edu	Oncology	608-890-4888		https://majumder.wiscweb.wisc.edu/welcome/	Assistant Professor													Hernando, Diego
210		paul.marker@wisc.edu	Paul	Marker	Genetic and Epigenetic Mechanisms	paul.marker@wisc.edu	Pharmacy	608-890-2150		https://apps.pharmacy.wisc.edu/sopdir/paul_marker/	Assistant Dean; Professor													Iyer, Gopal
211		jdmartell@wisc.edu	Jeffrey	Martell	Developmental Therapeutics	jdmartell@wisc.edu	Chemistry	608-263-6249		http://chem.wisc.edu/users/jdmartell	Assistant Professor													Jeraj, Robert
212		mmartin3@uwhealth.org	Maria Daniela	Martin Rother	Cancer Prevention and Control	mmartin3@uwhealth.org	Radiology			https://radiology.wisc.edu/profile/maria-daniela-martin-1301/	Assistant Professor (CHS)													Johnson, Sterling
215		drmatson@wisc.edu	Daniel	Matson	Genetic and Epigenetic Mechanisms	drmatson@wisc.edu	Pathology and Laboratory Medicine	608-265-4377		https://pathology.wisc.edu/staff/matson-daniel/	Assistant Professor													Kim, David
216		rjmattison@medicine.wisc.edu	Ryan	Mattison	Developmental Therapeutics	rjmattison@medicine.wisc.edu	Medicine	608-262-5697		http://www.uwhealth.org/findadoctor/profile/ryan-j-mattison-md/8440	Associate Professor (CHS)													Kimple, Randall
Membership-115		Mc Dermott-DT	Sarah	Mc Dermott	Developmental Therapeutics	semcdermott@wisc.edu	Pediatrics	6082623860		https://www.uwhealth.org/providers/sarah-mcdermott-do	Assistant Professor of Pediatrics, Pediatric Hematology/Oncology/BMT		Affiliate		Pending									Laeseke, Paul
217		demccarthy@ctri.wisc.edu	Danielle	McCarthy	Cancer Prevention and Control	demccarthy@ctri.wisc.edu	Medicine	608-265-5949		https://www.medicine.wisc.edu/people-search/people/staff/2276/McCarthy_Danielle	Professor													Lee, Fred
218		mmcclean@wisc.edu	Megan	McClean	Developmental Therapeutics	mmcclean@wisc.edu	Biomedical Engineering	608-890-0416		https://cmb.wisc.edu/staff/mcclean-megan/	Assistant Professor													McCulloch, Timothy
Membership58		McCoy-DT	Sara	McCoy	Developmental Therapeutics	ssmccoy@medicine.wisc.edu	Medicine	5857043972		https://www.medicine.wisc.edu/rheumatology/mccoy-research	Associate Professor		Core		Complete									McMillan, Alan
219		mccull@surgery.wisc.edu	Timothy	McCulloch	Imaging and Radiation Sciences	mccull@surgery.wisc.edu	Surgery	608-263-0192		https://www.surgery.wisc.edu/staff/timothy-mcculloch/	Department Chairperson; Professor													Morris, Zachary
220		smcgregor@wisc.edu	Stephanie	McGregor	Tumor Microenvironment	smcgregor@wisc.edu	Pathology and Laboratory Medicine	608-264-9468		http://www.uwhealth.org/findadoctor/profile/stephanie-mcgregor-md/10249	Assistant Professor (CHS)													Perlman, Scott
221		abmcmillan@wisc.edu	Alan	McMillan	Imaging and Radiation Sciences	abmcmillan@wisc.edu	Radiology	608-262-2622		https://www.radiology.wisc.edu/profile/alan-mcmillan-313/	Associate Professor (CHS)													Pickhardt, Perry
222		dm3@medicine.wisc.edu	Douglas	McNeel	Developmental Therapeutics	dm3@medicine.wisc.edu	Medicine	608-263-4198	608-265-8131	https://www.medicine.wisc.edu/people-search/people/staff/395/McNeel_Douglas	Professor													Pirasteh, Ali
Membership-92		Mehta-unaligned	Kavi	Mehta	Human Cancer Virology	kmehta@wisc.edu	Comparative Biosciences	6082132055		mehtalab.vetmed.wisc.edu	Assistant Professor		Affiliate		Complete									Reeder, Scott
Membership-85		Meimetis-IR	Labros	Meimetis	Imaging and Radiation Sciences	meimetis@wisc.edu	Radiology	8576008206		I am still waiting for my UW profile to come online as I started my position this week.	Research Assistant Professor		Core	23/11/2008	Complete									Rosado-Mendez, Ivan
223		merrins@wisc.edu	Matt	Merrins	Developmental Therapeutics	merrins@wisc.edu	Medicine	256-256-1901		https://www.medicine.wisc.edu/endocrinology/merrins-lab	Assistant Professor													Russell, John
Membership-78		Meyer-GEM	Mark	Meyer	Genetic and Epigenetic Mechanisms	markmeyer@wisc.edu	Nutritional Sciences	6088900857		https://nutrisci.wisc.edu/mark-b-meyer/	Assistant Professor		Affiliate	23/12/2005	Complete									Sadowski, Elizabeth
Membership-71		Meyers-unaligned	Ross	Meyers	Developmental Therapeutics	romeyers@wisc.edu	Carbone Cancer Center	6082627820		https://pact.wisc.edu/our-team/	Director of Cell Manufacturing Operations/Scientist III		Affiliate		Complete									Samsonov, Alexy
Membership-70		Miller-CPC	Megan	Miller	Cancer Prevention and Control	miller89@wisc.edu	School of Nursing	5866045862		https://nursing.wisc.edu/staff/miller-megan/	Assistant Professor		Affiliate		Complete									Strigel, Roberta
226		minter@surgery.wisc.edu	Rebecca	Minter	Cancer Prevention and Control	minter@surgery.wisc.edu	Surgery	608-265-8854		https://www.surgery.wisc.edu/staff/rebecca-minter/	Department Chairperson; Visiting Professor													Tibbetts, Randal
228		smiyamot@wisc.edu	Shigeki	Miyamoto	Developmental Therapeutics	smiyamot@wisc.edu	Oncology	608-262-9281		https://mcardle.wisc.edu/who-we-are/mcardle-faculty/shigeki-miyamoto-phd	Professor													Varghese, Tomy
229		kmontgomery@uwhealth.org	Kathleen	Montgomery	Cancer Prevention and Control	kmontgomery@uwhealth.org	School of Nursing	608-890-9679		https://cancer.wisc.edu/research/staff/montgomery-kathleen/	Faculty Associate													Wassarman, David
230		zmorris@humonc.wisc.edu	Zachary	Morris	Imaging and Radiation Sciences	zmorris@humonc.wisc.edu	Human Oncology	608-263-2603		https://www.humonc.wisc.edu/index.php/Zachary_Morris	Assistant Professor													Weichert, Jamey
232		marlon.mundt@fammed.wisc.edu	Marlon	Mundt	Cancer Prevention and Control	marlon.mundt@fammed.wisc.edu	Family Medicine and Community Health	608-263-5123		https://ctri.wisc.edu/researchers/research-staff/dr-marlon-mundt/	Associate Professor													Wheeler, Deric
233		murtaza@surgery.wisc.edu	Muhammed	Murtaza	Genetic and Epigenetic Mechanisms	murtaza@surgery.wisc.edu	Surgery	608-890-4154		https://www.surgery.wisc.edu/staff/muhammed-murtaza/	Associate Professor													Zhao, Shuang
235		knadimin@medicine.wisc.edu	Kalyan	Nadiminti	Developmental Therapeutics	knadimin@medicine.wisc.edu	Medicine			https://www.medicine.wisc.edu/people-search/people/staff/6813/Nadiminti_Kalyan%20Vara%20Ganesh	Assistant Professor (CHS)													Ziemlewicz, Timothy
236		aknarayan2@wisc.edu	Anand	Narayan	Cancer Prevention and Control	aknarayan2@wisc.edu	Radiology			https://radiology.wisc.edu/profile/anand-narayan-2475/	Associate Professor													Al-Adra, David
237		neuman@surgery.wisc.edu	Heather	Neuman	Cancer Prevention and Control	neuman@surgery.wisc.edu	Surgery	608-265-5852		http://www.surgery.wisc.edu/profile/heather-neuman	Associate Professor													Anderson, Rozalyn
Membership-73		Neumann-VR	Donna	Neumann	Human Cancer Virology	dneumann3@wisc.edu	Ophthalmology and Visual Sciences	6082636176			Associate Professor		Core		Complete									Arendt, Lisa
Membership-138		Neuner-CPC	Joan	Neuner	Cancer Prevention and Control	jneuner@wisc.edu	Medicine	4145172530		https://www.medicine.wisc.edu/directory/neuner_joan	Visiting Professor Associate Chief for Research Division of General Internal Medicine, Department of Medicine University of Wisconsin–Madison		Core		Complete									Beebe, David
238		newton@biostat.wisc.edu	Michael	Newton	Genetic and Epigenetic Mechanisms	newton@biostat.wisc.edu	Statistics	608-262-0086	608-263-0357	https://www.biostat.wisc.edu/content/newton-michael	Department Chairperson; Professor													Campagnola, Paul
Membership-110		Ngo-TM	Mai	Ngo	Tumor Microenvironment	mtngo2@wisc.edu	Chemical and Biological Engineering	5404945763		https://directory.engr.wisc.edu/che/Faculty/Ngo_Mai/	Assistant Professor		Core	24/08/2011	Complete									Dempsey, Robert
Membership-142		Nguyen-TM	Duc-Huy	Nguyen	Tumor Microenvironment	dtnguyen35@wisc.edu	Biomedical Engineering	6263849318		https://directory.engr.wisc.edu/bme/Faculty/Nguyen_Duc-huy/	Assistant Professor		Affiliate		Complete									Dey, Mahua
Membership-151		Niemeyer-unaligned	Matthew	Niemeyer	Imaging and Radiation Sciences	mmniemeyer@wisc.edu	Radiology	7346454751		https://radiology.wisc.edu/profile/matthew-niemeyer-2730/	Associate Professor (CHS), Division of Interventional Radiology		Core		Complete									Eliceiri, Kevin
239		jknotbohm@wisc.edu	Jacob	Notbohm	Tumor Microenvironment	jknotbohm@wisc.edu	Engineering	608-890-0030		https://directory.engr.wisc.edu/ep/Faculty/Notbohm_Jacob/	Assistant Professor													Emamekhoo, Hamid
Membership61		O'LEARY-TM	CLAIRE	O'LEARY	Tumor Microenvironment	coleary@wisc.edu	Pediatrics	16083545360			Assistant Professor		Core	22/11/2011	Complete									Fan, Jing
240		irene.ong@wisc.edu	Irene	Ong	Genetic and Epigenetic Mechanisms	irene.ong@wisc.edu	Obstetrics and Gynecology	608-265-2359		http://pages.cs.wisc.edu/~ong/	Assistant Professor													Franck, Christrian
Membership-128		O'Reilly-IR	Shannon	O'Reilly	Imaging and Radiation Sciences	seoreilly@wisc.edu	Human Oncology	9046992340		https://www.humonc.wisc.edu/team_member/shannon-oreilly/	Associate Professor		Core		Complete									Galipeau, Jacques
Membership-105		Osorio-DT	Jorge	Osorio	Developmental Therapeutics	jorge.osorio@wisc.edu	Global Health Institute	6084389558		https://ghi.wisc.edu/?s=jorge+osorio	Director &. Professor		Affiliate	24/09/2008	Complete									Galmozzi, Andrea
Membership-130		Pagel-IR	Marty	Pagel	Imaging and Radiation Sciences	mdpagel2@wisc.edu	Medical Physics	7132058515		https://medphysics.wisc.edu/blog/staff/pagel-marty/	Professor		Core		Complete									Ge, Ying
242		sppalecek@wisc.edu	Sean	Palecek	Tumor Microenvironment	sppalecek@wisc.edu	Chemical and Biological Engineering	608-262-8931		http://www.engr.wisc.edu/che/faculty/palecek_sean.html	Professor													Huttenlocher, Anna
243		xpan24@wisc.edu	Xuan	Pan	Genetic and Epigenetic Mechanisms	xpan24@wisc.edu	Medical Sciences	608-265-4718		http://www.vetmed.wisc.edu/people/xpan24/	Assistant Professor													Jorgensen, Joan
246		patankar@wisc.edu	Manish	Patankar	Developmental Therapeutics	patankar@wisc.edu	Obstetrics and Gynecology	608-262-8871	608-263-1201	http://www.obgyn.wisc.edu/directory/detail.aspx?id=40	Professor													Keller, Nancy
247		mapatel@medicine.wisc.edu	Monica	Patel	Cancer Prevention and Control	mapatel@medicine.wisc.edu	Medicine			https://www.uwhealth.org/findadoctor/profile/monica-a-patel-md/11624	Assistant Professor (CHS)													Kosoff, David
Membership62		Pennati-DT	Andrea	Pennati	Developmental Therapeutics	pennati@wisc.edu	Medicine	4045363101		https://www.medicine.wisc.edu/people-search/people/staff/5526	Scientist III, Director of R&D, Program for Advanced Cell Therapy		Affiliate	22/11/2011	Complete									Kreeger, Pamela
249		sb.perlman@hosp.wisc.edu	Scott	Perlman	Imaging and Radiation Sciences	sb.perlman@hosp.wisc.edu	Radiology	608-263-6301		https://www.radiology.wisc.edu/profile/scott-perlman-39/	Professor (CHS)													Lang, Joshua
250		dmpeter2@wisc.edu	Donna	Peters	Tumor Microenvironment	dmpeter2@wisc.edu	Pathology and Laboratory Medicine	608-262-4626	608-262-7576	https://www.cmp.wisc.edu/trainers/donna-peters	Professor													Li, Lingjun
Membership-106		Phung-CPC	Minh Tung	Phung	Cancer Prevention and Control	mphung2@wisc.edu	Population Health Sciences	7347809524		https://pophealth.wisc.edu/staff/phung-minh-tung/	Assistant Professor		Core		Complete									McGregor, Stephanie
Membership45		Piasecki-CPC	Thomas M.	Piasecki	Cancer Prevention and Control	tpiasecki@ctri.wisc.edu	Medicine			https://ctri.wisc.edu/researchers/research-staff/thomas-piasecki-phd/	Visiting Professor		Affiliate		Complete									Notbohm, Jacob
252		ppickhardt2@uwhealth.org	Perry	Pickhardt	Imaging and Radiation Sciences	ppickhardt2@uwhealth.org	Radiology	608-263-8969	608-263-9028	https://www.radiology.wisc.edu/profile/perry-pickhardt-40/	Professor (CHS)													Palecek, Sean
254		mep@ctri.wisc.edu	Megan	Piper	Cancer Prevention and Control	mep@ctri.wisc.edu	Medicine	608-265-5472		https://www.medicine.wisc.edu/people-search/people/staff/227/Piper_Megan	Associate Professor													Peters, Donna
255		mlp@medicine.wisc.edu	Michele	Pipp-Dahm	Developmental Therapeutics	mlp@medicine.wisc.edu	Medicine	608-265-0246	608-260-6576	http://www.uwhealth.org/findadoctor/profile/michele-l-pipp-dahm-md/7153	Clinical Assistant Professor													Ponik, Suzanne
256		pirasteh@wisc.edu	Ali	Pirasteh	Imaging and Radiation Sciences	pirasteh@wisc.edu	Medical Physics Radiology	608-265-6044		https://www.radiology.wisc.edu/profile/ali-pirasteh-2191/	Assistant Professor													Rakhmilevich, Alexander
Membership50		Brian Pogue - IR	Brian	Pogue	Imaging and Radiation Sciences	bpogue@wisc.edu	Medical Physics	608-263-8037		https://www.medphysics.wisc.edu/blog/staff/pogue-brian/	Professor & Chair		Core	22/11/2002	Complete									Reynolds, Matt
258		ponik@wisc.edu	Suzanne	Ponik	Tumor Microenvironment	ponik@wisc.edu	Cell and Regenerative Biology	608-265-5094		https://crb.wisc.edu/staff/ponik-suzanne/	Assistant Professor													Ricke, William
259		ppophali@medicine.wisc.edu	Priyanka	Pophali	Cancer Prevention and Control	ppophali@medicine.wisc.edu	Oncology			https://www.uwhealth.org/findadoctor/profile/priyanka-pophali-md/11194	Assistant Professor (CHS)													Rogers, Jeremy
260		taprolla@wisc.edu	Tomas	Prolla	Genetic and Epigenetic Mechanisms	taprolla@wisc.edu	Genetics	608-265-5204		https://genetics.wisc.edu/staff/prolla-tomas/	Professor													Ronnekleiv-Kelly, Sean
Membership-97		Pytel-DT	Nicholas	Pytel	Developmental Therapeutics	pytel2@wisc.edu	Pediatrics	6082637969		https://www.pediatrics.wisc.edu/staff/pytel-do-nicholas/	Assistant Professor (CHS)		Core	24/09/2002	Complete									Saha, Krishanu
262		srajguru@medicine.wisc.edu	Saurabh	Rajguru	Developmental Therapeutics	srajguru@medicine.wisc.edu	Medicine	608-287-2552		http://www.uwhealth.org/findadoctor/profile/saurabh-a-rajguru-md/9887	Clinical Assistant Professor													Sandor, Matyas
263		rakhmil@humonc.wisc.edu	Alexander	Rakhmilevich	Tumor Microenvironment	rakhmil@humonc.wisc.edu	Human Oncology	608-263-5193		https://www.researchgate.net/profile/Alexander_Rakhmilevich	Distinguished Scientist													Seroogy, Christine
264		earanheim@wisc.edu	Erik	Ranheim	Developmental Therapeutics	earanheim@wisc.edu	Pathology and Laboratory Medicine	608-263-0057		https://www.uwhealth.org/findadoctor/profile/erik-a-ranheim-md-phd/7223	Professor (CHS)													Sheehan, John
266		sb.reeder@hosp.wisc.edu	Scott	Reeder	Imaging and Radiation Sciences	sb.reeder@hosp.wisc.edu	Radiology	608-265-9964		https://www.radiology.wisc.edu/profile/scott-reeder-46/	Professor													Skala, Melissa
268		mrreynol@wisc.edu	Matt	Reynolds	Tumor Microenvironment	mrreynol@wisc.edu	Pathobiological Sciences	608-890-0842		https://reynolds.labs.wisc.edu/staff/reynolds-matt/	Assistant Professor													Stietz, Kimberly
270		richardsk@urology.wisc.edu	Kyle	Richards	Cancer Prevention and Control	richardsk@urology.wisc.edu	Urology	608-960-3337		http://urology.wisc.edu/staff/richards-md-facs-kyle-a/	Assistant Professor (CHS)													Suresh, Marulasiddappa
Membership-67		Richards-DT	Becky	Richards	Developmental Therapeutics	rrichards5@gmail.com	Pediatrics	6082659645		https://www.pediatrics.wisc.edu/staff/richards-md-rebecca-becky/	Assistant Professor		Core		Complete									Tamplin, Owen
271		rickew@urology.wisc.edu	William	Ricke	Tumor Microenvironment	rickew@urology.wisc.edu	Urology	608-265-3202		https://metc.wisc.edu/william-ricke-phd/	Professor													Wesley, Umadevi
273		jdrogers5@wisc.edu	Jeremy	Rogers	Tumor Microenvironment	jdrogers5@wisc.edu	Biomedical Engineering	608-262-8357		https://directory.engr.wisc.edu/bme/Faculty/Rogers_Jeremy/	Assistant Professor													Wilke, Lee
276		promero2@wisc.edu	Philip	Romero	Developmental Therapeutics	promero2@wisc.edu	Biomolecular Chemistry	608-262-5943		https://biochem.wisc.edu/faculty/romero	Assistant Professor													Woods, Jon
277		ronnekleiv-kelly@surgery.wisc.edu	Sean	Ronnekleiv-Kelly	Tumor Microenvironment	ronnekleiv-kelly@surgery.wisc.edu	Surgery	303-532-6084		https://www.surgery.wisc.edu/staff/sean-ronnekleiv-kelly/	Assistant Professor													Yesilkoy, Filiz
278		asroopra@wisc.edu	Avtar	Roopra	Genetic and Epigenetic Mechanisms	asroopra@wisc.edu	Neuroscience	608-262-6930		https://neuro.wisc.edu/staff/roopra-avtar/	Associate Professor													Asthana, Sanjay
279		rosadomendez@wisc.edu	Ivan	Rosado-Mendez	Imaging and Radiation Sciences	rosadomendez@wisc.edu	Medical Physics	608-265-6116		https://www.medphysics.wisc.edu/blog/staff/rosado-mendez-ivan/	Assistant Professor													Engin, Feyza
280		srose2@wisc.edu	Stephen	Rose	Developmental Therapeutics	srose2@wisc.edu	Obstetrics and Gynecology	608-263-1209	608-263-1210	https://www.obgyn.wisc.edu/directory/detail.aspx?id=32	Professor (CHS)													Kamp, Timothy
282		sroy@biostat.wisc.edu	Sushmita	Roy	Genetic and Epigenetic Mechanisms	sroy@biostat.wisc.edu	Biostatistics and Medical Informatics	608-316-4453		https://wid.wisc.edu/people/sushmita-roy/	Assistant Professor													Le, Hau
283		lrui@medicine.wisc.edu	Lixin	Rui	Developmental Therapeutics	lrui@medicine.wisc.edu	Medicine	608-265-8525		http://www.medicine.wisc.edu/people-search/people/staff/4456/Rui_Lixin/	Associate Professor													Martell, Jeffrey
284		russell@surgery.wisc.edu	John	Russell	Imaging and Radiation Sciences	russell@surgery.wisc.edu	Surgery	608-263-3839		https://www.surgery.wisc.edu/staff/john-russell/	Senior Scientist					Developmental Therapeutics	MD			UWCCC Admin	UW2020 WARF Discovery Initiative Grant - "Metabolic profiling of leukemic cells through isotope tracing in patients with chronic lymphocytic leukemia" (Role: Co-PI) VA Merit Award - "A Metabolic Decision Point in the Progression of Lymphoid Malignancies" (Role: Co-PI) VA CSP Collaborative Grant - "VA Lung Precision Oncology Program" (Role: Co-PI) CCSG Pilot - "Landscape of EBV positive Diffuse Large Cell Lymphoma and Post-Transplant Lymphoproliferative Disease in Wisconsin" (Role: PI, collab with Johannsen and Ranheim)	Dr. Fletcher’s clinical interests include clinical management of cancers of the blood, particularly lymphoma and multiple myeloma. Dr. Fletcher’s clinical research focuses on clinical trials of chemotherapy and/or immunotherapy agents for treatment of lymphomas.		Fletcher, Christopher	DT	TRUE
286		esadowski@uwhealth.org	Elizabeth	Sadowski	Imaging and Radiation Sciences	esadowski@uwhealth.org	Radiology	608-263-9028		https://www.radiology.wisc.edu/profile/elizabeth-sadowski-48/	Professor (CHS)					Developmental Therapeutics	PhD			Christian Capitini		Tumor immunotherapy; drug delivery system; CAR-T therapy.	22/08/2003 03:29 PM	Hu, Quanyin
287		ksaha@wisc.edu	Krishanu	Saha	Tumor Microenvironment	ksaha@wisc.edu	Biomedical Engineering	608-316-4313		https://directory.engr.wisc.edu/bme/faculty/saha_krishanu	Associate Professor					Developmental Therapeutics Genetic and Epigenetic Mechanism		bdrolet		Nihal Ahmad, Rich Halberg		Oncogenes in vascular development and vascular anomalies		Drolet, Beth	DT	TRUE
Membership-103		Sahasrabudhe-DT	Kieran	Sahasrabudhe	Developmental Therapeutics	kdsahasr@medicine.wisc.edu	Medicine - Hematology, Medical Oncology and Palliative Care	5852171849		https://www.medicine.wisc.edu/directory/sahasrabudhe_kieran	Assistant Professor		Affiliate		Pending	Developmental Therapeutics	MD	VTMA30	https://orcid.org/0000-0002-8417-2787	Dr. Mark Albertini	Title: Targeting Liver Metastases to Enhance Durable Anti-Tumoral Immunity in Melanoma Source: Rogel Cancer Center Translational and Clinical Research Grant Total Award: $150,000 (direct costs) Award Dates: 04/01/21 – 03/31/23 PI: Michael Green Candidate’s Role: Co-Investigator (no effort) Description: Dr. Ma provided preliminary data and conceptualized the trial protocol/schema Title: Targeting Liver Metastases to Enhance Immunotherapy Efficacy in Melanoma Source: Melanoma Research Alliance Young Investigator Award Total Award: $150,000 Award Dates: 04/01/21 – 03/31/23 PI: Michael Green Candidate’s Role: Co-Investigator (no effort) Description: Dr. Ma provided preliminary data and conceptualized the trial protocol/schema	My research interest is in optimizing therapeutic strategies in melanoma and other advanced cutaneous malignancies with an emphasis in early phase clinical trial investigation involving immunotherapy and molecular targeted agents. Recently, I've worked on grant proposals and submitted manuscripts looking at the role of a response-adapted treatment strategy in advanced melanoma using biomarkers of response in the early course of treatment with immunotherapy. Since starting faculty in August 2021, I have collaborated with several members of the UW Carbone Cancer Center on various projects and submitted several grant proposals. These projects include: evaluating the predictive role of PET imaging with immunotherapy, validating a melanoma circulating tumor cell assay, and evaluating the therapeutic role of targeting PLK1 in melanoma. As a member of UWCCC, I hope to take advantage of core grant and various pilot grant opportunities to fund various investigator initiated trial proposal. My hope is to submit a future grants looking at the role of liver-directed radiation therapy in combination with dual checkpoint blockade therapy in advanced stage melanoma. I hope to continue collaborating with scientists at UW to evaluate various molecular targets and translate these findings into the clinical trial setting.	22/04/2004 04:27 PM	Ma, Vincent
398		lsalkowski@uwhealth.org	Lonie	Salkowski	Cancer Prevention and Control	lsalkowski@uwhealth.org	Radiology			https://radiology.wisc.edu/profile/lonie-salkowski-49/	Professor (CHS)		Core		Complete	Imaging and Radiation	PhD	bwpogue	0000-0002-9887-670X	Robert Jeraj	R01 EB023909 PI R01 EB032337 subcontract PI	see attached	22/04/2004 05:08 PM	Pogue, Brian
Membership-137		Samarasinghe-TM	Amali	Samarasinghe	Tumor Microenvironment	amali.samarasinghe@wisc.edu	Medicine	6082623446		https://www.medicine.wisc.edu/directory/samarasinghe_amali	Associate Professor		Core		Complete	Cancer Prevention and Control	MD MPH	Balentine		colleague	currently NIH K76 but not cancer related	Evaluating outcomes of treatment for thyroid cancer		Balentine, Courtney	CPC	TRUE
288		samsonov@wisc.edu	Alexy	Samsonov	Imaging and Radiation Sciences	samsonov@wisc.edu	Radiology	608-265-2104		https://www.radiology.wisc.edu/profile/alexey-samsonov-415/	Associate Professor (CHS)					Tumor Microenvironment	PhD	AYUSODOMINGUE	0000-0002-9414-1845	David J Beebe, Nihal Ahamd, Paul Harari	1. State Economic Engagement and Development (SEED) Research Program grant.	I develop advanced in vitro microphysiological platforms to mimic the tumor microenvironment structure. These platforms allow us to generate complex 3D systems that include tumor, immune, and stromal cells provided with lymphatic and endothelial vasculature. Further, we can monitor and control nutrient, pH, and oxygen concentration in the system. Overall, these platforms enable us to visualized the effect of multiple aspects of the tumor microenvironment in tumor progression and treatment response.		Ayuso Dominguez, Jose Maria	TM	TRUE
Membership-147		Sandbo-TM	Nathan	Sandbo	Tumor Microenvironment	nsandbo@medicine.wisc.edu	Medicine	6082654576		https://www.medicine.wisc.edu/apcc/sandbo-research	Professor Associate Chief for Research, Division of Allergy, Pulmonary, and Critical Care		Core		Complete	Tumor Microenvironment	PhD	ALEXANDERB (14265668)	0000-0003-1015-2561	Dr. Nihal Ahmad	CNPQ-Universal 405977/2018-2 Birbrair (PI) 12/06/18-12/06/21 The role of GFAP+ cells in the tumor microenvironment Instituto Serrapilheira Serra-1708-15285 Birbrair (PI) 01/10/18-07/14/23 Regulation of prostate cancer by the peripheral nervous system FAPEMIG-Universal APQ-01321-21 Birbrair (PI) 11/01/21-11/01/24 The role of sensory neuronal activity in tumor development	My major research interest is how the nervous system regulates cancer progression. To explore this, we will investigate the interactions of peripheral neuronal circuits within the tumor; the central nervous system involvement with the intra-tumoral neurons; the neuron-glia communication within the tumor microenvironment; the neuro-vascular interaction in the TME and the role of nerves in metastatic niches. Our goal is to identify novel potential cellular and molecular targets for cancer therapy.	22/11/2005 08:38 PM	Birbrair, Alexander
290		msandor@wisc.edu	Matyas	Sandor	Tumor Microenvironment	msandor@wisc.edu	Pathology and Laboratory Medicine	608-265-8715		https://www.cmp.wisc.edu/trainers/matyas-sandor	Professor					Tumor Microenvironment	PhD	Witzenburg	0000 0002 9117 4422	Kevin Eliceiri		Within a soft tissue, damage or disease often causes cells to remodel their surrounding extracellular matrix (ECM), which dictates mechanical response, in a non-uniform manner. For example, tumor formation often involves local degradation and synthesis of collagen and other ECM proteins, altering regional stiffness and anisotropy of a tissue. Currently, there few methods to quantify regional variability in the mechanical behavior or properties of soft tissues. The state of the art is to compress small regions (often a non-physiologic loading modality) or by cutting tissue into increasingly smaller samples. We have successfully created an anisotropic inverse mechanics method capable of quantifying regional differences in mechanical properties and applied it to tissue analogs. Our goal is to apply this method to various soft tissues alongside quantitative histology to capture how structure and mechanics vary locally around tumorous tissues.		Witzenburg, Colleen	TM	TRUE
291		geltzeiler@surgery.wisc.edu	Cristina	Sanger	Cancer Prevention and Control	geltzeiler@surgery.wisc.edu	Surgery	608-263-2521		https://www.surgery.wisc.edu/staff/cristina-geltzeiler/	Assistant Professor (CHS)					Developmental Therapeutics	MD PhD	ssmccoy30	0000-0002-5293-4185	Jacques Galipeau	Wisconsin Head and Neck Cancer SPORE Career Enhancement Program (Pending)	My research focuses on defining minor salivary gland mesenchymal stromal cell (MSC) immunobiology in SjD, a systemic autoimmune disease with hallmark features of severe dry eye and mouth (aka xerostomia). My unique ability to perform minor salivary gland biopsies, isolate, and culture adapt minor salivary gland MSCs has recently opened new horizons in other areas of xerostomia research. More specifically, I am working collaboratively with Drs. Galipeau (heme/onc), Kimple (rad onc), and Blitzer (rad onc) to address the critical need to develop new effective therapies to treat radiation-induced xerostomia. MSCs serve as a cellular product that can promote tissue healing in a variety of settings, primarily through the MSC secretome. Our long-term goal is to develop MSC products that cure radiation-induced xerostomia. Toward this end, we recently submitted a proposal to characterize culture-adapted MSCs derived from minor salivary glands of head and neck cancer (HNC) patients.		McCoy, Sara	DT	TRUE
292		sauer3@wisc.edu	John-Demian	Sauer	Developmental Therapeutics	sauer3@wisc.edu	Medical Microbiology and Immunology	608-263-1529	608-263-4230	https://www.cmp.wisc.edu/trainers/john-demian-sauer	Associate Professor					Imaging and Radiation	MD		0000-0003-3178-3004	Dr. Randall Kimple	ASCO Young Investigator Award $50,000 for phase I clinical trial investigating mesenchymal stem cells for radiation-induced xerostomia	I am an assistant professor in the Department of Human Oncology at the University of Wisconsin. My goal over the next several years is to become an independent clinical scientist, leading clinical trials that utilize laboratory discoveries, such as the use of circulating tumor DNA (ctDNA) as a risk stratification tool for endometrial cancer. I am currently involved in a clinical trial investigating ctDNA to guide prostate cancer treatment. I additionally am involved in translational research investigating cellular therapies to improve the quality of life of cancer patients. I have played a key role in prior clinical trials investigating cellular therapy – mesenchymal stromal cells (MSCs) – as a curative therapy for radiation-induced xerostomia. I wrote the clinical trial protocols for both the pilot FDA Investigation New Drug (IND) enabling study as well as the phase I clinical trial of MSCs and am assisting in the ongoing phase I clinical trial. As a radiation oncologist and translational researcher I will bring my experience in clinical trials to the UWCCC and ensure successful collaborations with other UWCCC researchers.	22/04/2007 02:53 PM	Blitzer, Grace	unaligned
294		tschmidt@medicine.wisc.edu	Timothy	Schmidt	Developmental Therapeutics	tschmidt@medicine.wisc.edu	Medicine			https://www.medicine.wisc.edu/people-search/people/staff/7217/Schmidt_Timothy	Assistant Professor (CHS)					Genetic and Epigenetic Mechanism	PhD	CIJILIM	0000-0003-3327-1926		R00GM131023	Telomeres are repetitive DNA and associated proteins at the ends of linear chromosomes. They protect our chromosome ends from being misread as broken ends, underlining the importance of telomeres for genome stability, and they also serve as a “clock” for our biological lifespan. Our lab seeks to investigate the molecular mechanisms of human telomere maintenance using an interdisciplinary approach. This includes structural studies using cryo-electron microscopy (cryo-EM) and spatial/temporal studies using single-molecule imaging techniques. Specially, our lab focuses on two major areas – 1) Telomere chromatin organization and 2) Telomere replication mechanism		Lim, Ci Ji	unaligned
296		schneiderd@surgery.wisc.edu	David	Schneider	Cancer Prevention and Control	schneiderd@surgery.wisc.edu	Surgery	608-263-1903		http://www.surgery.wisc.edu/profile/david-schneider	Assistant Professor					Tumor Microenvironment	PhD	cloleary	0000-0001-9052-4593	Christian Capatini, Jim Gern	K22AI166029 pending	I am broadly interested in epithelial-immune interactions in the gastrointestinal tract, with a particular focus on tuft cells, barrier function, and microbiome-derived tuft cell ligands. Tuft cells are normally found throughout the GI and in many "hollow" organs, but also arise in the pancreatic duct and esophagus during precancerous injury/lesions. The role of tuft cells in early tumorigenesis remains controversial. I hope to use my expertise and mouse models to investigate these questions in collaboration with UWCCC members. In addition, I hope to expand my work in the biliary tree into cholangiocarcinoma studies, as this is a deadly and poorly understood cancer which I am uniquely positioned to investigate.		O'LEARY, CLAIRE	TM	TRUE
301		cmseroogy@pediatrics.wisc.edu	Christine	Seroogy	Tumor Microenvironment	cmseroogy@pediatrics.wisc.edu	Pediatrics	608-263-2652	608-265-6366	http://www.cmp.wisc.edu/trainers/chris-seroogy	Professor					Developmental Therapeutics	MS PhD	apennati	https://orcid.org/ 0000-0001-8435-1999	Dr. Capitini	UG3DE030431 (Kimple, PI) 07/1/2021−06/30/2022 NIH/NIDCR Intra-salivary gland autotransplantation of marrow mesenchymal stromal cells for treatment of radiation induced xerostomia. This award serves to complete an IND application for a first-in-human clinical trial of MSC for xerostomia.	Andrea Pennati, M.Sc., Ph.D., Scientist III, UW-SMPH Dep. of Medicine, Director R&D, Program for Advanced Cell Therapy (PACT) UW – Madison: Our collaborative team’s research mission, led by Dr. Jacques Galipeau, MD FRCP(C), is to develop rationally designed immunotherapy-based combination treatments for cancer, capable of generating long-term cures against all stages of disease burden. Within Dr. Galipeau’s research program, some projects that I lead involve the use of phenotypic and cellular assays, as well as translationally relevant in vivo models, to investigate novel approaches to improve immunotherapeutic outcomes and care. The projects that I am involved in are multifaceted, including investigating the combination immunotherapy and ex vivo stimulated  T cell-depleted PBMCs to improve antibody-dependent cell-mediated cytotoxicity (ADCC); augment the persistency and activity of tumor infiltrating lymphocytes (TILs), and improve salivary function post-radiation-induced xerostomia for patients who underwent head and neck cancer radiation therapy. I began my tenure in Dr. Galipeau’s lab as a postdoc in 2011 at Emory University, investigating the role of fusion protein for immunotherapies and cancer vaccines. Engineered chimeric cytokines can generate gain-of-function activity in immune cells as the potent antitumor activity for the fusion cytokine generated by the N-terminal coupling of GM-CSF to IL-4, aka GIFT4. B cells treated with GIFT4 clustered GM-CSF and IL-4 receptors on the cell surface and displayed a pan-STAT hyper-phosphorylation associated with the acquisition of a distinct phenotype and function. Human GIFT4-licensed B cells primed cytotoxic T cells and specifically killed melanoma cells in vitro and in vivo. We showed GIFT4 could mediate the expansion of B cells with potent antigen-specific effector function. As an Associate Scientist, when I moved to UW – Madison in 2016, I have expanded my research within the lab to include in vivo research, leading a series of translationally relevant projects interrogating the use of ex vivo stimulated  T cell-depleted PBMCs in combination with 1) anti-CD38 for multiple myeloma -in collaboration with Dr. Capitini; 2) cetuximab for head and neck cancer -in collaboration with Dr. Kimple; 3) cetuximab for pancreatic cancer -in collaboration with Dr. Morris. Other lines of research included augmented activity and persistency of TILs from ascites with new engineered fusion proteins -with Dr. Patankar, and intra-salivary gland autotransplantation of marrow mesenchymal stromal cells for treatment of radiation-induced xerostomia -in collaboration with Dr. Kimple/Dr. Blitzer. The information gathered from these studies will allow for rationally designed, effective combination therapies aimed at harnessing the immune system to eradicate cancer while simultaneously disabling the ability of the disease to recur.		Pennati, Andrea	DT	TRUE
Membership-132		Serritella-DT	Anthony (Tony)	Serritella	Developmental Therapeutics	serritella@medicine.wisc.edu	Department of Medicine, Division of Hematology, Medical Oncology, and Palliative Care				Assistant Professor		Affiliate		Complete	Tumor Microenvironment	MD		0000-0002-4079-9051	David Jarrard	"Spatial Immunophenotype as a Prognostic Biomarker in Renal Cell Carcinoma" Pilot Grant, Wisconsin Urological Society PI: Daniel Shapiro	I am an assistant professor of urologic oncology within the department of urology. My research is focused on understanding how kidney cancer tumor cells stimulate immune infiltration, how the immune cells organize within the tumor microenvironment, and how the immune response to kidney tumors can impact patient prognosis. Beyond looking the type of immune cell infiltration, I am specifically interested in understanding how immune cells organize in the microenvironment to create functional interactions that result in improved tumor control. It seems clear in other malignancies than an ordered response and the establishment of functional immune structures, such as tertiary lymphoid structures, in the tumor immune microenvironment leads to improved outcomes, but this has not been explored in kidney cancer. Current studies I am conducting are using tumor samples to explore the spatial interactions between effector and regulatory immune cells and how this relates to tumor progression after surgical resection. Additionally, I am investigating how the presence of mature tertiary lymphoid structures in the RCC tumor microenvironment impacts patient prognosis. Finding potential ways to stimulate an effective and organized immune response may enhance our ability to prevent tumors from recurring after surgical resection of localized disease and improve responses to immunotherapy in the metastatic setting. My research is in line with the thematic aims of the Tumor Microenvironment Program within the UWCCC, which is focused on how the host-tissue environment impacts tumor formation and progression. The studies I will be conducting will be directly evaluating the host immune response to kidney cancer tumors and how this impacts patient prognosis. Additionally, I aim to try and determine pathways that may be targeted to produce a more organized immune response within the microenvironment. The collaborative environment and resources available through the UWCCC will help me to better achieve my research goals, improve patient care, and advance the mission of the tumor microenvironment program.		Shapiro, Daniel	TM	TRUE
303		vsetaluri@dermatology.wisc.edu	Vijay	Setaluri	Developmental Therapeutics	vsetaluri@dermatology.wisc.edu	Dermatology	608-263-5362	608-262-8133	https://dermatology.wisc.edu/staff/setaluri-vijayasaradhi/	Professor					Genetic and Epigenetic Mechanism	PhD	JESWEBER711	0000-0003-4839-6684	Dr. Randy Kimple--colleague, Dr. Pippa Cosper--colleague	R35GM142891--Mining natural infection variation to find the genetic basis of coevolution between vertebrate hosts and helminth parasites DUNS#614209054NSF-Understanding the Rules of Life: Emergent Networks. Does re-wilding lead to re-wiring of gene expression and species interaction networks? (Senior Personnel--2yrs grad student RA support)	1) Most of my research focuses on the evolution and genetics of complex adaptive traits. I have developed a laboratory infection model that uses forward genetics and population genomics to study how vertebrates evolve immune responses to detect and purge parasites, as well as how parasites evolve to evade and suppress host immunity. 2) I am also starting to examine the overlap between methylation-associated responses to aging and environmental stress, potentially looking at correlations with cancer biomarkers. 3) I am eager to develop collaborations that develop and test models of how cancer evolves under different demographic (i.e., tumor size constraints) and selective regimes (i.e., under different combinations and cycles of chemical and radiation therapy).		Weber, Jesse	GEM	TRUE
Membership63		Shapiro-TM	Daniel	Shapiro	Tumor Microenvironment	ddshapiro@wisc.edu	Urology	9207403911		https://urology.wisc.edu/blog/staff/shapiro-md-daniel/	Assistant Professor		Core	22/11/2011	Complete	Developmental Therapeutics	MD PhD	RRICHARDS5		Christian Capitini	American Society of Hematology Scholar Award MACC Fund project-focused gift fund	My lab aims to develop next-generation CAR-T cells to advance therapy for AML patients, and to establish principles of CAR-T cell and tumor cell biology that will be broadly applicable in the Immuno-oncology field.	22/02/2009 03:45 PM	Richards, Becky	DT	TRUE
Membership-72		Sharifi-TM	Marina	Sharifi	Tumor Microenvironment	msharifi@wisc.edu	Medicine	6082633618			Assistant Professor		Affiliate		Complete	Cancer Prevention and Control	MD MS	12233458		Sharon Weber	I do not hold currently active grants but plan to apply for grant funding this fall.	I am a clinical and translational researcher with particular interest in gastric cancer. I aim to obtain grant funding for early detection of gastric cancer in the state of Wisconsin and to broaden the clinical trials portfolio for gastric cancer patients as well as for other upper GI cancers at the cancer center. I also aim to grow the biobank specimens that we have for gastric and other upper GI cancers to develop a resource for future molecular based studies.		Kelly, Kaitlyn	CPC	TRUE
305		brshaw@wisc.edu	Bret	Shaw	Cancer Prevention and Control	brshaw@wisc.edu	Life Sciences Communication	608-890-1878		https://lsc.wisc.edu/staff/shaw-bret/	Associate Professor					Cancer Prevention and Control	PhD RN	MEGAN.MILLER	0000-0001-7345-1687	Dr. Kristine Kwekkeboom, mentor and collaborator	Kwekkeboom, K., Campbell, T., Miller, M. (2022-2023). University of Wisconsin–Madison, Vice Chancellor for Research and Graduate Education. Feasibility Study of Coordinated Management for Co-Occurring Cancer-Related Symptoms. Role: Co-I. (Budget $58,442.00). Funded. Role: Co-Investigator. Miller, M. (2021-2023). American Holistic Nurses Association (AHNA) Research Grant Award for The Role of Spiritual Well-Being in Pain Experiences among Adults with Cancer: An Explanatory Sequential Mixed-Methods Study. Role: PI. (Budget $5,000). Funded. Role: Principal Investigator.	I am passionate about exploring the role of spirituality in supporting holistic wellbeing for cancer patients, and especially how spirituality might influence symptom self management. My current mixed-methods research examines the various meanings of spirituality and the role it plays among patients who are facing cancer-related pain. I am also moving my program of research toward developing and testing supportive therapies (mindfulness meditation, yoga, psilocybin-assisted therapy).	22/09/2012 12:51 PM	Miller, Megan	CPC
306		jps@medicine.wisc.edu	John	Sheehan	Tumor Microenvironment	jps@medicine.wisc.edu	Medicine	608-262-1964		https://www.medicine.wisc.edu/people-search/people/staff/411/SHEEHAN_JOHN_P	Professor					Developmental Therapeutics	PhD	Not currently applicable	0000-0001-6499-8111	Christian Capitini	Not currently applicable	My role in the UW–Madison, Program for Advanced Cell Therapy (PACT) is to enable the development and implementation of first-in-human, cell and gene therapies under current Good Manufacturing Practices (cGMP) to meet FDA guidelines and requirements for Phase 1 clinical trials. PACT currently has one active, cancer-relevant, Phase I clinical trial for the treatment of head and neck cancer radiation therapy-induced Xerostomia. PACT is also currently developing a process for the manufacture of an autologous, GD2 tumor-associated antigen, chimeric antigen receptor T cell (CAR T) therapy for Sarcoma.		Meyers, Ross	unaligned	TRUE
Membership-114		Sheng-CPC	Jingxi	Sheng	Cancer Prevention and Control	jsheng29@wisc.edu	School of Nursing	6082635189			Assistant Professor		Affiliate		Complete	Tumor Microenvironment	MD, PhD	MNSHARIF	0000-0003-0128-3033	Joshua Lang	Department of Defense Physician Research Award (2023-2027) Grant: Interrogating the intersection of PSMA and PI3K pathway signaling as a novel combination approach in treatment resistant prostate cancer Total Costs: $1,166,252 Role: PI Prostate Cancer Foundation Young Investigator Award (2022-2025) Grant: Elucidating molecular correlates of PSMA expression in prostate cancer liquid biopsies to identify biomarkers of response and resistance to PSMA-targeted therapies. Total Costs: $225,000 Role: PI Doris Duke Physician Scientist Fellowship (2021-20203) Grant: Multiplex liquid biopsy as a novel biomarker for PI3K inhibitor therapies Total Costs: $220,000 Role: PI	My research uses rare cell protein, transcriptional and genomic analyses of patient-derived tissue and liquid biopsy specimens to elucidate tumor cell intrinsic and extrinsic mechanisms of resistance to targeted therapies in advanced breast and prostate cancer, with a focus on therapies targeting the PI3K pathway. The tumor microenvironment plays a key role in regulating PI3K pathway signaling in breast and prostate cancer, and thus understanding the microenvironmental contribution to Pi3K inhibitor resistance forms an integral part of my overall research program.	23/02/2001 06:07 PM	Sharifi, Marina	TM	TRUE
308		nsherer@wisc.edu	Nathan	Sherer	Human Cancer Virology	nsherer@wisc.edu	Oncology	608-890-2551		https://mcardle.wisc.edu/who-we-are/mcardle-faculty/nathan-m-sherer-phd	Associate Professor					Virology	PhD	dneum1		Robert Kalejta, Shannon Kenney	CTCF-mediated HSV-1 gene expression in latency and reactivation Source: NIH/NIAID R01AI134807 Molecular genetics of HSV reactivation Source: NIH-NIAID R01AI048633 HSV-1 reactivation and glaucomatous trabecular meshwork damage Source: NIH-NEI R21EY034295	I study chromatin control of viral infections. dsDNA viruses and eukaryotic cell share similar epigenetic mechanisms to regulate transcription. Understanding these complicated mechanisms and how they are dysregulated in the context of a virus can aid in the understanding of complex human diseases.		Neumann, Donna	VR	TRUE
Membership-79		Shields-unaligned	Bridget	Shields	Genetic and Epigenetic Mechanisms	bshields@dermatology.wisc.edu	Dermatology	3199365964		https://dermatology.wisc.edu/staff/shields-bridget/	Assistant Professor		Affiliate	23/12/2005	Complete	Cancer Prevention and Control	MD MPH			Colleague		My research is focused on several aspects of colorectal cancer care, disparities in administration of chemotherapy for colon cancer, sarcopenia and its role in colorectal cancer outcomes, focusing on pre-habilitation and improvement of outcomes after surgery for colorectal cancer	23/08/2003 02:38 PM	Hayden, Dana	CPC	TRUE
310		eshusta@wisc.edu	Eric	Shusta	Developmental Therapeutics	eshusta@wisc.edu	Chemical and Biological Engineering	608-265-5103		http://www.engr.wisc.edu/che/faculty/shusta_eric.html	Professor					Genetic and Epigenetic Mechanism	PhD	JDILWORTH@OHRI.CA	orcid.org/0000-0002-6265-8102	Colleague - Emery Bresnik	As a new investigator, funding is past funding: Targeting the epigenetic state of refractory and relapsing acute myeloid leukemia. Canadian Institutes of Health Research – CEEHRC Epigenetics Clinical Translation Grants. Duration: 4 years (2/01/2019-1/31/2023). Award $375,000 per year ($62,500 per year for the Dilworth Lab). Genomic Analysis of Rhabdomyosarcoma Tumor Initiating Cells. Canadian Institutes of Health Research – Operating Grant (Cancer Biology & Therapeutics Panel). Duration: 5 years (04/01/2014-09/30/2019). Award $65,000 per year for the Dilworth Lab.	As an epigenetics laboratory studying muscle stem cells in regeneration, we are interested in deciphering how the muscle stem cell determining transcription factor Pax7 causes the development of rhabdomyosarcoma when fused to Foxo transcription factors (Pax7-FKHR). Our working hypothesis is that Pax7-FHKR is a potent reprogramming factor that generates a cancer stem cell that drives rhabdomyosarcoma development.		Dilworth, F Jeffrey	GEM
311		sippel@surgery.wisc.edu	Rebecca	Sippel	Developmental Therapeutics	sippel@surgery.wisc.edu	Surgery	608-263-1387		http://www.surgery.wisc.edu/profile/rebecca-sippel	Professor					Genetic and Epigenetic Mechanism	PhD	markmeyer	0000-0001-6612-7491	Elaine Alarid, Emery Bresnick, Wei Xu	R01-CA260140 (PI: Elaine Alarid) - NCI, Role: Co-I Non-cancer: R01HL159645 - NHLBI (PI: Meyer), R01DK117475 NIDDK, Role: Co-I	See attached Research Interests Document. The Meyer Lab studies the dynamic chromatin environment responsible for serum calcium and phosphate maintenance and the impacts of vitamin D metabolism in skeletal, renal, and intestinal biology. A triumvirate of endocrine hormones – parathyroid hormone (PTH), fibroblast growth factor 23 (FGF23), and calcitriol (1,25(OH)2D3) – maintain this delicate balance by influencing enzymes, transporters, and transcription factors to drive genomic change. When dysfunctional, these mechanisms allow chronic inflammation and disease progression to worsen in chronic kidney disease-metabolic bone disorder (CKD-MBD), atherosclerosis, inflammatory bowel disease (IBD), and many others. Additionally, low vitamin D status has a correlation with an increase in cancer risk in cancers such as colorectal, breast, and prostate. Higher vitamin D status has been linked to longer survival rates in cancer patients. Dietary and nutritional supplementation of vitamin D rapidly corrects the body’s mineral deficiencies, however its ability to ameliorate inflammatory disease progression or improve cancer outcomes remains controversial. We study the intricate genomic and molecular mechanisms that regulate the biological changes controlling the intersection of metabolism, inflammation, and disease progression using unique animal models, genomic editing techniques, and -omics bioinformatic approaches to generate unbiased interrogation of chromatin changes.		Meyer, Mark	GEM	TRUE
312		mcskala@wisc.edu	Melissa	Skala	Tumor Microenvironment	mcskala@wisc.edu	Biomedical Engineering	608-316-4108		https://directory.engr.wisc.edu/bme/Faculty/Skala_Melissa/	Professor					Developmental Therapeutics Genetic and Epigenetic Mechanism Tumor Microenvironment	MD	BSHIELDS30	0000-0002-5734-0167	Nihal Ahmad PhD	1. Dermatology Foundation Medical Dermatology Career Development Award 2. Autofluorescence Imaging Platform for Clinical Tissues, UW Institute for Clinical and Translational Research 3. Clinical and molecular investigation of cutaneous granulomatous diseases to elucidate pathomechanisms, reveal new therapeutic targets, and understand associations with debilitating systemic disease, UW Skin Disease Research Center	I am a board-certified dermatologist and early-career investigator. My interests in skin cancer and the cutaneous manifestations associated with systemic malignancy were piqued during my dermatology residency at the University of Wisconsin, where I served as chief resident. I subsequently trained as a fellow in complex medical dermatology at the University of Pennsylvania. Throughout fellowship, I focused on understanding the clinical manifestations—and mechanisms underlying—the development of complex skin conditions as markers of underlying malignancy. I now run the UW inpatient consultation service where I interface with numerous cancer patients. My research interests focus on tumor microenvironment, novel imaging modalities for skin malignancy, and the mechanisms underlying granulomatous and neutrophilic dermatoses associated with hematologic cancer. I have multiple peer-reviewed publications and book chapters on these topics.		Shields, Bridget	unaligned	TRUE
Membership-140		Skop-CPC	Ahna	Skop	Cancer Prevention and Control	skop@wisc.edu	Medicine	6082621593		https://skoplab.weebly.com/, https://genetics.wisc.edu/staff/skop-ahna/	Professor of Genetics		Affiliate		Complete	Virology	PhD	mgaglia	0000-0002-1791-0663	Robert Kalejta	R01 CA268976, National Institutes of Health – NCI Gaglia, Marta Maria (PI) 12/01/21-11/30/26 Determining how Kaposi's sarcoma-associated herpesvirus hijacks caspase function to inhibit anti-viral responses	One of the focus of my laboratory is the human oncogenic virus Kaposi's sarcoma-associated herpesvirus (KSHV). In particular, we study how this virus blocks host innate immune responses to replicate. Replication of KSHV is important for tumor development and/or maintenance	23/04/2004 02:53 PM	Gaglia, Marta	VR
Membership-157		slagowski@wisc.edu	Jordan	Slagowski	Imaging and Radiation Sciences	slagowski@wisc.edu	Human Oncology	6082621147		https://www.humonc.wisc.edu/team_member/jordan-slagowski-phd-dabr/	Assistant Professor
313		islukvin@wisc.edu	Igor	Slukvin	Developmental Therapeutics	islukvin@wisc.edu	Pathology and Laboratory Medicine	608-263-0058	608-265-5822	https://www.cmp.wisc.edu/trainers/igor-slukvin	Professor					Cancer Prevention and Control Genetic and Epigenetic Mechanism	MD	LISAARKIN	0000-0002-0468-9568	Nihal Ahmad, PhD	Dermatology Foundation Career Development Award: Towards a Precision Based Approach to Port Wine Birthmarks	My research focuses on investigation of the underlying genetics and vascular biology of vascular anomalies to drive improved targeted therapeutics and more precise use of laser. These anomalies are caused by mosaic variants in genes associated with cell growth and proliferation, most of which are also observed in malignancy. The field has begun to repurpose therapeutics created for cancer in vascular anomalies, but understanding how and why these interrupt the downstream pathways is of paramount importance. We are also looking at in vivo cutaneous imaging of vascular anomalies to better understand vascular biology based on genotyping, and how to create more precise laser settings when this is utilized.	23/06/2004 02:29 PM	Arkin, Lisa	CPC	TRUE
Membership46		Slutske-CPC	Wendy	Slutske	Cancer Prevention and Control	slutske@wisc.edu	Family Medicine and Community Health			https://ctri.wisc.edu/researchers/research-staff/wendy-slutske-phd/	(visting) Professor		Affiliate		Complete	Cancer Prevention and Control	PhD	BBOLLING01	0000-0002-4222-2467	Dr. Nihal Ahmad	Pilot study of the anti-cancer effects of phytochemicals from Greorgia-06H peanut cultivar on a leukemia cell line. (The Peanut Institute) Anti-inflammatory activity of yogurt mediated by the intestinal barrier. (National Dairy Council) Bioavailability of aronia berry polyphenols (UW–Madison VCGRE)	We are studying food chemistry, metabolism of dietary bioactives, and prevention of chronic inflammation to reduce chronic disease risk. Chronic inflammation and oxidative stress contributes to cancer risk, and optimizing diets can reduce cancer risk and improve cancer treatment. We are studying dietary bioactives from vegetables, fruits, nuts, and fermented dairy products and their impact on intestinal immune function and chronic inflammation. We are using cell models and human intervention studies to investigate mechanisms by which foods inhibit chronic inflammation.		Bolling, Bradley	CPC	TRUE
314		smith@chem.wisc.edu	Lloyd	Smith	Genetic and Epigenetic Mechanisms	smith@chem.wisc.edu	Chemistry	608-263-2594	608-262-9207	https://www.chem.wisc.edu/users/smith	Professor					Imaging and Radiation	PhD	LMEIMETIS	0000-0002-5304-2066	Jamey Weichert	1. "PSMA-Targeted In Situ Immunization for the Treatment of Metastatic Castration-Resistant Prostate Cancer", Dept. of the Army -- USAMRAA, (PC210330). $1.2M over 3yr	My lab is developing new compounds to address a clinical challenge seen in a variety of late-stage cancers which is tumor heterogeneity and lack of immune response. I believe that drug combinations coupled with intelligent drug delivery systems may provide success. Currently, we are evaluating targeted radionuclide therapy and antibody-drug conjugates with the goal of branching out into biologic prodrugs.	23/07/2007 02:38 PM	Meimetis, Labros	IR
Membership-87		Sobecki-CPC	Janelle	Sobecki	Cancer Prevention and Control	janelle.sobecki@wisc.edu	Obstetrics and Gynecology, Division of Gynecology Oncology	7737181252		https://www.obgyn.wisc.edu/Directory/Profile/janelle.sobeckiwi	Assistant Professor (CHS)		Affiliate	23/08/2009	Complete	Developmental Therapeutics Imaging and Radiation	MD PhD	QSODJI	0000-0002-9469-1388			My research focuses on the development of novel cancer immunotherapy agents that can be used as a monotherapy or in combination with radiation therapy. I have a particular interest in exploiting the immunostimulatory effects of radiation including targeted radionuclide therapy to enhance the safety and efficacy of immunotherapy including adoptive cell therapy such CAR T cells.		Sodji, Quaovi	IR
Membership-86		Sodji-IR	Quaovi	Sodji	Imaging and Radiation Sciences	qsodji@wisc.edu	Human Oncology	6082623301			Assistant Professor		Core	23/11/2008	Pending	Cancer Prevention and Control	MD	JSOBECKI	0000-0001-6107-8408	Lisa Barroilhet, MD	Type: Grant Title: Bone Health and Osteoporosis Screening in Gynecologic Cancer Survivors Source: University of Wisconsin–Madison American Cancer Society (ACS) Total Award: $50000 Years of Award: May 1, 2022 - April 30, 2023 PI: Sobecki, J. N. Type: Grant Title: Bone Health and Osteoporosis Screening in Gynecologic Cancer Survivors Source: NIH Loan Repayment Program Total Award: $100000 Years of Award: July 1, 2022 - June 30, 2024 PI: Sobecki, J. N.	I am an active researcher in the area of gynecologic cancer survivorship and quality of life. I was also recently appointment as the Gyn DOT co-leader for Carbone Cancer Center.		Sobecki, Janelle	CPC
317		pmsondel@humonc.wisc.edu	Paul	Sondel	Developmental Therapeutics	pmsondel@humonc.wisc.edu	Pediatrics	608-263-9069	608-263-8556	https://www.cmp.wisc.edu/trainers/paul-sondel	Professor					Developmental Therapeutics	MD PhD	HONGTAOLUI		Christian Capitini	Source: Elsa U. Pardee Foundation Title: Identification of the Predictive Biomarkers in AML Patients Treated with Immunotherapy Amount: $129,150.00 Years: 1/1/2022 – 12/31/2023 PI: Hongtao Liu Effort: 10% Role: Project leader Summary This grant allows us to do the correlative studies using the patients samples enrolled on the national clinical trial. Source: N/A Title: DOD/Radiation Injury Treatment Network (RITN) Amount: $8000/year Years: 2019 to present PI: Hongtao Liu Effort: 2% Role: Program grant. As the medical director of the participating center Summary This grant supports University of Chicago to be part of RITN. The Radiation Injury Treatment Network® (RITN) prepares to respond to the medial surge resulting from a mass casualty incident with marrow toxic injuries. RITN Centers adopt, to the extent practical, the ARS treatment guidelines, donor selection criteria, data collection plan, and other related documents developed by the RITN Committees. RITN is a cooperative effort of the National Marrow Donor Program® (NMDP) and The American Society for Blood and Marrow Transplantation (ASBMT). Source: Ullman Scholar Award Title: Immune checkpoint inhibition will induce T cell activation against leukemia-specific antigens to eliminate minimal residual disease and maintain remission in AML patients Amount: Selected for funding $90,000/years x 2 years Years: 7/1/2016 to 6/30/2018, extended PI: Hongtao Liu Effort: 18% but no salary recovery Role: Project leader Summary This grant allows us to do correlative studies using the patients samples enrolled on the national clinical trial. Source: UCCCC pilot grant Title: Immunotherapy in AML using anti-PD-1 antibody, Nivolumab Amount: $35000 Years: 1/1/2016 to 12/31/2016, extended PI: Hongtao Liu Effort: 5% Role: Project leader Summary This grant supported the conduct of the investigator-initiated clinical trial	I chose the field of leukemia and stem cell transplant where my research background of immunology, signal transduction and molecular biology will make a difference. Since the completion of my fellowship in 2011, I have devoted myself in the clinical research in the field of leukemia, stem cell transplant and later cellular therapies. My research interests focus on exploring novel agents to treat leukemia, especially myeloid leukemia. I have extensive experience in conducting clinical research in the field of leukemia and stem cell transplantation. The trial of prophylactic donor lymphocyte infusion to prevent disease relapse after stem cell transplant for hematologic malignancies had been funded by Cancer Research Foundation young investigator award. I also developed conditioning regimen incorporating total marrow irradiation for second stem cell transplant. I have been the national PI of the NCI ETCTN 9706 trial in the past several years to test checkpoint inhibitor, nivolumab, to eradicate minimal residual disease in AML patients, which reached full enrollment at the end 2019 and the clinical results were presented at 2022 ASH meeting orally. In the long term, I envision myself as an independently funded clinical investigator with a focus on developing novel clinical trials especially immunotherapeutic or cellular therapy approaches for the treatment of hematologic malignancies.	23/02/2008 08:32 AM	Liu, Hongtao	DT
Membership-126		South-TM	Andrew	South	Tumor Microenvironment	apsouth@wisc.edu	Dermatology	6082629880		Pending	Professor		Core		Complete	Tumor Microenvironment	PhD	XGAO37	0000-0001-8520-5109	Jing Zhang; Emery Bresnick	NIDDK K01 Award ASH Fellow-to-Faculty Scholar Award Startup funds	The overarching goal of the research in my lab is to understand the functional roles of bone marrow microenvironment in regulating hematopoietic stem cells (HSCs) during normal, pre-malignant and malignant hematopoiesis. My current projects focus on three general areas: 1. understand the functions of nociceptive nerves in regulating HSC aging and blood cancers; 2. explore the contributions of aged bone marrow microenvironment to ASXL1-mutated pre-malignant clonal hematopoiesis; 3. investigate the roles of macrophages in the HSC niche and develop novel strategies to improve transplantation therapy for blood cancers. My laboratory combines in vivo and in vitro approaches, including molecular and cellular techniques, mouse models as well as patients-derived xenotransplantation models. Ultimately, we hope that our research will help inform the development of novel strategies to advance the diagnosis, prevention and treatment of blood cancers.	23/09/2008 10:37 AM	Gao, Xin	TM
318		rjspencer2@wisc.edu	Ryan	Spencer	Cancer Prevention and Control	rjspencer2@wisc.edu	Obstetrics and Gynecology	608-265-1700		http://www.obgyn.wisc.edu/directory/detail.aspx?id=186	Assistant Professor (CHS)					Tumor Microenvironment	MS PhD	virumbralesm	0000000336608651	Manish Patankar, David Beebe		I develop in vitro microfluidic models of the tumor microenvironment for translational research, with a specific focus on gynecological cancers, kidney, and breast.	23/12/2009 01:42 PM	Virumbrales-Muñoz, María	TM
320		megan.spurgeon@wisc.edu	Megan	Spurgeon	Human Cancer Virology	megan.spurgeon@wisc.edu	Oncology	608-262-6407		https://cancer.wisc.edu/research/staff/spurgeon-megan/	Assistant Professor					Genetic and Epigenetic Mechanism Virology	MS PhD	KAVIMEHTA	0000-0002-2582-073X	John Svaren	NIEHS The mutagenic consequences of replication-coupled DNA repair mechanisms, 4R00ES034058-02	Cells experience tens of thousands of DNA lesions per day that must be repaired to ensure that genetic stability is maintained. These lesions include base damage and strand breaks caused by environmental genotoxins as well as viral insult. My lab focuses on understanding the replication stress response and the mutagenic consequences of DNA-strand specific obstacles. Our goal is to provide a new context for understanding how endogenous and exogenous/environmental stresses including genotoxins including the small tumor virus HPV mutagenize DNA and how repair mechanisms maintain faithful replication. These studies have the potential to mechanistically inform future therapeutic interventions.		Mehta, Kavi	unaligned
321		rsridharan@discovery.wisc.edu	Rupa	Sridharan	Genetic and Epigenetic Mechanisms	rsridharan@discovery.wisc.edu	Cell and Regenerative Biology	608-316-4422		https://crb.wisc.edu/staff/sridharan-rupa/	Associate Professor					Genetic and Epigenetic Mechanism	PhD	MBRAND@OHRI.CA	orcid.org/0000-0001-8915-8012	colleague - Emery Bresnick	Cancer relevant funding prior to joining UW: “Deciphering the Molecular Mechanism of Acquired Resistance in Leukemia” Canadian Institutes of Health Research - Project Grant – MOP-89834 Duration: 5 years (04/01/2018-03/31/2023) Amount (total): $925,650 (CAD) Role: Lead PI (Effort 20%). Targeting the epigenetic state of refractory and relapsing acute myeloid leukemia” Canadian Institutes of Health Research Operating Grant: CEEHRC Epigenetics Clinical Translation Grants Duration: 4 years (02/01/2019-01/31/2023). Amount (total): $375,000 (CAD) (my share: $62,500) Role: Co-PI (Effort 2.5%). (Co-PIs include Drs W. Stanford (Lead), M. Brand, J-F. Couture, F.J. Dilworth, C. Ito) “Understanding the Mechanism of TLX1-induced T cell Acute Lymphoblastic Leukemia” Canadian Institutes of Health Research - Project Grant PJT 175303 Duration: 5 years (4/01/2021-3/31/2026). Amount (total): $937,125 (CAD) Role: Lead PI (Effort 20%).	Hematopoietic Stem cells have the capacity to differentiate along multiple lineages potentially giving rise to all cells present in the blood. This process is controlled by cell-specific and ubiquitously expressed transcription factors and cofactors. Defects in the transcriptional regulatory network of these cells can lead to leukemia. The major goal of the Brand laboratory is to decipher the molecular mechanism of hematopoietic stem cell differentiation such that we can understand how deregulation of this process can contribute to leukemia development. Towards this goal, we are using a multi-disciplinary approach that combines in vitro and in vivo techniques in both cell lines and primary human cells. These approaches include relative and absolute quantitative proteomics (isotope tagged methods), single cell multi-omics (CITEseq, TEAseq, sc-CUT&Tag, sc-RNAseq) and bioinformatics as well as patients-derived xenotransplantation models of leukemia and leukemia murine models.		Brand, Marjorie	GEM
322		kkeil@wisc.edu	Kimberly	Stietz	Tumor Microenvironment	kkeil@wisc.edu	Comparative Biosciences	608-265-2879		https://www.vetmed.wisc.edu/people/kkeil/	Assistant Professor					Imaging and Radiation	MD PhD	michaelveronesi	0000-0001-8551-151X	Dr. Howard Bailey	IIS with Blue Earth Diagnostics to study 18F-Fluciclovine and MR CEST in patients with brain metastases following radiation therapy and immunotherapy RSNA grant to study 18F-Fluroethyltyrosin and MR CEST in a rat GBM model prior to and after combination therapy.	As the Director of Neuro-Oncological Imaging within the University of Wisconsin (UW) Department of Radiology, my research program involves applying novel imaging technologies for the diagnosis and treatment of brain malignancies. In 2020 I began a PET/MRI program for imaging of patients with malignant brain tumors. My team became the first to integrate the use of the amino acid PET imaging agent, 18F-Fluoroethyltyrosine (FET), into routine clinical practice for management of patients with high grade glioma and brain metastases. Our recently accepted article in the Journal of Nuclear Medicine in 2023 by Smith et al. provides a full account of this program. This initiative has morphed into an academic-industry partnership intended for gaining FDA approval for use of 18F-FET for management of glioma patients in the United States. The success of this work has also led to another recently funded investigator-initiated study with Blue Earth Diagnostics on the use of 18F-Fluciclovine and MR chemical exchange saturation transfer for the diagnosis of recurrent brain metastases in patients following radioimmunotherapy. At UW, I am a co-investigator on a third PET agent, 68Ga-Fibroblast Activating Inhibitor (68Ga-FAPI) working with Dr. Ankush Bhatia (Neuro-Oncology) and Dr. Ali Pirasteh (Nuclear Medicine) to study the potential diagnostic use of 68Ga-FAPI for detection of glioblastoma in patients at UW. Pre-clinically, I am interested in the use of novel rodent models of glioblastoma and development of novel theranostic agents, which includes the study of quantitative imaging biomarkers using small animal PET/CT and PET/MRI. I am the PI of an active Research Scholar Grant from the Radiological Society of North America for developing neuroimaging biomarkers to assess novel combination therapies in a novel rat model of glioblastoma. My team and I published the precursor to this work in Frontiers in Oncology (Jackson et al., 2022).		Veronesi, Michael	IR
323		rstrigel@uwhealth.org	Roberta	Strigel	Imaging and Radiation Sciences	rstrigel@uwhealth.org	Radiology	608-263-9377		https://www.radiology.wisc.edu/profile/roberta-strigel-696/	Associate Professor (CHS)					Cancer Prevention and Control Imaging and Radiation	PhD	akuchnia	0000-0002-3418-0965	Perry Pickhardt and Howard Bailey	NIH NCATS KL2TR002374 Role: PI 7/1/2020 – 6/30/2024 Total direct costs: $400,000 Dedicated effort: 9 calendar months Title: Identification of muscle wasting and intervention targets using novel imaging-based measures of muscle quality. The goal of this project is to identify biomarkers of myosteatosis (i.e. muscle quality) that can be used to improve diagnosis and outcomes in clinical populations suffering from muscle wasting syndromes, including lung cancer and heart transplant.	My lab utilizes a translational research approach to understand the mechanisms involved in the pathogenesis of muscle wasting and its effect on clinical outcomes in aging and age-related diseases. In this pursuit, my lab has developed a clinical approach utilizing a combination of imaging techniques in human populations suffering from muscle wasting (e.g. cancer cachexia) to develop biomarkers capable of identifying risk of consequential outcomes. I have established expertise in various imaging techniques, including CT and MR, to describe muscle wasting in cancer cachexia. Utilizing sophisticated imaging and collaborating with a multidisciplinary team of researchers, I am committed to the early and accurate diagnosis of cancer cachexia, thereby improving quality of life and prognosis in those affected with cancer. As such, my research interests align with UWCCC's mission and programs listed above.		Kuchnia, Adam	CPC	TRUE
324		rtstriker@wisc.edu	Robert	Striker	Human Cancer Virology	rtstriker@wisc.edu	Medicine	608-263-2994	608-263-1545	http://www2.medicine.wisc.edu/home/people-search/people/staff/385/Striker_Robert/	Associate Professor					Developmental Therapeutics	DO	NPYTEL30	0000-0002-2853-9230	Christian Capitini, MD		My research is clinically focused on pediatric neuro-oncology in clinical trials and developmental therapeutics, particularly in molecularly targeted therapeutics based on personalized cancer biology. I am also interested in limiting potential brain tumor treatment-related toxicities and the quality of life issues that arise in our patient population.	24/05/2001 01:58 PM	Pytel, Nicholas	DT
Membership-109		Stuckert-DT	Austin	Stuckert	Developmental Therapeutics	astuckert@wisc.edu	Pediatrics	2624880499		https://www.pediatrics.wisc.edu/staff/stucker-md-austin/	Assistant Professor		Core		Pending	Cancer Prevention and Control	MD MPH			Lisa Barroilhet, Ellen Hartenbach		My research interests are two-fold: improving gynecologic cancer prevention and identifying novel methods for minimally invasive screening. As a gynecologic oncology fellow at the University of Wisconsin, I developed a droplet digital PCR assay for detection of circulating tumor HPV DNA in plasma in cervical cancer patients. Currently I am in the process of opening a pilot study to determine the clinical utility of plasma circulating tumor HPV DNA in HPV-associated cancers in diagnosing cancer, assessing response to treatment and detecting recurrence during the surveillance period.		Zhang, Ran Catherine	CPC	TRUE
325		sugden@oncology.wisc.edu	Bill	Sugden	Human Cancer Virology	sugden@oncology.wisc.edu	Oncology	608-262-1116		https://mcardle.wisc.edu/who-we-are/mcardle-faculty/bill-sugden-phd	Professor						BA MD	MHOOVERREGAN	0000-0002-6804-1218	Christian Capitini, MD	None	I enroll and monitor patients on Children's Oncology Group cooperative clinical trials, investigator initiated clinical trials within the Division of Pediatric Hematology/Oncology, and multi/limited institution clinical trials in which our division is involved. I also have an interest in quality of life and palliative medicine research.		Hoover-Regan, Margo	DT	TRUE
327		sureshm@svm.vetmed.wisc.edu	Marulasiddappa	Suresh	Tumor Microenvironment	sureshm@svm.vetmed.wisc.edu	Pathobiological Sciences	608-265-9791		http://www.vetmed.wisc.edu/people/sureshm/	Professor					Developmental Therapeutics	PhD	mebrown	0000-0003-1836-0218	Christian Capitini	NIH NIAID Broad Agency Announcement Contract (PI; Brown) 75N93021C00004 NIH NHLBI (PI; Capitini) 1R01HL153721-01A1 Industry-Sponsored SRA Taconic Biosciences (PI; Brown) MSN278672	Our research program focuses on the nexus of immunology and pluripotent stem cell (PSC) biology. We are evaluating the adaptive and innate immune cell responses to autologous and allogeneic PSC-derived cellular therapies. We have developed multiple cutting-edge humanized mouse models to study the in vivo immune response to these cells. We are also interested in patient-derived xenograft studies in humanized mouse models, as there are a number of fundamental immune processes with relevance to both cancer and transplantation biology.		Brown, Matthew	DT	TRUE
328		msussman@wisc.edu	Michael	Sussman	Genetic and Epigenetic Mechanisms	msussman@wisc.edu	Biomolecular Chemistry	608-262-8608		http://www.biochem.wisc.edu/faculty/sussman/	Professor					Genetic and Epigenetic Mechanism	MD	ABECK2	0000-0003-0592-9540	Dr. Lee Wilke	Start up funds from the Department of Surgery, UWCCC and UWSMPH	My current research is focused on understanding the genomic drivers of breast cancer risk in patients diagnosed with benign breast diseases, specifically LCIS, that lead to the eventual development of breast cancer and I feel fits well with the mission of the Genetic and Epigenetic Mechanism Program Area.		Beck, Anna	GEM	TRUE	Sam Poore MD PhD, Mark Burkard MD PhD, Stephanie McGregor MD PhD, Evie Carchman MD
329		aussie.suzuki@wisc.edu	Aussie	Suzuki	Genetic and Epigenetic Mechanisms	aussie.suzuki@wisc.edu	Oncology	608-262-1686		https://cancerbiology.wisc.edu/staff/suzuki-phd-aussie/	Assistant Professor					Tumor Microenvironment	PhD	JMBROCKMAN	0000000327753478	Dr. Jacob Notbohm, Pam Kreeger	American Cancer Society Institutional Review pilot award MSN228402	My goal is to create technologies to quantify and control the piconewton forces that cells transmit to their environment with a focus on understanding and controlling immune cell forces. Specifically, I seek to understand how T cell forces influence activation and cytotoxicity in the context of the tumor microenvironment, for example with changes in the extracellular matrix components, stiffness, or viscoelasticity. Additionally, I seek to understand whether T cell generated forces are required for the function of current immunotherapies (e.g. bispecific T cell engagers and chimeric antigen receptor T cell therapy).		Brockman, Joshua	TM	TRUE	Dr. Megan McClean, Dr. Kevin Eliceiri, Dr. Christian Franck, Dr. Randy Bartles
330		jpsvaren@wisc.edu	John	Svaren	Developmental Therapeutics	jpsvaren@wisc.edu	Comparative Biosciences	608-263-4246	608-263-4413	https://www.vetmed.wisc.edu/people/svaren/	Professor					Developmental Therapeutics	MD		0000-0001-8919-1189	Ryan Mattison, Kari Wisinski	Full industry funding and drug supply from Syndax Pharmaceuticals for IIT: Safety and Efficacy of Dual Menin and FLT3 Inhibition in Patients with Relapsed/Refractory FLT3-Mutated Acute Myeloid Leukemia Containing a Concurrent KMT2A-Rearrangement or NPM1 Mutation: A Phase 1 Study of SNDX-5613 + Gilteritinib Full industry funding and drug supply from Incyte Pharmaceuticals for IIT: Phase 1b/2 Study of Axatilimab + Azacitidine in Advanced Phase MPN, MPN/MDS Overlap or High-Risk CMML	I have an interest in early phase clinical trials studying novel therapies in patients with acute leukemias and myeloid malignancies. I developed three IIT concepts under the guidance of my mentor Dr. Borate during my time at Ohio State prior to coming to UW. Two of these are approved for full industry funding and drug supply, and one remains in development. We plan to open these studies at UW as well. I am interested in continuing to expand the clinical trial portfolio in the leukemia program here and continuing to grow as a clinical investigator. Joining the Developmental Therapeutics committee would provide skills and knowledge to help me achieve these goals.	24/10/2005 03:50 PM	Sahasrabudhe, Kieran	DT	TRUE	Vaishalee Kenkre, Hongtao Liu, Hamid Emamekhoo, and Erica Reinig
331		steve.swanson@wisc.edu	Steven	Swanson	Developmental Therapeutics	steve.swanson@wisc.edu	Pharmacy	608-262-1414		http://apps.pharmacy.wisc.edu/sopdir/steven_swanson/	Dean; Professor					Genetic and Epigenetic Mechanism	PhD	rblanc	0000-0001-7069-4085	Jeff Dilworth		Research Interests: My research centers on the inflammatory-driven epigenetic regulation of stem cell biology, particularly focusing on aging. While I was a junior faculty at the University of Rochester Medical Center (URMC), I worked extensively with Dr. Paula Vertino, Dr. Laura Calvi, and Dr. Brian Marples on cancer-related projects as a member of the Microenvironment Program at the Wilmot Cancer Center. My research primarily investigates how inflammation affects epigenetic erosion, leading to premature cell death upon loss of quiescence in stem cells. One of my significant projects, funded by the National Institute on Aging (NIA), explores targeting H4K20 methylation to rejuvenate the aged stem cell epigenome and improve regenerative function. My studies have demonstrated that epigenetic changes due to inflammation lead to the premature disruption of stem cell quiescence, causing irreversible loss of function and accelerated aging, such as impaired regeneration and sarcopenia. This research underscores the potential of preserving stem cell quiescence to improve radiotherapy outcomes, particularly in pediatric cancer survivors, a hypothesis supported by preliminary data from an R21 grant submission with Dr. Marples. Additionally, I was investigating the systemic effects of aerobic exercise on hematopoietic stem cell (HSC) clonality and niche remodeling in myelodysplastic syndromes (MDS) and leukemic models. This pilot project aimed to bridge aging research with cancer studies in collaboration with Dr. Alisson Yeh and Dr. Laura Calvi. Relevance to UW Carbone Center for Cancer Programs Given the numerous cellular and molecular parallels between cancer and aging, my research is highly relevant to the UW Carbone Center's mission to understand the molecular and cellular bases of cancer initiation and progression. My focus on inflammation-mediated epigenetic changes in stem cells during aging aligns with the Center's goal of elucidating the systemic impacts of cancer treatments on various tissues. My work on the long-term effects of radiotherapy on muscle stem cells and the potential to improve therapeutic outcomes by preserving stem cell quiescence directly contributes to advancing cancer treatment strategies. Furthermore, my interest in combining computational and machine-learning methodologies with molecular biology and mouse genetics offers innovative approaches to uncovering systemic interactions between diverse stem cell compartments. This interdisciplinary perspective can significantly enhance our understanding of the aging immune and skeletal systems post-cancer treatments and the links between musculoskeletal degeneration and hematological disorders. Joining the Carbone Center will provide a collaborative environment to further my research on the systemic impacts of aging and cancer, fostering new insights and therapeutic interventions that align with the Center's objectives.	24/12/2006 09:28 AM	Blanc, Romeo	GEM	TRUE	As a newly hired faculty, my chair Dr. Wellik and I have decided to wait a few months before forming a mentoring committee. I am eager to get to know my colleagues further and I am open to any suggestion from this reviewing committee.
Membership-136		Swietlik-IR	John	Swietlik	Imaging and Radiation Sciences	jswietlik@uwhealth.org	Radiology	6082031448		https://radiology.wisc.edu/profile/john-swietlik-2478/	Assistant Professor		Affiliate		Complete	Developmental Therapeutics	PhD	OSORIOJE	0000-0002-7474-6150	Krishanu Saha	Characterization of the mutational landscape and identification of biomarkers of 4 types of cancer of interest and present in Antioquia through next-generation sequencing (Government of Colombia)	Novel vaccines and Therapeutics.		Osorio, Jorge	DT	TRUE
332		tamplin@wisc.edu	Owen	Tamplin	Tumor Microenvironment	tamplin@wisc.edu	Cell and Regenerative Biology	608-890-0938		https://crb.wisc.edu/staff/tamplin-owen/	Assistant Professor					Cancer Prevention and Control	MPH PhD	phungmt	https://orcid.org/0000-0002-3573-4501	Collaborator	Risk-reducing Salpingectomy for Ovarian Cancer Precision Prevention Role: Principal Investigator Source: Prevent Cancer Foundation Total direct cost: $100,000 2024-2026 The major goal of this project is to obtain the perspectives from people who have different risk levels of ovarian cancer and ovarian cancer survivors on risk-reducing salpingectomy for ovarian cancer prevention. Optimization of a Risk Stratification Model for Ovarian Cancer Role: Co-Investigator Principal Investigator: Celeste Leigh Pearce, PhD Source: Department of Defense Pilot Award Total direct cost: $300,000 2024-2026 The major goals of this project are to define a risk threshold that is actionable for risk-reducing salpingectomy for ovarian cancer prevention among people with average risk of the disease based on the perspectives of healthcare providers, ovarian cancer survivors, and people at risk of the disease as well as a cost-effectiveness analysis for this procedure.	I am a cancer epidemiologist whose research interests span across the cancer continuum, including cancer etiology, prevention, and survivorship. My research has focused on (1) establishing new population-based studies to collect primary data to study cancer risk and survivorship, (2) developing and validating models for precision medicine in cancer, and implementing these models into clinical practice; (3) partnering with communities to develop and implement evidence-based and scalable interventions to improve cancer screening and health equity in underserved populations. My research has specifically focused on women’s cancers, including breast, cervical, endometrial, and ovarian cancers. My research interests are well aligned with the goal of the Cancer Prevention & Control Program's mission, which is to reduce the burden of cancer through improved prevention, early detection and survival.	24/01/2008 02:02 PM	Phung, Minh Tung	CPC	TRUE	Amy Trentham-Dietz, Shaneda Warren Andersen, Lisa Barroilhet
333		weiping.tang@wisc.edu	Weiping	Tang	Developmental Therapeutics	weiping.tang@wisc.edu	Pharmacy	608-890-1846		https://apps.pharmacy.wisc.edu/sopdir/weiping_tang/	Professor					Tumor Microenvironment	PhD	79382189	0000-0003-3064-7342	Jacob Notbohm		Overarching theme of our group is microscale soft robots for size-matched and spatiotemporally resolved physical and biochemical manipulation of cells and tissues, with applications in experimental modeling of tumor microenvironment, manufacturing cellular therapies for solid tumors, and developing synthetic therapeutic carriers with enhanced intratumoral penetration.		Alapan, Yunus	TM	TRUE	Christian Franck Melih Eriten
Membership-131		Taylor-TM	Amy	Taylor	Tumor Microenvironment	ataylor@medicine.wisc.edu	Department of Medicine, Division of Hematology, Medical Oncology, and Palliative Care	6088902696			Assistant Professor		Core		Complete	Tumor Microenvironment	MD	rdavi112	0000-0001-9592-932X	Susan Thibeault	None (planning to apply for Head and Neck SPORE Career Enhancement Pilot)	My research program studies the intersection of the laryngeal microenvironment, local immune response, and extracellular matrix remodeling, to develop novel targeted treatments for voice and airway disorders. Specifically relevant to the UWCCC TM program I am currently interested in studying the microenvironment of laryngeal leukoplakia and its progression to laryngeal cancer.		Davis, Ruth	TM	TRUE	Nathan Welham, David Andes, Evie Carchman, Sam Poore, Susan Thibeault
335		thibeault@surgery.wisc.edu	Susan	Thibeault	Developmental Therapeutics	thibeault@surgery.wisc.edu	Surgery	608-263-6751	608-263-0121	http://www.surgery.wisc.edu/profile/susan-thibeault	Professor					Developmental Therapeutics	MD MS	stuckerta	000-0002-5938-7495	Christian Capitini	N/A	As a physician-scientist in the Pediatric Hematology-Oncology-BMT Department at the University of Wisconsin and American Family Children's Hospital, I strive to identify promising pre-clinical therapies and adapt them into clinical practice. My focus is in pediatric neuro-oncology, immunotherapeutic approaches, and early phase clinical trial design. I have close collaborations with leaders in the field of neuro-oncology, immunotherapy, and genomic and precision medicine. Through a number of diverse academic pursuits, I am building the clinical and research expertise to develop translational projects that will improve therapeutic options for patients with difficult to treat brain and spinal cord tumors. My ultimate career goal is to become an independent, translational physician scientist developing novel clinical trials as well as an improved understanding of molecular drivers of pediatric brain tumors with the purpose of improving outcomes for our patients.	24/05/2009 09:54 AM	Stuckert, Austin	DT	TRUE	TBD
338		rstibbetts@facstaff.wisc.edu	Randal	Tibbetts	Imaging and Radiation Sciences	rstibbetts@facstaff.wisc.edu	Human Oncology	608-262-0027	608-262-0332	https://www.humonc.wisc.edu/team_member/randal-tibbetts-phd/	Professor					Tumor Microenvironment	PhD	MAI_NGO	https://orcid.org/0000-0002-2459-1701	Eric Shusta (colleague and mentor)	As a new assistant professor, I am currently on start-up funding. I intend to apply to the following foundations/funding mechanisms related to cancer during the academic year: Breast Cancer Research Alliance, Elsa U Pardee Foundation, American Cancer Society, METAvivor, and Rita Allen Scholars	Broadly, my lab is interested in developing and using tissue-engineered models of the tumor microenvironment in order to study how cell-cell communication and extracellular matrix cues influence tumor initiation and progression. My graduate work in Brendan Harley’s lab at the University of Illinois Urbana-Champaign focused on developing vascularized biomaterials in order to investigate how vascular signaling influences glioblastoma progression and therapeutic response. My postdoctoral work was performed in Christopher Chen’s lab at Boston University; while my postdoctoral training did not focus explicitly on cancer, I gained skills in utilizing molecular biology tools for genetic manipulation and developing perfused microfluidic models of vascularized tissues. At UW–Madison, I will leverage my prior research training to study brain metastasis. Specifically, I will investigate how cell-cell interactions within the primary tumor influence the ability for tumor cells to metastasize to the brain. Additionally, I am interested in investigating the mechanisms by which chemotherapy and radiation may lead to alterations in the brain microenvironment that lead to disease recurrence. Finally, within the brain microenvironment itself, I will investigate how paracrine signaling and extracellular matrix cues influence the behavior of tumor cells that have extravasated across the blood-brain barrier. Collectively, my research interests align with the Tumor Microenvironment program area within the UWCCC. However, I am also interested in collaborating with other program areas within the UWCCC in order to further our collective understanding of cancer biology, as well as position engineered tissue models as valuable tools for developing and screening new therapeutics.	24/06/2010 11:08 AM	Ngo, Mai	TM	TRUE	Eric Shusta (committee chair), Sean Palecek, David Lynn, John Yin
395		PTiwari9@wisc.edu	Pallavi	Tiwari	Imaging and Radiation Sciences	PTiwari9@wisc.edu	Radiology		Tiwari	https://radiology.wisc.edu/profile/pallavi-tiwari-2631/	Associate Professor		Core		Complete	Developmental Therapeutics Tumor Microenvironment	PhD	weaversr	0000-0001-6034-214X	Janelle Sobecki		My research program is based on the molecular mechanisms underlying bone and cartilage regeneration. Shortly after beginning at UW this fall, I was approached by Janelle Sobecki, MD in Gynecologic Oncology, who is leading a clinical project examining ovarian cancer and associated therapies' effects on bone. As I bring in an expertise in basic bone biology, Dr. Sobecki and I are planning on translating some of her clinical studies from patients undergoing treatment for ovarian cancer into rodents in my laboratory. In my lab, we will use these pre-clinical rodent models to examine the cellular and molecular effects of ovarian cancer and ovarian cancer therapies on aberrant bone turnover and low bone mass with the goal of optimizing treatment strategies for patients.	24/09/2010 03:37 PM	Weaver, Samantha	DT	TRUE	Lisa Arendt, Troy Hornberger, Deneen Wellik
340		trentham@wisc.edu	Amy	Trentham-Dietz	Cancer Prevention and Control	trentham@wisc.edu	Population Health Sciences	608-265-4175		http://pophealth.wisc.edu/amy-trentham-dietz	Professor					Cancer Prevention and Control	MD	HKATHURIA	0000-0002-9062-409X	Michael Fiore	Source: NIH R01 Award Number: R01 HL156851 Title: Implementing Effective Pharmacotherapy for Hospitalized Smokers with Cardiopulmonary Disease Years: 3/15/2022-03/14/2027 PI: Quinn Pack, MD Effort: 10% Role: PI Subaward Summary To test in a parallel-group implementation-effectiveness RCT if hospital-based tobacco treatment increases smoking cessation rates and is cost effective Source: NIH R01 Grant number: R01 HL175602-01 Title: Longitudinal Effects of E-cigarette Use on Cardiovascular and Pulmonary Health Years: 07/2024 - 06/2029 PI: Baker/Stein Effort: 5% Role: Co-investigator Summary To quantify the effects of long-term ENDS use on biomarkers of cardiovascular and pulmonary disease and how they are influenced by use heaviness, age, body weight, and co-use of other products	My research program aims to reduce tobacco treatment disparities in socioeconomically disadvantaged populations. I have expertise in implementing research studies within clinical care settings and conducting intervention trials within lung cancer screening and safety-net environments. My mixed methods and implementation studies include clinical settings with high representation of individuals experiencing tobacco-related health disparities, ensuring interventions reach those disproportionately affected by tobacco.		Kathuria, Hasmeena	CPC	TRUE
341		nvuboha@medicine.wisc.edu	Nataliya	Uboha	Developmental Therapeutics	nvuboha@medicine.wisc.edu	Medicine	608-265-9966		http://www.uwhealth.org/findadoctor/profile/nataliya-v-uboha-md-phd/10070	Assistant Professor (CHS)					Developmental Therapeutics	PhD			Dudley Lamming	NIH-NIA U01AG081482 NIH-NIA R21 AG083782 NIH-NIA 1R01AG064951 NIH-NIA U01 AG076941 NIH-NIA R01 AG064951 AFAR/Hevolution New Investigator Award	My work focuses on age associated diseases. We are currently testing the utility of repurposing the drug class of mTOR inhibitors to combat the development of chronic conditions and expand healthspan.	24/07/2011 04:01 PM	Konopka, Adam	DT	TRUE
344		tvarghese@wisc.edu	Tomy	Varghese	Imaging and Radiation Sciences	tvarghese@wisc.edu	Medical Physics	608-265-8797		http://www.medphysics.wisc.edu/directory/varghese.php	Professor					Cancer Prevention and Control	PhD	SHENG_J	https://orcid.org/0000-0003-0911-2423	Lisa Cadmus-Bertram	University of Wisconsin–Madison School of Nursing Sheng (PI) 01/01/2024 – 12/31/2025 Exploring the feasibility of leveraging physical activity to reduce breast cancer risk in Asian American women	My research is highly relevant to the Cancer Prevention and Control program at UWCCC. I focus on health behaviors, lifestyle modifications, and community-based interventions to reduce cancer risk and promote health among ethnic minority populations. My work on early detection, diagnosis, and improving quality of life for cancer patients aligns with the program's goals. Additionally, I incorporate biomarker data to understand cancer mechanisms and use health tracking technology to develop innovative prevention strategies. My interdisciplinary approach ensures that cancer prevention efforts are effective and culturally sensitive.	24/05/2012 10:47 AM	Sheng, Jingxi	CPC	TRUE	Lisa C. Bratzke; Anne L. Ersig
Membership-94		Veronesi-IR	Michael	Veronesi	Imaging and Radiation Sciences	mveronesi@wisc.edu	Radiology			https://radiology.wisc.edu/profile/michael-veronesi-2779/	Assoc Prof, Radiology in the Neuroradiology Section and Director of Neuro-oncological imaging		Core		Complete	Imaging and Radiation	Other (MD Equivalent)		0000 0002 9057 5910	Christian Capitini	N/A	I am a sub-investigator on all COG applicable to the pediatric hematology/oncology population. Additionally, I will be PI/Sub-I on protocols pertinent to vascular anomalies as we expand our program of targeted therapies for this population.	24/09/2012 12:19 PM	Mc Dermott, Sarah	DT	TRUE	Christian Capitini, Lisa Arkin, Ryan McAdams
346		cmvezina@wisc.edu	Chad	Vezina	Developmental Therapeutics	cmvezina@wisc.edu	Comparative Biosciences	608-890-3235	608-890-3236	http://www.vetmed.wisc.edu/people/cmvezina/	Professor					Imaging and Radiation	PhD	12411089	https://orcid.org/0000-0003-4573-4406	Brian Pogue	Title: Cherenkov Excited Luminescence Molecular Sensing (CELMS) Source: NIH R01 Total Award: $2.3M Award Dates: 12/2023 – 11/2027 PI: Brian Pogue and Sergei Vinogradov Candidate’s Role: Co-I Percent Effort: 6.25% Description: Oxygen and pH sensing within tissue using high-energy radiation beams Title: Oxygen dynamics in FLASH radiotherapy Source: NIH R01 Total Award: $2.5M Award Dates: 06/2023 – 05/2028 PI: Brian Pogue and Sergei Vinogradov Candidate’s Role: Co-I Percent Effort: 5% Description: Investigate dependence of oxygen in FLASH radiotherapy Title: Traceability in Medical X-ray Imaging Dosimetry (TraMeXI) Source: Euramet Total Award: $1.1M Award Dates: 09/2022 – 09/2025 PI: Paula Toroi Candidate’s Role: Key Stakeholder Percent Effort: 0% Description: X-ray multimeter calibration for international dose standardization	My research is primarily in novel methods of dose measurement and radiation detector design. I am collaborating with Brian Pogue and perform measurements on the Mobetron electron accelerator for FLASH dosimetry.		Culberson, Wesley	IR	TRUE
Membership-90		Virumbrales-Muñoz-TM	María	Virumbrales-Muñoz	Tumor Microenvironment	virumbralesm@wisc.edu	Obstetrics and Gynecology	6084244156		I am currently working on my UW website. Happy to provide link once it is ready. Same with the headshot, although I am providing a preliminary one for now.	Assistant Professor		Core		Pending	Imaging and Radiation	PhD	AUKHAN49	https://orcid.org/0000-0002-0340-572X	Brian Pogue		My research area includes advancing radiation dosimetry methods for emerging radiation therapy techniques such as FLASH radiotherapy or radiopharmaceutical therapy. These modalities have great clinical translational potential to advance the treatment of cancers.		Khan, Ahtesham Ullah	IR	TRUE	The committee will be assigned after the start date
348		swallace9@wisc.edu	Sumer	Wallace	Cancer Prevention and Control	swallace9@wisc.edu	Obstetrics and Gynecology	608-263-1210		https://www.uwhealth.org/findadoctor/profile/sumer-k-wallace-md/10635	Assistant Professor (CHS)					Cancer Prevention and Control	PhD	chengua	https://orcid.org/0000-0002-9314-2037	Michael Newton	Title: CP-CTNet Coordinating Center Major Goals: Frontier Science & Technology Research Foundation, Inc. (FSTRF) proposes to collaborate with Dr. KyungMann Kim and others to perform data management tasks in support of the Cancer Prevention Clinical Trials Network (CP-CTNet): Data Management, Auditing, and Coordinating Center (DMACC). Project Number: 1U24CA242637 Name of PD/PI: Kim, KyungMann Project/Proposal Start and End Date: (MM/YYYY) (if available): 09/2019-07/2024 My role: Co-I Title: Identifying Colorectal Cancer Screening Strategies in Rural Communities Major Goals: The goals of this grant are to characterize healthcare system and clinic factors that distinguish high- from lower-performing rural primary care clinics across the upper Midwest and identify successful CRC screening strategies used in high-performing clinics that can be disseminated to lower-performing rural clinics. Project Number: ACS RSG-20-128-01-CPPB Name of PD/PI: Weiss, Jennifer Source of Support: American Cancer Society Project/Proposal Start and End Date: (MM/YYYY) (if available): 07/2021-06/2025 My role: Co-I	My research is deeply aligned with the mission of the UWCCC Carbone Cancer Center through its focus on precision medicine and individualized treatment strategies that are critical to advancing cancer care. For example, my work on developing novel statistical methods for estimating individualized treatment rules (ITRs) has been directly applied to cancer treatment, including our analysis of Tamoxifen therapy that identified TSPAN8 as a potential biomarker for personalized breast cancer treatment. Additionally, as a co-investigator on the NIH-funded Cancer Prevention Clinical Trials Network Coordinating Center (U24CA242637), I have provided essential statistical support in designing and analyzing clinical trials aimed at cancer prevention. Together with my contributions to developing generalizable risk prediction models using -omics and EHR data, my research not only addresses key methodological challenges in precision medicine but also supports the center’s goal of improving cancer outcomes through tailored therapeutic interventions.		Chen, Guanhua	CPC	TRUE
349		ecward@wisc.edu	Earlise	Ward	Cancer Prevention and Control	ecward@wisc.edu	Nursing	608-263-0745		https://nursing.wisc.edu/staff/ward-earlise/	Associate Professor					Cancer Prevention and Control Imaging and Radiation Tumor Microenvironment	PhD	AARUSHIBHARGAVA	0000-0003-0340-2681	Kevin Eliceiri	None	Ultrasound-based technologies, particularly histotripsy, are gaining momentum as promising non-invasive treatments for cancer. Histotripsy, a form of acoustic cavitation, involves the rapid nucleation, growth, and collapse of bubbles under focused ultrasound waves. This collapsing bubble induces high strain in nearby tissues, leading to their fractionation. This method has already received FDA approval for liver cancer treatment and is currently being tested in clinical trials for other cancers, including those of the pancreas, kidney, and breast. Building on my previous work, which explored histotripsy for ablation of fibrous blood clots and the study of fibrin network alterations, my current research focuses on utilizing this technology to disrupt collagen-rich extracellular matrices. These matrices, particularly in the tumor microenvironment, play a crucial role in tumor progression and metastasis. I aim to understand how the physical modification of collagen via cavitation affects cellular behavior, with particular attention to tumor-associated macrophages. The ultimate goal of my work is to leverage acoustic cavitation techniques to engineer the extracellular matrix morphology and mechanical properties. By controlling these matrix alterations, we hope to influence cellular responses, potentially providing new non-invasive therapeutic avenues for cancer treatment, including immune modulation.		Bhargava, Aarushi	IR	TRUE	Kevin Eliceiri, Chris Brace, William L Murphy, Jacob Notbohm
350		snandersen@wisc.edu	Shaneda	Warren Andersen	Cancer Prevention and Control	snandersen@wisc.edu	Population Health Sciences	608-265-9993		https://pophealth.wisc.edu/news/welcome-shaneda-warren-andersen	Assistant Professor					Developmental Therapeutics Tumor Microenvironment	MPH PhD	MSHOSSAN	0000-0001-6136-6741	Jeremy D. Kratz	Applied, waiting for the decisions.	My research is highly aligned with the UW Carbone Cancer Center (UWCCC) programs, particularly in the areas of Developmental Therapeutics, Tumor Microenvironment, and Precision Medicine. As a Scientist II at the University of Wisconsin–Madison, my work focuses on patient-derived 3D organoid models, tumor-immune interactions, and drug discovery in pancreatic and hepatobiliary cancers. These efforts directly support UWCCC’s mission to develop translational and precision oncology approaches that can be rapidly integrated into clinical practice. Within the Developmental Therapeutics Program, I investigate novel therapeutic strategies by integrating high-throughput drug screening, CRISPR-based gene editing, and multi-drug synergy studies to identify effective combination therapies for resistant tumors. My research on tumor microenvironment (TME) modulation and ECM stiffness is particularly relevant to Tumor Microenvironment Program, as it seeks to understand how cancer cells respond to biochemical and biophysical cues that drive malignancy and therapeutic resistance. Additionally, my work in engineering synthetic hydrogel matrices to mimic physiological TME conditions contributes to Precision Medicine efforts, enabling personalized treatment predictions for pancreatic and biliary tract cancers. These models serve as ex vivo platforms to evaluate individualized responses to chemotherapeutics and targeted agents, bridging the gap between laboratory research and patient-specific treatment strategies. Through interdisciplinary collaborations, mentorship, and grant development, I aim to contribute to UWCCC’s leadership in translational oncology and support its commitment to improving cancer patient outcomes through scientific innovation. My research complements existing efforts within UWCCC and provides novel experimental platforms for testing and optimizing emerging cancer therapeutics.	25/06/2003 11:47 PM	Hossan, Md Shahadat	DT	TRUE	I am an academic Scietist II
351		dawassarman@facstaff.wisc.edu	David	Wassarman	Imaging and Radiation Sciences	dawassarman@facstaff.wisc.edu	Genetics	608-262-6648		https://genetics.wisc.edu/staff/wassarman-david/	Professor					Virology	MD PhD	ALBAILEY	0000-0002-6560-9680			I am interested in understanding the molecular, cellular, and organismal biology of RNA viruses, including human viruses associated with increased risk of cancer development.		Bailey, Adam	VR	TRUE	Andy Mehle, David Evans, David Yang, William Rehrauer
353		baweaver@wisc.edu	Beth	Weaver	Developmental Therapeutics	baweaver@wisc.edu	Cell and Regenerative Biology	608-263-5309		https://crb.wisc.edu/staff/weaver-beth/	Associate Professor					Cancer Prevention and Control Developmental Therapeutics Imaging and Radiation	PhD	eboros1		by invitation (Capitini)	d) Source of Support: National Institute of Health, NIBIB Grant Number: R01EB032349 Title: Harnessing scandium chelation chemistry for the development of radiopharmaceuticals Total Award Period Covered: 08/15/22-08/14/26 Total Amount (Direct): $1,034,612 Person Months Effort: 0.5 calendar month effort Goals of Project: The major goals of this application are the development of scandium coordination chemistry to enable the successful development and translation of scandium-based radiopharmaceuticals. g) Source of Support: National Institute of Health, NIBIB Grant Number: R21EB030071-01A1 Title: Cherenkov luminescence mediated excitation of discrete lanthanide optical probes Total Award Period Covered: 04/01/21 – 12/30/2025 Total Amount (Direct): $400,000 Person Months Effort: 0.5 calendar month effort Goals of Project: This proposal aims to develop in vivo compatible, lanthanide-based optical probes combined with Cherenkov emissive radioactive isotopes for the targeted imaging of cancer	I develop imaging and therapy tools with applications in cancer diagnosis (nuclear, optical) and therapy (radiotherapy and targeted therapy)		Boros, Eszter	IR	TRUE
Membership-111		Weaver-DT	Samantha	Weaver	Developmental Therapeutics	srweaver@wisc.edu	Comparative Biosciences	504120434		https://www.vetmed.wisc.edu/people/samantha-weaver/	Assistant Professor		Affiliate	24/08/2011	Complete	Tumor Microenvironment	BS MS PhD	AHEATON	0000-0003-4144-5535	Melissa Skala and Paul Sondel	none	My research is highly relevant to the Tumor Microenvironment and Developmental Therapeutics Programs. For the last 5+ years I have worked on TME focused mouse models of oncology – initiating new collaborations with many other UWCCC labs, including Paul Sondel, Manish Patankar, Lixin Rui, and Huy Dinh. I am particularly interested in immune and tumor cell interactions, phenotype, and metabolic changes as well as collagen structural changes that occur during immunotherapy. I study these changes using in vivo single cell mouse optical imaging technology and correlate our imaging findings to flow cytometry, histology, and single cell sequencing assays. To propel this work, I have characterized and validated novel transgenic mouse models that contain labeled immune cells for clear in vivo tracking and imaging. In parallel, I monitor collagen and other microenvironmental changes using label free second harmonic generation imaging. I am particularly focused on immunologically cold tumors including melanoma and neuroblastoma. Throughout this work, I focus on deep understanding of new drug combinations at the single cell level. All these projects are applicable to both the Tumor Microenvironment and Developmental Therapeutics Programs.		Heaton, Alexa	TM	TRUE	not applicable
354		webers@surgery.wisc.edu	Sharon	Weber	Developmental Therapeutics	webers@surgery.wisc.edu	Surgery	608-265-0500		https://www.surgery.wisc.edu/staff/sharon-weber/	Professor					Imaging and Radiation	PhD	jhannan	0000-0002-8469-8105	William Ricke, David Jarrard	Idea Development Award; Department of Defense; Prostate Cancer Research Program (PCRP) Title: Novel SDF-1 mRNA therapy for prostatic radiation-induced erectile dysfunction Role: Principal Investigator (25% effort) Total Budget: $ 1,161,618 Support Period: 03/24/2023 – 03/23/2026 R01 Research Project Grant; NIH NIDDK (DK132425) Title: Localized SDF-1 mRNA nanoparticle delivery for treating erectile dysfunction Role: Co-Principal Investigator (20% effort; Co-PI: Jung Soo Suk, University of Maryland) Total Budget: $ 2,046,606 Support Period: 05/01/2022 – 04/30/2026	The overall goal of my research is to improve bladder and sexual dysfunction in all cancer survivors so they can have a high quality of life. Sexual and bladder dysfunction significantly impact the quality of life of patients with chronic illnesses and cancer survivors. Cancer patients value quality of life over length of life and frequently rate both sexual function and bladder continence as primary concerns over mortality when selecting treatment options. We have developed novel male and female models of pelvic radiation-induced urogenital dysfunction to allow us to examine the pathophysiological mechanisms impacting vascular and neuronal supply and pelvic organ function. Additionally, we also use an established preclinical model of pelvic nerve injury which mimics radical prostatectomy-induced neuropathy and erectile dysfunction. While there have been key discoveries improving symptoms of erectile dysfunction (ED) and bladder overactivity, these therapies do not prevent or reverse the underlying disease pathology. We are exploring novel delivery mechanisms to administer therapeutics to mitigate the adverse side effects of radiation (DOD IDEA) and pelvic nerve injury (NIH R01). We also work closely with a radiation oncologist and biomedical engineer at Mt Sinai in developing a hydrogel that can help mitigate the adverse vaginal tissue damage post-radiation. We believe that our findings will help cancer survivors be free of burdensome underlying treatment side effects and improve their quality of life.	25/03/2004 09:18 AM	Hannan, Johanna	IR	TRUE
Membership-65		Weber-GEM	Jesse	Weber	Unaligned	jnweber2@wisc.edu	Integrative Biology	6082626391		https://weberlab.integrativebiology.wisc.edu/	Assistant Professor		Affiliate		Complete	Tumor Microenvironment	PhD	APSOUTH	0000-0001-7650-0835		National Cancer Institute of the National Institutes of Health, Award No. R01 CA244522 “Tissue Damage-Driven Squamous Cell Carcinoma” $1,784,250 January 2021 - December 2025 National Institute of Arthritis, Musculoskeletal and Skin Diseases Research, the National Institutes of Health, Award No. R01 AR082944 “The role of collagen VII in extracellular matrix protein secretion” $1,716,000 June 2024-May 2028 EB Research Partnership, “Targeted Therapies for Junctional and Kindler Epidermolysis Bullosa-Associated Squamous Cell Carcinoma.” $163,522 May 2025-April 2026 Cure EB, “APOBEC inhibition for RDEB SCC prevention”, $173,405 May 2025 - September 2027	The long-term goal of my laboratory is to elucidate driving mechanisms of squamous cell carcinoma (SCC) amenable to preventative or curative intervention. One approach to achieving this goal is to study rare familial prone disorders that can inform on more common cancer. For the past 20 years, I have been working to understand aggressive SCC occurring in patients with the genetic skin blistering disease recessive dystrophic epidermolysis bullosa (RDEB) and determining pathways that intersect aggressive forms of sporadic SCC, primarily in the head and neck (HNSCC). Central to this work is understanding how the complex molecular and cellular outcomes of tissue damage drive initiation and progression of SCC. To do this, I utilize a wide variety of approaches that range from primary human cells to murine models, encompassing genetics, molecular biology and biochemistry, to obtain a comprehensive understanding of the driving malignant processes. I have identified APOBEC mutagenesis and the tumor microenvironment as key drivers of SCC in both RDEB and head and neck SCC with relevance to all SCC. I bring to the cancer center a number of mouse models of inducible human APOBEC enzyme expression as well as expertise in cancer genomics and primary cell culture from multiple tissues, principally stratifying epithelia and SCC but also breast tissue. My work is translational and has led to a clinical trial in Europe and the United States of an experimental PLK1 inhibitor to treat SCC arising in patients with RDEB (NCT03786237, NCT04177498) and the first two patients to receive drug have had a complete response after 6 months.	25/05/2004 11:29 AM	South, Andrew	TM	TRUE
355		mvwegner@wisc.edu	Mark	Wegner	Cancer Prevention and Control	mvwegner@wisc.edu	Population Health Sciences	608-267-3835		https://pophealth.wisc.edu/mark-wegner	Adjunct Associate Professor					Imaging and Radiation	PhD	OREILLYSH		Carri Glide-Hurst		A large portion of my research background is related to radiation therapy in combination with the use of advanced imaging techniques which I believe would be relevant to the "Imaging and Radiation" program. My current research specializes in the use of dual energy computed tomography for proton therapy dose calculation. I have a research background in the use of functional imaging for thoracic radiotherapy as well. Additionally, I will be working on the novel upright CT system for the new proton therapy center at UW Eastpark.		O'Reilly, Shannon	IR	TRUE
356		jweichert@uwhealth.org	Jamey	Weichert	Imaging and Radiation Sciences	jweichert@uwhealth.org	Radiology	608-265-0835		https://www.radiology.wisc.edu/profile/jamey-weichert-63/	Professor					Cancer Prevention and Control	PhD					To identify the contributors related to healthcare access/utilization, patter of care, and prognosis for a variety of cancer types using multiple large-scale datasets and develop prediction tool using machine learning methods.		Zhu, Ping	CPC	TRUE
358		jmw@medicine.wisc.edu	Jennifer	Weiss	Cancer Prevention and Control	jmw@medicine.wisc.edu	Medicine	608-263-4034		http://www.uwhealth.org/findadoctor/profile/jennifer-m-weiss-md/7890	Associate Professor					Imaging and Radiation	PhD	markpagel	0000-0002-8109-3995	Brian Pogue, Chair, Department of Medical Physics	R01 CA269354, “Magnetic Resonance Fingerprinting of Tumor Vascular Perfusion and Acidosis”, 04/01/2022 – 03/31/2027, Co-PI.	Molecular imaging of the tumor microenvironment, including pre-clinical and clinical imaging of solid tumors for a variety of cancer types.	25/01/2005 12:40 PM	Pagel, Marty	IR	TRUE	Not applicable. As a side note, I have often served as a mentor or career coach for early career researchers, often organically than through a formal program. I wold look forward to this role to help early career cancer center members.
360		wellik@wisc.edu	Deneen	Wellik	Genetic and Epigenetic Mechanisms	wellik@wisc.edu	Cell and Regenerative Biology	608-262-5491		https://stemcells.wisc.edu/staff/wellik-deneen-m/	Department Chairperson; Professor						MD		https://orcid.org/0009-0006-9887-3054				25/02/2005 11:53 AM	Serritella, Anthony (Tony)	DT	TRUE	Joshua Lang, Nataliya Uboha, Dusty Deming
Membership-148		Wells-DT	Leah	Wells	Developmental Therapeutics	lewells@medicine.wisc.edu	Department of Internal Medicine, Division of Hematology, Medical Oncology, and Palliative Care	2293920319		https://www.medicine.wisc.edu/directory/wells_leah	Assistant Professor		Core		Complete	Cancer Prevention and Control	MA PhD	Shellie_Ellis	0000-0002-3599-0804	CPC leadership	TEAMSPORT to Community TEAMSPORT: Validating and Adapting a Precision Oncology Reflex Testing Team Intervention to Reduce Rural Disparities in Cancer Care Delivery	My primary focus of research is cancer care delivery. I am testing an intervention I designed to increase somatic testing for cancer patients in community oncology programs via an NCI-funded R01. I also pioneered the application of implementation science to cancer clinical trial recruitment and created an intervention for use among community urology practices. I have two pending projects, one of which is part of a multi-institutional P01 to improve use and quality of active surveillance among favorable-risk prostate cancer patients.		Ellis, Shellie	CPC	TRUE
Membership47		Wentland-IR	Andrew	Wentland	Imaging and Radiation Sciences	alwentland@wisc.edu	Radiology			https://radiology.wisc.edu/profile/andrew-wentland-453/	Assistant Professor		Affiliate	22/11/2002	Complete	Genetic and Epigenetic Mechanism	PhD	PL2147	0000-0001-5655-2259	Emery Bresnick; Wei Xu	University of Wisconsin Carbone Cancer Center Support Grant, Cancer Informatics Shared Resource (P30CA014520, Sub-Project ID 9864)	As a long-time team member of Cancer Informatics Shared Resource at UWCCC, I have been providing bioinformatics support for more than 20 UWCCC research groups in the past 10 years. Many of the groups are from the GEM program, including those of Drs. Emery Bresnick, Wei Xu, Xuan Pan, Dan Matson, Tony Gitter, Irene Ong, and Colin Dewey. Of all the aforementioned GEM groups, I have co-authored papers in peer-reviewed journal and received funding from their research grants.		LIU, PENG	GEM	TRUE	N/A
361		u.wesley@neurosurgery.wisc.edu	Umadevi	Wesley	Tumor Microenvironment	u.wesley@neurosurgery.wisc.edu	Neurological Surgery	608-262-7962	608-263-1410	https://ntp.neuroscience.wisc.edu/staff/wesely-umadevi/	Distinguished Scientist					Cancer Prevention and Control Imaging and Radiation	MBA MD MS	STOPHLEE	0000-0002-8185-7721	Scott Reeder, Christian Capitini, Amy Trentham-Dietz	NIH/NCI grants: R37CA240403, R01CA266377, R01CA262023, P01CA154292	Breast cancer screening, artificial intelligence in medical imaging, health disparities, population health	25/12/2006 02:26 PM	Lee, Christoph	IR	TRUE
362		rpw@medicine.wisc.edu	Ryan	Westergaard	Human Cancer Virology	rpw@medicine.wisc.edu	Medicine	608-265-7927		https://www.medicine.wisc.edu/people-search/people/staff/1066/Westergaard_Ryan	Associate Professor					Imaging and Radiation	MD	78923445	0000-0002-7180-794X	Paul Laeseke and Timothy Ziemlewicz	Current: Title: CSP #2023 - Preventing Liver Cancer Mortality through Imaging with Ultrasound vs. MRI (PREMIUM) Award Dates: September 2022 - December 2032 Agency: VA Office of Research and Development Cooperative Studies Program Total Award: $3,356,809 PI: George N. Ioannou Role (if not PI): Lead Site Investigator Description: Multi-center research trial of surveillance for hepatocellular carcinoma (HCC). The goal of PREMIUM is to compare an abbreviated version of the diagnostic gold standard for HCC (aMRI) +AFP to the standard-of-care screening (US+AFP) in patients at high risk of developing HCC. We hypothesize that HCC will be detected at earlier stages, allowing for more curative treatments and resulting in a reduction in HCC-related mortality. Percent of Effort: <5% Salary Support: Previously 1/8th of VA salary Title: Targeted Pancreatic Histotripsy via a Cone Beam CT Targeting System (R&D 2305-005) Award Dates: 08/01/23 – 08/01/26 Agency: University of Wisconsin – Department of Radiology and Medical Physics Total Award: $18,582 PI: John Swietlik Description: Preclinical animal study designed for comparison and optimization of pancreatic targeting for histotripsy using ultrasound and Cone Beam CT (aim 1) and characterization of pancreatic and peripancreatic tissue response post treatment (aim 2). Percent of Effort: <5% Salary Support: Pending Proposals: Title: Real-world evaluation of the HistoSonics Edison® System for treatment of liver tumors across multidisciplinary users BOOMBOX: Master Study Award Dates: TBD Agency: Industry (Histosonics, Inc.) Total Award: $10,100.00 (expected) PI: John Swietlik Description: To collect prospective information on the use of the HistoSonics Edison® System for the treatment of liver tumors. Percent of Effort: <5% Salary Support: PI compensation within budget. Title: Combination therapy using durvalumab and histotripsy for treatment of intrahepatic cholangiocarcinoma (CODAH trial) Award Dates: TBD Agency: Industry (Histosonics, Inc.) Total Award: $319,729.14 (expected) PI: John Swietlik Description: To gain knowledge regarding the efficacy and safety of combination immunotherapy with histotripsy for intrahepatic cholangiocarcinoma iCCA). 12 patients will undergo histotripsy while on maintenance Durvalumab to assess for increased T-Cell activity and infiltration and establish safety of combination histotripsy therapy with immunotherapy. Percent of Effort: <10% Salary Support: PI compensation within budget.	My research interests align nicely with Aim 1 of the Imaging & Radiation Sciences Program, with a focus on optimizing diagnosis of malignancy through imaging, and to develop innovative minimally invasive image-guided therapies to improve the outcomes for patients with cancer. I have research experience with both preclinical and clinical cancer studies and routinely perform cancer treatments in my practice as an Interventional Radiologist at UW. Over the last 8 years I have been a part of the tumor ablation lab at the University of Wisconsin and have participated in numerous large animal laboratory studies on translational research, including multiple GLP-compliant swine studies. More recently my research has focused on the development and clinical translation of histotripsy, a novel cancer treatment technique with an expanding role in interventional oncology therapy. My work in histotripsy has involved application of the therapy to multiple organ systems, variation in treatment parameters to improve efficacy and safety, and the development of a novel CBCT based targeting system for histotripsy targeting. Additionally, over the last 2 years I have served as the site PI for the National VA study CSP-PREMIUM2023, designed to compare an abbreviated MRI to current standard-of-care screening (US+AFP) in patients at high risk of developing HCC with the hope of detecting HCC earlier and ultimately improving HCC-related mortality. I have leveraged my preclinical and clinical knowledge of histotripsy with my recent experience as site PI for a clinical trial and have subsequently designed an investigator-initiated trial and obtained industry funding to further the use and understanding of histotripsy as a liver directed therapy to continue to improve cancer treatment outcomes.	25/02/2007 01:36 PM	Swietlik, John	IR	TRUE	Paul Laeseke MD, PhD Timothy Ziemlewicz MD Michael Woods MD
363		dlwheeler@wisc.edu	Deric	Wheeler	Imaging and Radiation Sciences	dlwheeler@wisc.edu	Human Oncology	608-262-7837		http://www.humonc.wisc.edu/index.php/Deric_L._Wheeler	Associate Professor					Tumor Microenvironment	BS MS PhD	ASAMARASINGHE	0000-0002-3104-2823			I study pulmonary immunology as it pertains to asthma and respiratory infections. There is a significant correlation between the development between chronic inflammation and remodeling/injury repair to subsequent lung cancer. There are projects in the laboratory that pertain to hematopoietic stem cells that may play a role in this transition from health to disease.	25/01/2008 04:39 PM	Samarasinghe, Amali	TM	TRUE	Not applicable
364		wilke@surgery.wisc.edu	Lee	Wilke	Tumor Microenvironment	wilke@surgery.wisc.edu	Surgery	608-265-5852		http://www.surgery.wisc.edu/profile/lee-wilke	Professor					Cancer Prevention and Control	MD PhD	KLDITTUS	0009-0000-9919-2281		no independent research funding currently	I am interested in lifestyle interventions for individuals with cancer and integrative approaches for dealing with cancer and cancer treatment related side effects.		Dittus, Kim	CPC	TRUE
365		williams@medicine.wisc.edu	Eliot	Williams	Developmental Therapeutics	williams@medicine.wisc.edu	Medicine	608-265-0861		https://www.medicine.wisc.edu/people-search/people/staff/332/Williams_Eliot	Professor													Salkowski, Lonie
366		kbwisinski@medicine.wisc.edu	Kari	Wisinski	Developmental Therapeutics	kbwisinski@medicine.wisc.edu	Medicine	608-262-2876		https://www.uwhealth.org/findadoctor/profile/kari-b-wisinski-md/8310	Associate Professor (CHS)													Tiwari, Pallavi
Membership57		Witzenburg-TM	Colleen	Witzenburg	Tumor Microenvironment	witzenburg@wisc.edu	Biomedical Engineering	6088903332		https://cbl.engr.wisc.edu/ https://directory.engr.wisc.edu/bme/Faculty/Witzenburg_Colleen/	Assistant Professor		Affiliate		Complete									Kerr, Sheena
368		jpwoods@wisc.edu	Jon	Woods	Tumor Microenvironment	jpwoods@wisc.edu	Medical Microbiology and Immunology	608-265-6292		https://mmi.wisc.edu/staff/woods-jon/	Professor					Tumor Microenvironment	PhD	0000-0003-0805-8103	duchuynguyen	Pam Kreeger, David Beebe	My lab is funded by startup.	Both of my previous work and current research are highly relevant to the UWCCC program, especially in the area of tumor microenvironment. In my previous work, I focused on engineering in vitro models to reconstitute angiogenesis, a critical process that supports tumor growth and survival. Additionally, I investigated the interactions between pancreatic ductal adenocarcinoma (PDAC) and blood vessels. Our study identified a key role for Activin-ALK7 signaling in endothelial cell ablation within the PDAC microenvironment, providing a mechanistic explanation for PDAC’s uniquely hypovascular nature. My current work builds upon my expertise in vascular biology and organ-on-chip technologies. A central focus of my laboratory is vascular engineering within 3D organ-on-chip platforms, not only to sustain tissue viability, but also enable the study of dynamic interactions between vascular and tissue-resident cells across physiological and pathological conditions. While these vascularized systems are applicable across various organs, my present work centers on the liver, with an emphasis on liver biology and diseases such as metabolic dysfunction-associated steatotic liver disease (MASLD) and liver cancer which affect a substantial portion of the US population.	25/08/2010 03:00 AM	Nguyen, Duc-Huy	TM	TRUE	William Murphy, Kevin Eliceiri, Megan McClean
369		xing@oncology.wisc.edu	Yongna	Xing	Developmental Therapeutics	xing@oncology.wisc.edu	Oncology	608-262-8376	608-262-1989	https://mcardle.wisc.edu/xing/	Associate Professor					Cancer Prevention and Control	BS PharmD	Needs updating through affiliation with UW–Madison	https://orcid.org/0000-0001-9489-0224	Paul Hutson and Noelle Loconte	None	My research focuses have been based on team-based care delivery and barriers to effective use of anticancer treatment for individuals with cancer. This has including research and publications on the 1) role and documented value of the oncology pharmacist; 2) interprofessional team-based care; 3) cannabis use and outcomes; 4) cancer screening and risk reduction; 5) optimal pretreatment screening; 6) documentation of supportive care outcomes; and 7) shared decision making. These research focuses seem to align with the thematic aims of the Cancer Prevention & Control program: prevention & biomarkers and cancer care delivery		Holle, Lisa	CPC	TRUE
Membership36		Xu-unaligned	Jin	Xu	Tumor Microenvironment	jxu3@wisc.edu	Pathology and Laboratory Medicine			https://www.uwhealth.org/providers/jin-xu-md	Assistant professor		Affiliate		Complete	Imaging and Radiation	MD PhD	melarson3	0000000211256760	Steve Cho		I have several research interests relevant to the mission of the Carbone Cancer Center. I am trained in both nuclear medicine/molecular imaging and neuroradiology. As such, I am interested in pursuing imaging projects that further the diagnosis and characterization of malignancies in the CNS, including but not limited to meningioma, glioma, and metastatic disease. Through my background in nuclear medicine, I am interested in theranostic agents for cancer imaging and treatment. To that end, I currently serve as an authorized user and participate in many ongoing clinical trials. I also participate in cancer imaging through the UWCCC Cancer Research Imaging Core, and plan to take on a leadership role within CRIC.		Larson, Matthew	unaligned	TRUE	Louis Hinshaw Tess Chapman Vivek Prabhakaran
371		yxu@dermatology.wisc.edu	Yaohui	Xu	Developmental Therapeutics	yxu@dermatology.wisc.edu	Oncology	608-265-5540	608-262-9834	https://www.uwhealth.org/findadoctor/profile/yaohui-xu-md-phd/8054	Associate Professor (CHS)					Imaging and Radiation	PhD	14351308	0000-0002-5291-5662		AWD-100305, Dosimetry calculations of 86/90Y-NM600 in Patients with Metastatic Cancer AGR00011017, Dosimetry Calculations of 111In-ART-101 In Patients with Metastatic Cancer FP00015049, Chemical-shift-encoded MRI for active bone marrow dosimetry in radiopharmaceutical therapy, (in contracting phase) AWD-100696, Siemens Reserach Collaboration	I am actively involved in research focused on advanced imaging technologies such as spectral computed tomograph and chemical shift encoded MRI, and their use to enhance cancer therapies. The imaging tools we have can be better optimized and utilized to provide previously unavailable information to clinicians to better inform them on how to achieve both effective and safe treatments for patients	25/05/2011 12:38 PM	Lawless, Michael	unaligned	TRUE
370		wxu@oncology.wisc.edu	Wei	Xu	Genetic and Epigenetic Mechanisms	wxu@oncology.wisc.edu	Oncology	608-265-5540	608-262-9834	https://mcardle.wisc.edu/who-we-are/mcardle-faculty/wei-xu-phd	Professor					Developmental Therapeutics	MD	CHERYLCZERLANIS		Kari Wisinski		Lung cancer therapeutics and lung cancer screening	25/08/2010 05:27 PM	Czerlanis, Cheryl	DT	TRUE	N/A
372		dtyang@wisc.edu	David	Yang	Developmental Therapeutics	dtyang@wisc.edu	Pathology and Laboratory Medicine	608-263-5965	608-354-4793	https://pathology.wisc.edu/staff/yang-david/	Professor (CHS)					Developmental Therapeutics	MD	78993265	orcid.org/0000-0003-4559-4159		Source: University of Wisconsin Department of Medicine Title: Career Development Supplemental Pilot Award Amount: $30,000 Years: 2024 – 2028 PI: Amy Taylor, MD Effort: 0% Role: PI Summary: Supplemental award designed to support my DoD physician research career development award. Source: Department of Defense Prostate Cancer Research Program: Physician Research Training Award: HT94252410305 Title: A Liquid Biopsy Approach to Address Racial Disparities in Prostate Cancer Amount: $750,000 Years: 2024 – 2028 PI: Amy Taylor, MD Effort: 50% Role: PI Summary: Career development award with mentorship from Drs. Lang, Heath, and Yamoah to lead a multi-institution collaborative study of liquid biopsy applications in diverse patient populations to better elucidate molecular drivers of disease and identify novel therapies and patterns of treatment resistance in patients with metastatic prostate cancer. Source: Wisconsin Partnership Program Title: A pan-cancer AI-driven cell-free DNA sequencing platform for reducing disparities in early diagnosis, molecular characterization, and surveillance of multiple cancer types Amount: $600,000 Years: 2024 – 2027 PI: Joshua Lang, MD, MS Effort: 0% Role: Collaborator Summary: In this proposal, we will conduct a prospective study of molecular testing via liquid biopsy in patients with cancer to develop a novel cfDNA platform accessible to the entire UW system and state of Wisconsin. We propose to assess barriers to molecular testing access and will implement this novel strategy to increase adoption rates of molecular testing and education regarding testing strategies to both patients and providers. We will additionally test a transformative cfDNA platform that includes promoters as well as cancer gene exons for the simultaneous assessment of clinically actionable DNA alterations and fragmentomics to better guide treatment selection and detect cancer recurrence. Source: Prostate Cancer Foundation Mark & Debbie Attanasio Young Investigator Award Title: Eliminating Disparities in Molecular Testing with Comprehensive Liquid Biopsy Analysis Amount: $250,000 Years: 2023 – 2026 PI: Amy Taylor, MD Effort: 0% Role: PI Summary: This project will provide rationale for longitudinal liquid biopsy analysis in the management of prostate cancer and will establish an approach that serves to eliminate disparities in access to molecular testing for Black or African American patients with prostate cancer. Additionally, this project will identify blood-based biomarkers that are predictive of treatment resistance and will be the first large multi-institution study to evaluate molecular drivers of treatment resistance in this patient population.	I conduct translational research that utilizes liquid biopsy technologies to identify molecular targets for therapeutic study for genitourinary malignancies.	25/02/2005 08:21 AM	Taylor, Amy	TM	TRUE	Joshua Lang, George Zhao
373		filiz.yesilkoy@wisc.edu	Filiz	Yesilkoy	Tumor Microenvironment	filiz.yesilkoy@wisc.edu	Biomedical Engineering	608-262-5112		https://yesilkoylab.bme.wisc.edu/	Assistant Professor					Cancer Prevention and Control	MD MPH	7052408	0000-0003-0031-5988	Kari Wisinski	Source: National Cancer Institute R01 CA Title: Symptom Monitoring Using Patient-Reported Outcomes to Optimize Medication Use (SyMPTOM) Amount: $3,280,937 Dates: 8/6/24 – 7/31/29 PI: Flynn/Neuner Effort: 15.2% (mandated 17% cut to reach this) Role: Multiple Principal Investigator. Purpose: SyMPTOM is a randomized controlled trial to test whether clinical pharmacy teams can improve patient adherence to daily adjuvant endocrine therapy using routinely collected patient-reported symptom data and pharmacist support to manage symptoms. Source: Department of Defense E01-HT9452310654 Title: Chemotherapy Dosing in Patients with Obesity: Are Oncologists Optimally Balancing Risks and Benefits to Avoid Overtreatment and Undertreatment? Amount $2,310,000 Dates: 07/01/2023 – 06/30/2027 PI: Neuner/Schroeder Effort: 25% Role: Multiple Principal Investigator. Purpose: To examine real-world breast cancer chemotherapy dosing, its variation by weight, comorbidity, age and other factors, and the association of dosing with mortality. We will use data from 13 large cancer centers, and will use Oaxaca decomposition and advanced regression modeling to explore differences in dosing and mortality between groups. Source: NCI K01CA125414 Title: Micro-randomized Trial of a Physical Activity Intervention to Manage Pain Symptoms Among Older Cancer Survivors Amount: $805,220 Dates: 09/2022 – 08/2027 PI: Morelli Effort: 0% Role: Mentor. Purpose: To develop and test the timing of physical activity promotion messages to increase physical activity and reduce pain symptoms among older cancer survivors who experience chronic pain symptoms using a micro-randomized trial design. Source: Advancing a Healthier Wisconsin Endowment Title: Understanding the Role of Mammographic Quality in Wisconsin’s Breast Cancer Disparities Amount: $2,500,000 Dates: 04/01/21 – 03/30/26 PI: Joan Neuner, Beth Brunner and Tommi Thompson Effort: 20% Role: PI (MPI with community MPIs Beth Brunner and Tommi Thompson). Purpose: To develop collaborative infrastructure, pilot test and ultimately implement a sustainable measurement strategy for measuring and improving mammographic quality across multiple health systems.	My interest in cancer health delivery and cancer outcomes fit well with aim 3 of the program. As desdribed in my grants above, my current research is related to the provision of care, including provider- and system-factors, with the goal of enhancing quality of care throughout the cancer continuum	25/10/2009 09:49 AM	Neuner, Joan	CPC	TRUE	n/a
374		yin@engr.wisc.edu	John	Yin	Human Cancer Virology	yin@engr.wisc.edu	Chemical and Biological Engineering	608-316-4323	608-316-4325	http://www.engr.wisc.edu/che/faculty/yin_john.html	Professor					Imaging and Radiation	MD PhD	wzhou02	0009-0007-1236-5970	Pallavi Tiwari	Radiological Society of North America (RSNA) Fellow Research Grant	My long-term clinical and research interests center on cancer imaging and therapeutics. My goal is to develop a precision imaging-focused research program that translates synergistic advances in multimodality anatomical imaging, computational data science, and biologically-guided PET radiopharmaceuticals into innovative solutions that personalize all aspects of cancer diagnosis and treatment. I believe the scope of my research areas is well-aligned with the programmatic priorities of the UW Carbone Cancer Center and the larger UW Health enterprise. I look forward to joining as a member of the UW Carbone Cancer Center and partnering with researchers on innovative cancer treatment and research.		Zhou, Wenhui	unaligned	TRUE	Pallavi Tiwari, Christoph Lee, Amy Fowler, Kari Wisinski
376		zafars@surgery.wisc.edu	Syed Nabeel	Zafar	Cancer Prevention and Control	zafars@surgery.wisc.edu	Surgery	608-890-4152		https://www.surgery.wisc.edu/staff/nabeel-zafar/	Assistant Professor (CHS)					Imaging and Radiation	MD PhD	melarson3	0000000211256760	Steve Cho		I have several research interests relevant to the mission of the Carbone Cancer Center. I am trained in both nuclear medicine/molecular imaging and neuroradiology. As such, I am interested in pursuing imaging projects that further the diagnosis and characterization of malignancies in the CNS, including but not limited to meningioma, glioma, and metastatic disease. Through my background in nuclear medicine, I am interested in theranostic agents for cancer imaging and treatment. To that end, I currently serve as an authorized user and participate in many ongoing clinical trials. I also participate in cancer imaging through the UWCCC Cancer Research Imaging Core, and plan to take on a leadership role within CRIC.		Larson, Matthew	unaligned	TRUE	Louis Hinshaw Tess Chapman Vivek Prabhakaran
378		zhang@oncology.wisc.edu	Jing	Zhang	Developmental Therapeutics	zhang@oncology.wisc.edu	Oncology	608-263-1147	608-263-1150	https://mcardle.wisc.edu/who-we-are/mcardle-faculty/jing-zhang-phd	Professor					Developmental Therapeutics	MD			Nataliya Uboha, Toby Campbell, Cheryl Czerlanis		my research focus is the development and promotion of novel therapeutics and treatment strategies in thoracic malignancies. I also aim to find ways of prognosticating outcomes/predicting response to therapies in thoracic malignancies, all with the intent of improving outcomes and feeding back into novel therapeutics/treatment strategy development.		Wells, Leah	DT	TRUE	Nataliya Uboha (Chair), Toby Campbell, Vaishalee Kenkre, Andrew Baschnagel
Membership-98		Zhang-CPC	Ran Catherine	Zhang	Cancer Prevention and Control	ran.c.zhang@wisc.edu	Obstetrics and Gynecology			https://www.obgyn.wisc.edu/Directory/Profile/rzhang396wi	Gynecologic Oncologist		Affiliate	24/09/2002	Complete	Imaging and Radiation	PhD	10177635	0000-0002-1208-0568	Wes Culberson	R37 CA226518-01A1 R01 HL153720-01A1	My primary research is in proton radiotherapy modeling, optimization, and device development. I also have interests and clinical research projects in photon radiotherapy treatments involving adaptive therapy, image processing and deformable registration, stereotactic radiosurgery, and treatment of ventricular tachycardia.		Hill, Patrick	unaligned	TRUE
380		shgzhao@humonc.wisc.edu	Shuang	Zhao	Imaging and Radiation Sciences	shgzhao@humonc.wisc.edu	Oncology			https://www.humonc.wisc.edu/team_member/shuang-george-zhao-md/	Assistant Professor					Cancer Prevention and Control Genetic and Epigenetic Mechanism	PhD	skop30	0000-0003-3522-4939	Paul Lambert	1R21MH138941-01, WARF Accelerator	My research as a biomedical scientist at UW–Madison and co-founder of aMBR Genomics is closely aligned with the translational mission and innovative research focus of both programs in the Carbone Cancer Center. My laboratory is focused on the biology and clinical potential of midbody remnants (MBRs)—a unique class of translation-competent extracellular vesicles with emerging significance in cancer development and progression. Our translational pipeline leverages omics, imaging, and bioinformatic approaches to characterize MBRs and identify novel biomarkers for cancer detection and risk stratification. In parallel, my company, aMBR Genomics, develops technologies for liquid biopsy applications, with an emphasis on scalable platforms for early cancer detection and precision oncology.		Skop, Ahna	CPC	TRUE
381		wzhong3@wisc.edu	Weixiong	Zhong	Cancer Prevention and Control	wzhong3@wisc.edu	Pathology and Laboratory Medicine			https://www.uwhealth.org/findadoctor/profile/weixiong-zhong-md-phd/8014	Associate Professor					Tumor Microenvironment	MD	7790582	0000-0002-5732-4589	Glen Kwon	DOD, HT94252410543, Cell-Matrix Interactions Promoting Idiopathic Pulmonary Fibrosis Wisconsin Partnership Program, AWD-100712, The role of O-GlcNAcylation in the development of Idiopathic Pulmonary Fibrosis ICTR Pilot, AWD-004161, Development of a high-resolution ex vivo drug discovery platform for Idiopathic Pulmonary Fibrosis (IPF) using spatial transcriptomics DOM Pilot, GF000024025, Development of a high-resolution ex vivo drug discovery platform for Idiopathic Pulmonary Fibrosis (IPF) using spatial transcriptomics	Our research interest is to understand the mechanisms involved in the development of pulmonary fibrosis with the hope of discovering new ways to treat this very deadly and irreversible disease. One area of focus for us is the hexosamine biosynthetic pathway, a nutrient sensing pathway that is upregulated when the body has a need for metabolic reprogramming. This reprograming is required during the development of fibrosis as well as in most if not all cancers, where there is rapid growth. Therefore, our research findings, although we are investigating pulmonary fibrosis, can provide valuable data for use in cancer research. In addition, we extensively utilize the UW CCC TRIP lab, the TSB BioBank, the SAIRF, and the Flow Lab.	25/11/2011 04:14 PM	Sandbo, Nathan	TM	TRUE	n/a
Membership-145		Zhou-unaligned	Wenhui	Zhou	Imaging and Radiation Sciences	wzhou282@wisc.edu	Radiology	5109121027		https://radiology.wisc.edu/profile/wenhui-zhou-3182/	Assistant Professor		Affiliate		Complete	Developmental Therapeutics Imaging and Radiation Sciences	MD	78247269	0000-0003-4722-6026	Bryan Bednarz, PhD; John Swietlik, MD	Earli, Inc, Redwood City, CA Total Award: $904,327 PI: Ali Pirasteh, MD Role: Co-Principal Investigator Swine Models of Chronic and Inducible Tumors Percent Effort: 10% PENDING GRANTS: NIH R01 (submitted October 2025) Total Award: $3,789,238 Role: PI Title: Characterization of a Novel Porcine Lung Adenocarcinoma Model for Biodistribution Assessment and Radiobiological Modeling of 90Yttrium Radioembolization Therapy Percent Effort: 25% NIH STTR (submitted Sept 2025) Total Award: $239,630 PI: Tanja Dominko Role: Co-Investigator Title: Establishing Commercial Potential of the Wisconsin Miniature Swine (WMS)-Oncopig Pancreatic Ductal Adenocarcinoma Model” Percent of Effort: 1.6%	My specific clinical area of interest is on improving outcomes for patients with hepatocellular carcinoma and primary and metastatic lung cancer. My specific research interests include the use of translational large animal cancer models, specifically the Oncopig cancer model, to improve delivery, dosimetry, and efficacy/safety of transarterial Yttrium-90 for treatment of lung and liver cancer.	26/02/2002 09:57 AM	Niemeyer, Matthew	unaligned	TRUE
Membership-129		Zhu-CPC	Ping	Zhu	Cancer Prevention and Control	pzhu34@wisc.edu	Department of Surgery	8329416126			Health Services Scientist		Affiliate		Complete	Imaging and Radiation Sciences	MA MD			Tim Ziemlewicz, MD	HistoSonics, Inc: Funding for 3 studies including 2 prospective clinical trials and 1 pre-clinical animal study.	My research is focused on thermal and non-thermal techniques for tumor destruction. I am a part of the Tumor Ablation Clinical Program and Lab. We are conducting several prospective studies on histotripsy and I also participate in pre-clinical studies of histotripsy. I am the Director of the Interventional MRI where we perform prostate cryoablation are actively investigating this program for its impact on prostate cancer related care. I am the chief and member of the Interventional Radiology section where one of our pillars of treatment and research is Interventional Oncology. We provide Y90 and TACE procedures for active disease but are also involved in central venous access and palliative therapies for cancer patients. We are actively involved in multiple studies with our oncology collaborators. A partnership with the cancer center will help advance our oncologic mission in IR. It will allow us to partner with other providers within the cancer center and share resources across disciplines. We would especially like to partner for clinical trials and prospective protocols for new and innovative treatments.		Knavel Koepsel, Erica	unaligned	TRUE
382		tziemlewicz@uwhealth.org	Timothy	Ziemlewicz	Imaging and Radiation Sciences	tziemlewicz@uwhealth.org	Radiology	608-263-9028		https://radiology.wisc.edu/profile/timothy-ziemlewicz-658/	Associate Professor (CHS)						MD				Short Titles- LUGANO (PI); GALLOP (PI); Home OCT-Guided Treatment vs Treat and Extend for the Management of Neovascular AMD (CI); A Randomized Clinical Trial Evaluating Intravitreal Faricimab (6.0 mg) Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of Visual Acuity Loss due to Radiation Retinopathy (CI); UW19023 (SI); UW23027 (SI); CLARICO (SI)			Crabtree, Gordon	DT	TRUE	Dr. Jonathan Chang; Dr. Mark Albertini; Dr. Jen Larson
Row ID	Picture	Primary Column	First Name	Last Name	Program	Email	Department	Phone Number 1	Phone Number 2	Website	Title	Tags	Decision	Meeting Date	Status	Requested Program	Credentials/Degrees	eRA Commons ID	ORCID	Referral	Active Grants/Awards	Research Interest	Created	Ln Fn	Program Abb	Finalize	Mentor committee